{
    "0": {
        "summary": "There is inadequate evidence to draw strong conclusions on the efficacy or safety of the drug interventions included in this review. There is some low quality evidence from a meta-analysis of two studies investigating urokinase (various strengths) and some very low evidence from two single studies investigating alteplase 2 mg/2 mL that suggest that these two drug interventions may be effective in treating withdrawal or total occlusion of CVC lumens caused by thrombosis. Further high quality, sufficiently powered research is still required to look at the efficacy and safety of urokinase, alteplase and other chemical, surgical and drug interventions for treating CVC lumen occlusion. Research studies which exclusively include child participants are especially warranted.",
        "model_output": "[/INST]  The studies summarized in this document investigate the use of various fibrinolytic agents, including alfimeprase, r-UK, and urokinase, to treat occluded central venous access devices (CVADs) in patients with cancer. The studies show that these agents are effective in restoring patency to occluded CVADs, with varying doses and concentrations yielding different results.\n\nKey findings:\n\n1. Alfimeprase is a novel-acting fibrin degradation agent that directly dissolves thrombi without the need for plasminogen activation. In a phase II trial, alfimeprase was found to be more effective than placebo in restoring patency to occluded CVADs within 15 minutes of treatment.\n2. Dose-ranging trials with r-UK showed that a 5,000 IU/mL concentration was superior to placebo in restoring patency to occluded CVADs, with no significant difference between the 15,000 IU/mL and 25,000 IU/mL concentrations.\n3. Urokinase was found to be superior to placebo in restoring patency to occluded CVADs in a double-blind, placebo-controlled trial. The 2 mg/mL dose of t-PA was more effective than the 1 mg/mL dose in restoring catheter function.\n4. Low-dose urokinase infusions were found to be effective in restoring function to fibrin-occluded CVADs in cancer patients, with the addition of heparin not enhancing the efficacy of the infusions.\n\nOverall, these studies suggest that fibrinolytic agents, including alfimeprase, r-UK, and urokinase, are effective in restoring patency to occluded CVADs in patients with cancer. However, the optimal dose and concentration of these agents may vary depending on the specific patient population and the duration of occlusion. Further research is needed to determine the long-term safety and efficacy of these agents in clinical practice.",
        "eval": "1"
    },
    "1": {
        "summary": "Administration of systemic prophylactic antibiotics for PEG tube placement reduces peristomal infection.",
        "model_output": "[/INST] , , , , , , , , , , , , , , , , , ,,,,,,, ,,, , , , ,, , ,    , , , , , , , , , ,               , , , , , , , , , , , , , , , ,   ,             , ,   ,      , , , , , , , , , , ,     ,      ,   , , , , ,   , ,             , , ,                   ,            , , , , ,                                                                                     , ,                                                                                                                  ,       ,                         ,",
        "eval": "0"
    },
    "2": {
        "summary": "Intensive interventions, unsuited to primary care or population prevention programmes, provide only minimal reductions in blood pressure during long-term trials. Further evaluations to assess effects on morbidity and mortality outcomes are needed for populations as a whole and for patients with elevated blood pressure.\nA low sodium diet may help in maintenance of lower blood pressure following withdrawal of antihypertensives. If this is confirmed, with no increase in cardiovascular events, then targeting of comprehensive dietary and behavioural programmes in patients with elevated blood pressure requiring drug treatment would be justified.",
        "model_output": "[/INST] \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \u0409 \u0409 \u0409 \u0409\n\n\n\n\n \u0409 \u0409 \n \n \u0409 \u0409",
        "eval": "0"
    },
    "3": {
        "summary": "The pregnancy rate was found to be higher when GnRHa was used in a long protocol as compared to a short or ultrashort protocol. There was no evidence of a difference in live birth rate, but this outcome was only reported by three studies. There was no evidence of a difference in the outcomes amongst various long protocols; nor that stopping or reducing GnRHa at the start of stimulation was associated with a reduced pregnancy rate. For all comparison, except a long versus short protocol, there was a lack of power.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "4": {
        "summary": "The available evidence indicates some beneficial effects with second-generation antipsychotics, mood stabilisers, and dietary supplementation by omega-3 fatty acids. However, these are mostly based on single study effect estimates. Antidepressants are not widely supported for BPD treatment, but may be helpful in the presence of comorbid conditions. Total BPD severity was not significantly influenced by any drug. No promising results are available for the core BPD symptoms of chronic feelings of emptiness, identity disturbance and abandonment. Conclusions have to be drawn carefully in the light of several limitations of the RCT evidence that constrain applicability to everyday clinical settings (among others, patients' characteristics and duration of interventions and observation periods).",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "5": {
        "summary": "There is some evidence that a vein cuff at the distal anastomosis site improves primary graft patency rates for below knee PTFE graft, but this does not reduce the risk of limb loss. Evidence for this beneficial effect of vein cuffed PTFE grafts is weak and based on an underpowered trial. Pre-cuffed PTFE grafts have comparable patency and limb salvage rates to vein cuff PTFE grafts. The use of spliced veins improved secondary patency but this did not translate into improved limb salvage. The use of an AVF alone showed no added benefits. A large study with a specific focus on below knee vein cuff prosthetic grafts, including PTFE, is required.",
        "model_output": "[/INST]  The studies summarized above investigate the use of different techniques for bypass grafting in patients with critical limb ischemia. The findings can be synthesized as follows:\n\n1. Use of a vein collar at the distal anastomosis of a PTFE graft did not improve patency or limb salvage in patients undergoing bypass grafting for critical limb ischemia (Study #1).\n2. A multicenter randomized prospective trial comparing a pre-cuffed polytetrafluoroethylene graft to a vein cuffed polytetrafluoroethylene graft for infragenicular arterial bypass found that the two types of grafts had similar patency and limb salvage rates at 2 years (Study #2).\n3. A prospective randomized trial of spliced vein versus polytetrafluoroethylene graft with a distal vein cuff for limb-threatening ischemia found that spliced vein bypass grafting had better primary and secondary patency rates than polytetrafluoroethylene grafting with a distal vein cuff at 2 years (Study #4).\n4. A randomized trial comparing infrainguinal polytetrafluoroethylene bypass grafting with and without vein interposition cuff at the distal anastomosis found that the use of a distal vein cuff improved the short-term and medium-term patency and limb salvage rates of femoral-above-knee and femoral-below-knee popliteal artery polytetrafluoroethylene (PTFE) bypass procedures (Study #5).\n5. A prospective randomized multicentre trial evaluated the benefit of an adjuvant AV-fistula on the patency of a femorocrural PTFE bypass with a distal vein cuff and found that adjuvant AV-fistula did not improve the patency of a femorocrural PTFE bypass with a distal vein cuff (Study #6).\n\nOverall, the studies suggest that the choice of graft material and the use of distal vein cuff",
        "eval": "1"
    },
    "6": {
        "summary": "Limited evidence suggests that the method of antibiotic administration (oral versus parenteral) does not affect the rate of disease remission if the bacteria are sensitive to the antibiotic used. However, this and the lack of statistically significant differences in adverse effects need confirmation. No or insufficient evidence exists for other aspects of antibiotic therapy for chronic osteomyelitis.",
        "model_output": "[/INST]  The findings from the eight studies on the treatment of osteomyelitis with antibiotics are combined as follows:\n\n1. Ciprofloxacin and other antimicrobial therapies were compared in a randomized trial for the treatment of osteomyelitis. Of the 14 patients treated with ciprofloxacin, seven (50%) were cured at up to 13 months follow-up, and three (23%) appeared improved. Four patients (30%) experienced treatment failure or relapse.\n2. Oral ciprofloxacin was compared to parenteral antibiotics in a prospective, randomized study for the treatment of biopsy-proven osteomyelitis. The clinical success rates were 77% for oral ciprofloxacin and 79% for parenteral therapies.\n3. Ofloxacin was compared to parenteral antibiotics in a randomized trial for the treatment of chronic osteomyelitis. The study found that oral ofloxacin was as effective and safe as parenteral therapy for the treatment of osteomyelitis in adults.\n4. A controlled trial compared nafcillin therapy and nafcillin-rifampin therapy for the treatment of chronic osteomyelitis caused by Staphylococcus aureus. The study found that the combination of nafcillin and rifampin was not statistically superior to nafcillin alone.\n5. The efficacy and safety of three oral fluoroquinolones (lomefloxacin, levofloxacin, and ciprofloxacin) were analyzed for the treatment of chronic osteomyelitis. The study found that oral fluoroquinolones can be safe and effective therapy for infections caused by susceptible gram-positive and gram-negative organisms.\n6. Ceftazidime was compared to tobramycin and ticarcillin in a randomized trial for the treatment of osteomyelitis caused by gram-negative bacilli. The study found that ceftazidime was as effective as the combination of tobramycin and ticarcast",
        "eval": "1"
    },
    "7": {
        "summary": "Acupuncture appeared to be safe but without clear evidence of benefit. The number of patients is too small to be certain whether acupuncture is effective for treatment of acute ischaemic or haemorrhagic stroke. Larger, methodologically-sound trials are required.",
        "model_output": "[/INST]  The five studies synthesized in this summary investigate the effectiveness of acupuncture as a treatment for acute partial ischemic stroke, sensory stimulation in stroke patients, and its additional value to standard poststroke motor rehabilitation. The studies found that:\n\n1. Acupuncture is effective in improving neurological outcomes in acute stroke patients, with the greatest improvement seen in patients with poor neurological scores at baseline.\n2. Sensory stimulation, including acupuncture, improves functional outcome and quality of life in stroke patients, with the greatest differences seen in balance, mobility, and activities of daily living.\n3. Acupuncture treatment does not have additional value to standard poststroke motor rehabilitation, as there were no statistically significant differences in outcome measures between the acupuncture and control groups.\n4. Acupuncture and transcutaneous nerve stimulation have no beneficial effects on functional outcome or life satisfaction in stroke patients compared to subliminal electrostimulation.\n\nOverall, the studies suggest that acupuncture may be a useful adjunct to standard rehabilitation therapies in improving functional outcomes and quality of life in acute stroke patients, particularly those with poor neurological scores at baseline. However, further research is needed to confirm these findings and to determine the optimal dosage and duration of acupuncture treatment.",
        "eval": "0"
    },
    "8": {
        "summary": "No results are conclusive and all are based on small, short, studies. It would be understandable, however, if clinicians were cautious in prescribing doses in excess of 7.5 mg/day of haloperidol to a person with uncomplicated acute schizophrenia, and if people with schizophrenia were equally reticent to take greater doses. Further research is needed regarding the efficacy and tolerability of the >1.5-3.0 mg/day dose range.",
        "model_output": "[/INST]  The studies summarized in this output provide valuable insights into the effectiveness of different haloperidol dosages in treating acute schizophrenia. The findings can be synthesized as follows:\n\n1. Higher doses of haloperidol (> 10 mg/day) did not lead to greater improvement in measures of psychosis, but did produce more extrapyramidal side effects (Study #3).\n2. The optimal dose of haloperidol for acute schizophrenia is between 10-14.4 ng/ml (Study #11).\n3. Doses higher than 10 mg/day have no additional beneficial effect in the treatment of acute or exacerbated schizophrenia (Study #5).\n4. The relationship between haloperidol plasma levels and clinical response is complex and varies depending on the patient population and dosage (Studies #6-8).\n5. Dopamine D(2) receptor occupancy predicts clinical response, extrapyramidal side effects, and hyperprolactinemia (Study #10).\n6. The therapeutic window for haloperidol defines roughly three drug level ranges (low, optimal, and high or toxic) (Study #11).\n7. High-dose haloperidol (> 40 mg/day) did not lead to greater improvement in measures of psychosis, but did produce more extrapyramidal side effects (Study #2).\n8. The clinical response of schizophrenic patients to treatment from the plasma level after a single test dose is still an open question that requires further studies (Study #6).\n\nIn conclusion, the findings of these studies suggest that the optimal dosage of haloperidol for acute schizophrenia is between 10-14.4 ng/ml, and that higher doses may not provide additional benefits while increasing side effects. The relationship between haloperidol plasma levels and clinical response is complex and varies depending on the patient population and dosage. Dopamine D(2) receptor occupancy is an important mediator of response and side effects in antipsychotic treatment",
        "eval": "1"
    },
    "9": {
        "summary": "Oseltamivir and zanamivir appear to have modest benefit in reducing duration of illness in children with influenza. However, our analysis was limited by small sample sizes and an inability to pool data from different studies. In addition, the inclusion of data from published trials only may have resulted in significant publication bias. Based on published trial data, oseltamivir reduces the incidence of acute otitis media in children aged one to five years but is associated with a significantly increased risk of vomiting. One study demonstrated that laninamivir octanoate was more effective than oseltamivir in shortening duration of illness in children with oseltamivir-resistant influenza A/H1N1. The benefit of oseltamivir and zanamivir in preventing the transmission of influenza in households is modest and based on weak evidence. However, the clinical efficacy of neuraminidase inhibitors in 'at risk' children is still uncertain. Larger high-quality trials are needed with sufficient power to determine the efficacy of neuraminidase inhibitors in preventing serious complications of influenza (such as pneumonia or hospital admission), particularly in 'at risk' groups.",
        "model_output": "[/INST]  The findings from the provided abstracts suggest that zanamivir is an effective strategy for preventing influenza types A and B within households, with an efficacy of 82% and 78% against influenza types A and B, respectively. Laninamivir octanoate was also found to be effective in treating children with oseltamivir-resistant influenza A (H1N1) virus infection, with a significant reduction in the time to illness alleviation compared to oseltamivir. Early oseltamivir treatment of children with influenza within 24 hours of symptom onset was found to provide substantial benefits, with a reduction in the incidence of acute otitis media by 85% and a shortening of the median time to resolution of illness by 3.5 days. Zanamivir was effective in shortening the duration and severity of influenza symptoms among children 5 to 12 years of age, and was well-tolerated. Postexposure prophylaxis (PEP) provided a protective efficacy of 58.5% against proven influenza in households, and oral oseltamivir improved pulmonary function and reduced exacerbation frequency among influenza-infected children with asthma.\n\nOverall, the findings suggest that early treatment with zanamivir or oseltamivir, and the use of PEP in households, can significantly reduce the transmission and severity of influenza. Additionally, oral oseltamivir may improve pulmonary function and reduce asthma exacerbations among children with asthma and influenza.",
        "eval": "1"
    },
    "10": {
        "summary": "Despite reviewing 39 eligible trials, few firm conclusions could be reached because of the multiple comparisons considered, the small size of individual trials, and their low quality. Whether or not to use a particular policy is usually a trade-off between the risks of morbidity (especially infection) and risks of recatheterisation.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "11": {
        "summary": "The use of prophylactic steroids in pediatric patients to reduce postoperative complications commonly experienced following cardiopulmonary bypass surgery is not supported by the existing evidence. Further well designed and adequately powered randomized controlled trials are needed to more accurately estimate the benefit and harm of this intervention.",
        "model_output": "[/INST]  The four studies discussed in this summary investigate the use of dexamethasone and methylprednisolone in reducing the inflammatory response and improving clinical outcomes in children undergoing cardiopulmonary bypass (CPB) for congenital heart disease. The key findings from each study are as follows:\n\nStudy #1: Dexamethasone reduces the inflammatory response to CPB in children. Dexamethasone administration prior to CPB led to an eightfold decrease in interleukin-6 levels and a greater than threefold decrease in tumor necrosis factor-alpha levels. However, the study did not find any significant differences in clinical variables such as temperature, supplemental fluids, alveolar-arterial oxygen gradient, and days of mechanical ventilation between the dexamethasone-treated and control groups.\n\nStudy #2: High-dose methylprednisolone does not significantly modify the systemic inflammatory response to CPB in children. Although postoperative IL-6 and 8 levels were elevated above the preoperative levels in both groups, the difference between the two groups in terms of postoperative IL-6 and 8 levels was not statistically significant. The study also found that only one patient in the high-dose MP group had elevated liver enzymes, blood urea nitrogen, and creatinine in the postoperative period.\n\nStudy #3: Dexamethasone decreases C-reactive protein concentration on the first postoperative day but does not affect the release of von Willebrand factor antigen or S100B. The study found that dexamethasone decreased C-reactive protein concentration on the first postoperative day, but did not affect the release of von Willebrand factor antigen or S100B. There was no significant difference in oxygenation, body temperature, fluid balance, leucocyte and platelet counts, days in the intensive care unit, or days on mechanical ventilation between the placebo and dexamethasone-treated groups.\n\nStudy #4: Combined steroid treatment improves oxygen delivery and reduces postbypass inflammatory mediator expression.",
        "eval": "1"
    },
    "12": {
        "summary": "The overall analysis shows a benefit in pulmonary outcomes in the group electively ventilated with HFJV. Of concern is the significant increase in acute brain injury in one trial which used lower mean airway pressures when ventilating with HFJV. There are as yet no long term pulmonary or neurodevelopmental outcomes from any of the trials.",
        "model_output": "[/INST]  The three studies discussed in this summary investigate the use of high-frequency jet ventilation (HFJV) in the management of respiratory distress syndrome (RDS) in preterm infants. The studies aim to determine whether HFJV reduces mortality or morbidity rates associated with assisted ventilation in these infants.\n\nThe first study found that early use of HFJV does not prevent or substantially reduce mortality or morbidity rates associated with assisted ventilation in preterm infants with RDS. The study randomized 42 infants to either HFJV or conventional ventilation and found that the incidence of mortality, air leaks, bronchopulmonary dysplasia, intraventricular hemorrhage, and assignment crossover were similar between the two groups.\n\nThe second study found that HFJV reduces the incidence of bronchopulmonary dysplasia (BPD) and the need for home oxygen in premature infants with uncomplicated RDS, but does not reduce the risk of acute airleak. The study included 130 patients randomized to either HFJV or conventional ventilation and found that the incidence of BPD at 36 weeks and the need for home oxygen were significantly lower in infants receiving HFJV.\n\nThe third study found that HFJV in the early management of RDS is associated with a greater risk for adverse outcomes, including cystic periventricular leukomalacia and a poor outcome. The study randomized 73 premature infants to either HFJV or conventional ventilation and found that infants ventilated with HFJV were significantly more likely to develop cystic periventricular leukomalacia or to have a poor outcome.\n\nOverall, the studies suggest that HFJV may not be effective in reducing mortality or morbidity rates associated with assisted ventilation in preterm infants with RDS, and may be associated with a higher risk of adverse outcomes. However, the studies have some limitations, such as small sample sizes and variability in ventilator settings and management strategies, which may affect the interpretation of the results. Further research is needed to determine the optimal use of HFJV in",
        "eval": "0"
    },
    "13": {
        "summary": "Community-based interventions and antenatal contraceptive counselling improved uptake of copper IUD contraception. Since the copper IUD is one of the most effective reversible contraceptive methods, primary care and family planning and practitioners could consider adopting these interventions. Although our review suggests these interventions are clinically effective, a cost-benefit analysis may be required to evaluate applicability.",
        "model_output": "[/INST]  The findings from the eight studies suggest that there are several strategies that can improve contraceptive uptake and use among couples. These include:\n\n1. Educational leaflets and counseling: Providing educational leaflets and counseling to couples during the postnatal period can increase contraceptive uptake, with a shift towards more reliable methods.\n2. Integration of family planning services into primary health care: Integrating family planning services into primary health care through programs like the Lady Health Worker Programme can increase access to contraceptive services, particularly in rural areas.\n3. Use of traditional medical practitioners: Using traditional medical practitioners to deliver family planning services can be effective, especially among younger women.\n4. Antenatal counseling: Providing antenatal counseling on contraception can be effective in improving knowledge and practice among couples, although the impact on pregnancy rates may be limited.\n5. Community-based distribution of contraceptives: Community-based distribution of contraceptives can improve knowledge, correct choice, and usage of contraceptives, particularly in remote areas.\n6. Postpartum counseling: Providing postpartum counseling on contraception can increase exclusive breastfeeding and improve knowledge and practice of contraception, although other outcomes may not change.\n7. Involving husbands in family planning counseling: Involving husbands in family planning counseling can lead to joint decisions and encourage women's use of contraception.\n\nOverall, the findings suggest that a multi-faceted approach to contraceptive education and service delivery can be effective in improving contraceptive uptake and use among couples.",
        "eval": "1"
    },
    "14": {
        "summary": "Disconnect systems should be the preferred exchange systems in CAPD.",
        "model_output": "[/INST]  The provided abstracts present a collection of studies that compare the effectiveness of different disconnect systems used in continuous ambulatory peritoneal dialysis (CAPD). The studies compare the incidence of peritonitis, exit-site infections, and hospitalization days for each disconnect system. The studies show that the Y-set system is associated with a lower incidence of peritonitis and exit-site infections compared to the standard system. Additionally, the studies show that the B-bag system is better accepted by patients compared to the Y-set system. Overall, the studies suggest that the Y-set disconnect systems are associated with a lower incidence of peritonitis and exit-site infections compared to the standard system.",
        "eval": "1"
    },
    "15": {
        "summary": "Medication treatments can be effective in paediatric anxiety disorders, acting to reduce core symptoms, and should be considered as part of the treatment of these disorders. The greatest number of trials showing efficacy to date have assessed the SSRIs in treating paediatric OCD.\nThere is no clear evidence to show that any particular class of medication is more effective or better tolerated than any other. As quantitative data was only available for the SSRIs and venlafaxine the routine use of benzodiazepines cannot be recommended, especially given concerns of dependency and treatment -related emergent adverse events associated with this class of drugs. \n\nFuture RCTs could help identify potential clinical moderators of treatment efficacy. Studies of the long-term efficacy of medication treatment, optimal dosage, as well as direct comparisons of pharmacotherapy and psychotherapy are also warranted.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "16": {
        "summary": "Long-acting beta-2 agonists, particularly salmeterol, are more effective than theophylline in improving morning and evening PEF, but are not significantly different in their effect on FEV1. There is evidence of decreased daytime and nighttime short-acting beta-2 agonist requirement with salmeterol. Fewer adverse events occurred in participants using long-acting beta-2 agonists (salmeterol and formoterol) as compared to theophylline.",
        "model_output": "[/INST]\n,\n,\n,\n,\n,\n,\n,\n, \n\n\n\n,  to  to ,\n,\n,\n,\n,\n\n,\n,\n,\n,.\n.\n,.\n, \n,\n,\n, \n, \n.\n.\n.\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n, \n,\n,\n,\n,,,,,,,,,,,,,,,,,,,,,\n,,,,,,,,,,,,,,,,, ,,,,,,,,,,,,   , ,,,,,,,,,,,,,,,,\n,,,,,,,,,,,,,,,,,,,,,,  \n, ,,,,,,,,,,,,,,, ,,,,,,,,,,, ,,,,,,,,,,, , , ,           .  in in,0, bs, bs,  the   \n,  the \n, \n,\n,\n,\n,,,,,      \n           \n,  \n 0, sup sup              sup, sup          \u00a0               sup                                sup, 0 0 ...   to  to to,                                                you  you  you in than than than than than         you \n\n\n\n.\n.   .",
        "eval": "0"
    },
    "17": {
        "summary": "Chemotherapy is effective in prolonging time to disease progression and survival in patients with advanced colorectal cancer. The survival benefit may be underestimated by this meta-analysis, as a proportion of patients in the control arms of some trials received chemotherapy. No age related differences were found in the effectiveness of chemotherapy, but elderly patients were under represented in trials. Treatment toxicity and impact upon quality of life and symptom control have been inadequately assessed in the majority of trials and further research is needed to clarify the palliative benefit of chemotherapy.",
        "model_output": "[/INST]  The provided abstracts discuss various aspects of clinical trials related to colorectal cancer, including treatment outcomes, quality of life, and cost-effectiveness. The key findings from the studies can be synthesized as follows:\n\n1. Tauromustine (TCNU) in advanced colorectal cancer: Two phase III trials showed that TCNU improved overall survival and quality of life in patients with advanced colorectal cancer.\n2. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases: This study found that hepatic-artery floxuridine infusion improved survival and quality of life in patients with colorectal liver metastases.\n3. General condition of asymptomatic patients with advanced colorectal cancer receiving palliative chemotherapy: This study found that initial chemotherapy with methotrexate-5-FU with leucovorin rescue (MFL) improved symptom-free survival, progression-free survival, and survival in asymptomatic patients with advanced colorectal cancer, without compromising their general condition.\n4. Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer: This study found that palliative chemotherapy was cost-effective in patients with advanced gastrointestinal cancer, with improved quality of life and prolonged survival.\n5. Treatment of liver metastases from colorectal cancer with hepatic artery occlusion, intraportal 5-fluorouracil infusion, and oral allopurinol: This study demonstrated the efficacy of a combination of hepatic artery occlusion, intraportal 5-fluorouracil infusion, and oral allopurinol in prolonging survival in patients with nonresectable liver metastases from colorectal cancer.\n\nOverall, these studies suggest that various treatment modalities, including chemotherapy, hepatic artery occlusion, and palliative care, can improve survival and quality of life in patients with colorectal cancer, while also being cost-effective.",
        "eval": "1"
    },
    "18": {
        "summary": "PGS as currently performed significantly decreases live birth rates in women of advanced maternal age and those with repeated IVF failure. Trials in which PGS was offered to women with a good prognosis suggested similar outcomes. PGS technique development is still ongoing in an effort to increase its efficacy. This involves biopsy at other stages of development (polar body or trophectoderm biopsy) and other methods of analysis (comparative genome hybridisation (CGH) or array-based technologies) than used by the trials included in this review. These new developments should be properly evaluated before their routine clinical application. Until such trials have been performed, PGS should not be offered as routine patient care in any form.",
        "model_output": "[/INST]  The studies summarized provide valuable insights into the effectiveness of preimplantation genetic screening (PGS) in improving clinical outcomes in assisted reproductive technology (ART) cycles, particularly in women of advanced maternal age. The findings can be synthesized as follows:\n\n1. PGS does not improve clinical pregnancy rate in women of advanced maternal age, according to Study #3.\n2. Preimplantation aneuploidy testing does not appear to statistically significantly improve outcome parameters in infertile AMA patients, according to Study #4.\n3. PGS does not improve delivery rate in women under the age of 36 following single-embryo transfer, according to Study #5.\n4. Blastocyst biopsy and testing for aneuploidy may be a viable alternative to embryo biopsy and testing, according to Study #6.\n5. Preimplantation genetic screening for aneuploidy of embryos after in vitro fertilization in women aged at least 35 years did not show a significant improvement in clinical outcomes, according to Study #7.\n6. In a \"good prognosis\" population of women, PGS does not appear to improve pregnancy, implantation, or live birth rates, according to Study #8.\n\nOverall, the studies suggest that PGS may not be beneficial for all patient populations, particularly in women of advanced maternal age. Further research is needed to determine the optimal patient population for PGS and to improve clinical outcomes in ART.",
        "eval": "0"
    },
    "19": {
        "summary": "This systematic review suggests that the use of external stents following pancreaticoduodenectomy may be beneficial. However, only a limited number of RCTs with rather small sample sizes were available. Further RCTs on the use of stents after pancreaticoduodenectomy are warranted.",
        "model_output": "[/INST]  The findings from the five studies synthesized suggest that external drainage of the pancreatic duct with a stent reduces the rate of pancreatic fistula after pancreaticoduodenectomy, particularly in high-risk patients with soft pancreatic texture and a non-dilated pancreatic duct. The use of an internal stent during pancreaticojejunostomy is also associated with a lower rate of pancreatic fistula, although the difference may not be statistically significant. External drainage with a stent was found to be a safe and effective method for reducing morbidity after pancreaticoduodenectomy, with a shorter hospital stay compared to no stent group. However, the use of internal stenting may have a higher risk of pancreatitis or late-onset stenosis of the pancreatic duct. Further research is needed to determine the optimal stenting technique and patient population for pancreatic fistula prevention after pancreaticoduodenectomy.",
        "eval": "1"
    },
    "20": {
        "summary": "New studies should focus on patient-oriented outcomes to clarify the benefit-risk ratio of rosiglitazone therapy. Safety data and adverse events of all investigations (published and unpublished) should be made available to the public.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "21": {
        "summary": "The outcomes reported severely limit conclusions for clinical practice. We found little robust evidence that sterile water is effective for low back or any other labour pain. Neither did we find any difference in delivery or other maternal or fetal outcomes. Further large, methodologically rigorous studies are required to determine the efficacy of sterile water to relieve pain in labour.",
        "model_output": "[/INST]  The studies presented in this summary investigate the effectiveness of various methods of administering sterile water for pain relief during labour. The studies include intracutaneous injections, subcutaneous injections, and intradermal sterile water blocks. The findings can be summarized as follows:\n\n1. Intracutaneous injections of sterile water over the sacrum are a simple and effective method for controlling pain during labour, with significant reduction in pain scores at 10, 45, and 90 minutes after injection (Study #1).\n2. Subcutaneous injections of sterile water in the lower back region are also effective in reducing pain during labour, with a median reduction in visual analogue scale pain scores of 5.0 cm and 4.5 cm at 10 and 45 minutes after injection, respectively (Study #2).\n3. Intradermal sterile water blocks were found to be an effective treatment against low back pain during the first stage of labour, with a significantly higher degree of analgesia in the sterile water group (Study #5).\n4. Subcutaneous sterile water injection for labour pain was found to be effective in reducing low-back pain during labour, with a median pain score significantly lower in the sterile water group compared to the placebo group at 10 and 45 minutes after injection (Study #6).\n5. Intracutaneous injections of sterile water were found to be an effective treatment against lower back pain during the first stage of labour (Study #4).\n\nOverall, the studies suggest that administering sterile water in various methods, including intracutaneous, subcutaneous, and intradermal injections, can provide effective pain relief during labour. The method of administration and the timing of injection may affect the degree of pain relief, but the overall effectiveness of sterile water injections for pain relief during labour is supported by the findings of these studies.",
        "eval": "1"
    },
    "22": {
        "summary": "Simple advice has a small effect on cessation rates. Assuming an unassisted quit rate of 2 to 3%, a brief advice intervention can increase quitting by a further 1 to 3%. Additional components appear to have only a small effect, though there is a small additional benefit of more intensive interventions compared to very brief interventions.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "23": {
        "summary": "Methylphenidate, clonidine, guanfacine, desipramine and atomoxetine appear to reduce ADHD symptoms in children with tics.\u00a0Although stimulants have not been shown to worsen tics in most people with tic disorders, they may nonetheless exacerbate tics in individual cases.\u00a0In these instances, treatment with alpha agonists or atomoxetine may be an alternative. Although there is evidence that desipramine is effective for both tics and ADHD in children, safety concerns will likely continue to limit its use in this population.",
        "model_output": "[/INST]  The findings from the eight studies provide valuable insights into the treatment of attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders. The studies suggest that methylphenidate and clonidine are effective treatments for ADHD in children with comorbid tics, with clonidine appearing to be most helpful for impulsivity and hyperactivity, and methylphenidate for inattention. However, there is a need for caution when using methylphenidate, as it may exacerbate tics in some individuals. Guanfacine appears to be a safe and effective treatment for children with tic disorders and ADHD, with significant improvements in ADHD symptoms and tic severity. Desipramine may also be a useful alternative for the treatment of ADHD in children with TS. Finally, deprenyl may improve both ADHD and tics in children with TS, warranting further study.\n\nIn conclusion, the findings from these studies suggest that a combination of medications may be necessary to effectively treat ADHD and tic disorder in children with comorbid tics. Further research is needed to determine the optimal medication and dosages for each child, as well as the safety and efficacy of these treatments in the long-term.",
        "eval": "1"
    },
    "24": {
        "summary": "Parenteral high dose methotrexate and sulfasalazine are the only two agents with well demonstrated published efficacy in psoriatic arthritis. The magnitude of the effect seen with azathioprine, etretinate, oral low dose methotrexate and perhaps colchicine suggests that they may be effective but that further multicentre clinical trials are required to establish their efficacy. Furthermore, the magnitude of the improvement observed in the placebo group strongly suggests that uncontrolled trials should not be used to guide management decisions in this condition.",
        "model_output": "[/INST]  The findings from the 11 studies suggest that:\n\n1. Etretinate (Tigason) may have a specific action in treating psoriatic arthritis, as it improved skin lesions and statistical significance was seen for articular index in both groups. However, side effects such as cracked and dried lips and sore mouth were common.\n2. Colchicine is not an effective treatment for psoriatic arthritis, as no significant difference was noted between colchicine or placebo treatment for primary outcome measures or secondary outcome measures.\n3. Sulfasalazine is effective in treating psoriatic arthritis, with significant improvements in physician and patient global assessments, joint scores, 50 ft walking time, and global patient assessment. However, long-term studies are needed to determine whether such therapy can modify disease outcome.\n4. Auranofin is superior to placebo only in physician assessment of arthritis activity and in improvement of skin surface area with psoriasis. A small but statistically significant rise of serum total bilirubin occurred in the methotrexate-treated patients.\n5. Fumaric acid therapy may be effective in treating psoriatic arthritis, but further studies are needed to confirm this.\n6. Sulphasalazine is well tolerated and may be more effective than placebo in treating patients with psoriatic arthritis, with more benefit detected in those with the symmetrical polyarticular but seronegative pattern of arthritis associated with a high acute-phase response.\n7. The efficacy and tolerability of sulphasalazine (SSZ) in patients with psoriatic arthritis were evaluated in a randomized, multicentre, placebo-controlled study. SSZ appeared to be a safe treatment in patients with psoriatic arthritis, with significant improvements in pain compared to placebo.\n8. Enteric-coated sulphasalazine (SASP) is effective in managing psoriatic arthritis, with significant improvements in articular index, visual analogue scale, duration of morning stiffness, and ESR. However, the partial clinical response to placebo indicates the importance of placebo-controlled studies in this variable disease.\n\nIn",
        "eval": "1"
    },
    "25": {
        "summary": "There is no significant difference between once weekly versus thrice weekly subcutaneous administration of rHuEPO. Once weekly administration would require an additional 12 U/kg/wk for patients on haemodialysis, however this is based on one very small study. Cost of additional rHuEPO needs to assessed with regard to patient preference and compliance.",
        "model_output": "[/INST]  The studies summarized above investigate the effectiveness of subcutaneous administration of recombinant human erythropoietin (rHuEPO) in hemodialysis patients. The studies compare the efficacy of once-weekly versus twice-weekly administration of rHuEPO and evaluate the optimal dosing frequency for maintaining stable hemoglobin levels. The findings are as follows:\n\n1. Study #1: Once-weekly administration of rHuEPO is as effective as twice-weekly administration in reversing renal anemia in hemodialysis patients.\n2. Study #2: Once-weekly administration of rHuEPO is more convenient for patients than twice-weekly administration.\n3. Study #3: Once-weekly administration of rHuEPO is as effective as twice-weekly administration in maintaining stable hemoglobin levels in CAPD patients.\n4. Study #4: The optimal dosing frequency for rHuEPO in CAPD patients is once weekly, as it results in a more adequate profit ratio than i.p. administration.\n5. Study #5: Once-weekly administration of rHuEPO is statistically equivalent to three times weekly administration in terms of maintaining stable hemoglobin levels and dose requirements in hemodialysis patients.\n6. Study #6: Once weekly administration of rHuEPO is as safe and effective as two or three times weekly administration in maintaining hemoglobin levels in stable hemodialysis patients.\n7. Study #7: Once weekly administration of rHuEPO is equally effective in maintaining a stable hemoglobin level as thrice weekly administration in anemic CAPD patients.\n8. Study #8: The optimal injection frequency for rHuEPO in CAPD patients is once weekly, as it results in a dose reduction of 22% in patients with skin-fold thickness of less than 20 mm.\n\nIn conclusion, the studies suggest that once-weekly administration of rHuEPO is as effective as or more effective than twice-weekly administration in maintaining stable hemoglobin levels in hemodialysis and CAPD patients. Once weekly administration is also more convenient for patients and results in a do",
        "eval": "1"
    },
    "26": {
        "summary": "For the considered outcomes, it seems that adding any psychosocial support to standard maintenance treatments do not add additional benefits. Data do not show differences also for contingency approaches, contrary to all expectations. Duration of the studies was too short to analyse relevant outcomes such as mortality. It should be noted that the control intervention used in the studies included in the review on maintenance treatments, is a program that routinely offers counselling sessions in addition to methadone; thus the review, actually, did not evaluate the question of whether any ancillary psychosocial intervention is needed when methadone maintenance is provided, but the narrower question of whether a specific more structured intervention provides any additional benefit to a standard psychosocial support. These interventions probably can be measured and evaluated by employing diverse criteria for evaluating treatment outcomes, aimed to rigorously assess changes in emotional, interpersonal, vocational and physical health areas of life functioning.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "27": {
        "summary": "Aldosterone antagonists contribute to reduction of proteinuria in patients with CKD who are already on ACEi and ARB but increase the risk of hyperkalaemia. Available studies are small and have short follow-up.\u00a0Long-term effects on renal outcomes, mortality and safety are unknown.",
        "model_output": "[/INST]  The findings from the six studies suggest that spironolactone has a beneficial impact on proteinuria and renal function in patients with diabetic nephropathy. The studies show that spironolactone:\n\n1. Reduces proteinuria by 32-50% in patients with diabetic nephropathy, regardless of whether they are on dual blockade of the renin-angiotensin-aldosterone system or not.\n2. Lowers blood pressure by 4-6 mmHg in patients with diabetic nephropathy.\n3. Improves renal function by slowing the progression of nephropathy and increasing estimated glomerular filtration rate.\n4. Is well tolerated and does not cause significant changes in serum potassium levels.\n\nThe studies also suggest that spironolactone may be a useful addition to the treatment of diabetic nephropathy, particularly when used in combination with other renoprotective therapies such as ACE inhibitors and/or ARBs. However, the studies have some limitations, such as small sample size, and the results may not be generalizable to all patients with diabetic nephropathy. Further research is needed to confirm these findings and to determine the safety and efficacy of spironolactone in larger, more diverse patient populations.",
        "eval": "1"
    },
    "28": {
        "summary": "Family intervention may reduce the number of relapse events and hospitalisations and would therefore be of interest to people with schizophrenia, clinicians and policy makers. However, the treatment effects of these trials may be overestimated due to the poor methodological quality. Further data from trials that describe the methods of randomisation, test the blindness of the study evaluators, and implement the CONSORT guidelines would enable greater confidence in these findings.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "29": {
        "summary": "Prenatal TRH, in addition to corticosteroids, given to women at risk of very preterm birth do not improve infant outcomes and can cause maternal side-effects.",
        "model_output": "[/INST]  The findings from the seven studies suggest that the use of antenatal corticosteroids and thyrotropin-releasing hormone (TRH) therapy may improve fetal lung maturation and reduce the incidence of respiratory distress syndrome (RDS) in preterm infants. The studies provide evidence that the combination of antenatal corticosteroids and TRH may be more effective than corticosteroids alone in reducing the risk of RDS and improving neonatal outcomes. However, the studies also suggest that the addition of TRH to antenatal corticosteroids may not significantly reduce the incidence of chronic lung disease (CLD) or improve neonatal survival.\n\nThe studies highlight the importance of selecting the appropriate patients for antenatal TRH therapy, as the benefits of the treatment may be limited to those who are most likely to benefit from it. The studies also suggest that the optimal timing of TRH administration may be critical, as the treatment may be more effective when given closer to the time of delivery.\n\nOverall, the findings of these studies provide support for the use of antenatal corticosteroids and TRH therapy in the prevention of RDS and improving neonatal outcomes in preterm infants. However, further research is needed to determine the optimal dosage and timing of TRH administration, as well as to identify which patients are most likely to benefit from the treatment.",
        "eval": "1"
    },
    "30": {
        "summary": "Diflunisal has an analgesic effect similar to other NSAIDs in single dose, but benefits from providing significant analgesia for about twelve hours. This property may be useful when regular dosing is needed, or when taking several doses of a shorter acting analgesic is impractical.",
        "model_output": "[/INST]  The six studies reviewed here investigate the analgesic efficacy and safety of diflunisal, a new nonsteroidal anti-inflammatory analgesic, in various postoperative pain settings. The studies demonstrate that diflunisal is a highly effective and safe analgesic option for the treatment of postoperative pain, with a long duration of analgesic action.\n\nKey findings:\n\n1. Diflunisal is more effective than acetaminophen alone and the acetaminophen-codeine combination in postoperative pain relief, with a longer duration of analgesia.\n2. Diflunisal is significantly superior to aspirin and placebo in postoperative dental pain relief, with a similar onset of analgesia but a longer duration of action.\n3. Diflunisal 500 and 1000 mg are significantly superior to placebo for every measure of total and peak analgesia in postoperative pain, with a similar onset of action.\n4. Zomepirac is comparable to diflunisal in peak analgesia and significantly superior to diflunisal in total analgesia in postoperative oral surgery pain relief.\n5. Carprofen has a rapid onset of action and is effective in postoperative pain relief, but the duration of action is shorter than that of diflunisal.\n6. Diflunisal is effective in post-meniscectomy pain relief, with a longer duration of analgesia than oxyphenbutazone.\n7. Suprofen is as efficacious as diflunisal in postoperative pain relief, with a similar onset and duration of action.\n\nOverall, the studies suggest that diflunisal is a highly effective and safe analgesic option for the treatment of postoperative pain, with a long duration of analgesic action.",
        "eval": "1"
    },
    "31": {
        "summary": "This review of randomised controlled trials showed that vigabatrin can reduce seizure frequency in people with drug-resistant partial epilepsy. Short-term follow-up of patients showed that some side effects were associated with its use. Further analysis of longer-term observational studies is required to evaluate how likely patients are to develop visual field defects and whether such side effects are associated with dose and duration of drug use.",
        "model_output": "[/INST]\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \u0409 \u0409 \u0409 \u0409 \u0409 \u0409 \u0409 \u0409 \u0409 \u0409 \u0409 \u0409 \u0409 and \u0409 and \u0409.\n\n\n\n\n\n\n\n \u0409.\n\n\n\n\n \u0409 \u0409 \u0409 \n \u0409 \n \u0409\n \u0409\n\n\n\n\n\n\n\n\n\n\n \n \n\n \n\n\n clin clin\n\n kwiet everybody.\n\n\n\n \n \n \n \n  kwiet everybody, kwiet everybody.\n \u0409, \n \n \n \n  kwiet everybody  kwiet everybody, hopefully hopefully hopefully hopefully hopefully hopefully hopefully everybody everybody everybody everybody hopefully clin kwiet everybody, kwiet everybody, kwiet everybody, kwiet everybody, kwiet everybody, kwiet everybody, kwiet Hinweis, and \n       everybody  everybody, kwiet everybody, kwiet everybody, kwiet everybody, kwiet Hinweis r\u00e9f\u00e9rences.\n kwiet sierp kwiet everybody.\n everybody.\n everybody.\n everybody.\n everybody.\n everybody.\n everybody everybody everybody everybody everybody everybody everybody everybody.\n\n\n everybody\n\n\n\n\n\n\n\n\n\n\n\n everybody\n everybody Hinweis\n kwiet everybody everybody everybody Hinweis kwiet\n kwiet\n kwiet\n Hinweis everybody everybody everybody everybody everybody Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Unterscheidung Hinweis everybody everybody everybody everybody everybody everybody everybody everybody Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Unterscheidung Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Unterscheidung everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis nobody everybody everybody everybody everybody everybody Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis everybody Hinweis everybody Hinweis everybody Hinweis everybody everybody everybody everybody everybody everybody everybody,\n\n\n\n.\n\n,\n,- Einzeln everybody Hinweis Hinweis Hinweis",
        "eval": "0"
    },
    "32": {
        "summary": "In adolescents and adults with sub-optimal control on low dose ICS monotherapy, the combination of LABA and ICS is modestly more effective in reducing the risk of exacerbations requiring oral corticosteroids than a higher dose of ICS. Combination therapy also led to modestly greater improvement in lung function, symptoms and use of rescue \u00df2 agonists and to fewer withdrawals due to poor asthma control than with a higher dose of inhaled corticosteroids. Apart from an increased rate of tremor and less oral candidiasis with combination therapy, the two options appear relatively safe in adults although adverse effects associated with long-term ICS treatment were seldom monitored. In children, combination therapy did not lead to a significant reduction, but rather a trend towards an increased risk, of oral steroid-treated exacerbations and hospital admissions. These trends raised concern about the safety of combination therapy in view of modest improvement in children under the age of 12 years.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "33": {
        "summary": "The limited evidence suggests that home management is cost effective and preferred by patients. Further large trials comparing these treatments are unlikely to occur. Therefore, home treatment is likely to become the norm; further research will be directed to resolving practical issues.",
        "model_output": "[/INST]  The six studies compared the effectiveness and safety of low-molecular-weight heparin (LMWH) and unfractionated heparin (UFH) in treating deep vein thrombosis (DVT). The studies found that:\n\n1. LMWH can be used safely and effectively to treat patients with proximal DVT at home (Study #1).\n2. Long-term treatment of DVT with LMWH (tinzaparin) is at least as effective and safe as UFH followed by acenocoumarol in proximal DVT (Study #2).\n3. For patients with proximal DVT and no symptoms of pulmonary embolism or increased risk of major bleeding, home treatment using LMWH is an effective, safe, and cost-saving strategy (Study #3).\n4. A once-daily regimen of enoxaparin is at least as effective and safe as conventional treatment with a continuous intravenous infusion of UFH for the treatment of DVT (Study #4).\n5. In patients with proximal-vein thrombosis, treatment with LMWH at home is feasible, effective, and safe (Study #5).\n6. Once-daily subcutaneous enoxaparin in the outpatient setting is at least as effective and as well tolerated as in-hospital intravenous unfractionated heparin for the treatment of deep-vein thrombosis (Study #6).\n\nThe studies suggest that LMWH may be a safer and more convenient alternative to UFH for the treatment of DVT, particularly for patients who can be treated on an outpatient basis. However, the studies also highlight the need for further research to determine the optimal treatment strategy for DVT, including the role of LMWH in different patient populations and the potential for combination therapy with other anticoagulants.",
        "eval": "1"
    },
    "34": {
        "summary": "Internal fixation is associated with less initial operative trauma but has an increased risk of re-operation on the hip. Definite conclusions cannot be made for differences in pain and residual disability between the two groups. Future studies should concentrate on better reporting of final outcome measures and function. There is still a need for studies to define which patient groups are better served by the different treatment methods.",
        "model_output": "[/INST] \n                      .      . . . .     . .                         .           \n. . \u0409 .          after  after             \n                       \n. . \u0409 \u0409 . \u0409 . \n\n.\n\u0409 \u0409 \u0409 \u0409\n\u0409..\u0409\u0409....... .   \n \n. \u0409 \u0409 \u0409 \u0409.\u0409 \n      \u0409 \u0409 \u0409 \u0409 \u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409.\u0409 \u0409 \u0409.\u0409.\u0409.\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409...\n\u0409\n. . \u0409\n\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409.\u0409\u0409\u0409..\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "35": {
        "summary": "There was evidence individual TFCBT, EMDR, stress management and group TFCBT are effective in the treatment of PTSD. Other non-trauma focused psychological treatments did not reduce PTSD symptoms as significantly. There was some evidence that individual TFCBT and EMDR are superior to stress management in the treatment of PTSD at between 2 and 5 months following treatment, and also that TFCBT, EMDR and stress management were more effective than other therapies. There was insufficient evidence to determine whether psychological treatment is harmful. There was some evidence of greater drop-out in active treatment groups. The considerable unexplained heterogeneity observed in these comparisons, and the potential impact of publication bias on these data, suggest the need for caution in interpreting the results of this review.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "36": {
        "summary": "Methenamine hippurate may be effective for preventing UTI in patients without renal tract abnormalities, particularly when used for short-term prophylaxis. It does not appear to work in patients with neuropathic bladder or in patients who have renal tract abnormalities. The rate of adverse events was low, but poorly described.\nThere is a need for further large well-conducted RCTs to clarify this question, particularly for longer term use for people without neuropathic bladder.",
        "model_output": "[/INST]  The studies presented in this summary investigate the effectiveness of methenamine hippurate in preventing and treating urinary tract infections (UTIs) in various patient populations. The studies include:\n\n1. Study #1: This study compared the effectiveness of methenamine hippurate with placebo in preventing recurrent UTIs in patients with a history of recurrent UTIs. The study found that methenamine hippurate was significantly more effective than placebo in preventing recurrent UTIs.\n2. Study #2: This study evaluated the value of prophylactic treatment with methenamine hippurate after routine gynecologic surgery to prevent postoperative bacteriuria and UTIs. The study found that prophylactic treatment with methenamine hippurate significantly reduced the incidence of postoperative bacteriuria and UTIs.\n3. Study #3: This study investigated the effectiveness of methenamine hippurate in preventing UTIs in spinal cord injury patients. The study found that methenamine hippurate was not statistically effective in preventing bacteriuria infections in these patients.\n4. Study #4: This study evaluated the use of prophylactic antibacterial therapy to prevent UTIs in fertile women. The study found that prophylactic antibacterial therapy was not beneficial in preventing UTIs in these patients.\n5. Study #5: This study investigated the preventive effect of methenamine hippurate on UTIs after short-term catheterization in gynecologic surgery. The study found that methenamine hippurate was effective in preventing UTIs after short-term catheterization.\n6. Study #6: This study compared the effectiveness of methenamine hippurate with placebo in preventing UTIs in general practice. The study found that methenamine hippurate was significantly more effective than placebo in preventing UTIs.\n7. Study #7: This study evaluated the persistence of bacteriuria following gynaecological surgery and the effectiveness of methenamine",
        "eval": "1"
    },
    "37": {
        "summary": "We found no evidence to support or refute antioxidant supplements in patients with liver disease. Antioxidant supplements may increase liver enzyme activity.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "38": {
        "summary": "From the available evidence we cannot determine whether or not preoperative analgesics are of benefit in paediatric dentistry for procedures under local anaesthetic. There is probably a benefit in prescribing preoperative analgesics prior to orthodontic separator placement.",
        "model_output": "[/INST]  The five studies reviewed investigate the use of pre-emptive analgesia in reducing post-extraction pain in children and adolescents. The studies compared the efficacy of pre-emptive administration of ibuprofen, paracetamol, and placebo in reducing post-extraction pain. The findings suggest that pre-emptive administration of ibuprofen and paracetamol may provide a pre-emptive analgesic effect in paediatric patients who receive adequate analgesia during mandibular primary tooth extraction. Additionally, ibuprofen exhibited lower pain scores compared to paracetamol at certain time points. The studies also suggest that preoperative administration of ibuprofen may reduce post-extraction pain in children, although the results were not statistically significant in all studies. Further research with a larger sample size and more reliable pain-assessment methods may help to elucidate the efficacy of preoperative analgesic administration in children.",
        "eval": "1"
    },
    "39": {
        "summary": "In contrast to the previous version of this review, our results suggest that therapeutic ultrasound may be beneficial for patients with osteoarthritis of the knee. Because of the low quality of the evidence, we are uncertain about the magnitude of the effects on pain relief and function, however. Therapeutic ultrasound is widely used for its potential benefits on both knee pain and function, which may be clinically relevant. Appropriately designed trials of adequate power are therefore warranted.",
        "model_output": "[/INST]  The five studies discussed in this summary investigate the use of various physical agents, including ultrasound, hot packs, and electrical nerve stimulation, in the management of knee osteoarthritis (OA). The studies aim to determine the effectiveness of these agents in improving functional status, reducing pain, and increasing muscle strength in patients with knee OA.\n\nThe findings of the studies can be synthesized as follows:\n\n1. Ultrasound therapy may not contribute to the management of patients with chronic knee stiffness and OA, but the exercise program and increased activity secondary to program participation probably influenced the overall improvement (Study #1).\n2. Hot packs and short-wave diathermy are more effective than ultrasound in improving muscular strength, pain, and functional status in women with knee OA (Study #2).\n3. An integrated therapy that includes isokinetic exercises, pulse ultrasound, and intraarticular hyaluronan therapy is more effective than isokinetic exercises alone in improving muscular strength, pain, and functional status in patients with knee OA (Study #3).\n4. The use of ultrasound to increase the effectiveness of isokinetic exercise improves muscular strength, reduces pain, and improves functional status in patients with knee OA (Study #4).\n5. Therapeutic ultrasound is safe and effective in reducing pain and improving functions in patients with knee OA (Study #5).\n\nOverall, the studies suggest that a combination of physical agents, including ultrasound, hot packs, and electrical nerve stimulation, may be more effective in managing knee OA than any single agent. Additionally, integrated therapy that includes isokinetic exercises and other interventions may be more effective than isokinetic exercises alone. Further research is needed to determine the optimal dosage and duration of these interventions, as well as their long-term effects on knee OA management.",
        "eval": "1"
    },
    "40": {
        "summary": "This review was unable to demonstrate any advantage of CCPT over other airway clearance techniques in terms of respiratory function, but this may have reflected insufficient evidence rather than real equivalence between methods. There was a trend for participants to prefer self-administered airway clearance techniques. Limitations of this review included a paucity of well-designed, adequately-powered, long-term trials.",
        "model_output": "[/INST]  The studies reviewed here investigate the effectiveness of various chest percussion techniques in hospitalized patients with cystic fibrosis. The findings can be synthesized as follows:\n\n1. Comparison of manual and mechanical chest percussion during hospitalization for acute exacerbations of cystic fibrosis: Although equal efficacy of outpatient therapy remains to be proved, this study suggests that patients can be encouraged to use the form of chest percussion that they prefer.\n2. Comparison of the flutter device to standard chest physiotherapy in hospitalized patients with cystic fibrosis: Although the Flutter appears to be a useful device for independent, cost-effective, and safe administration of CPT, a much larger clinical trial would be necessary to make definitive conclusions.\n3. Role of conventional physiotherapy in cystic fibrosis: Conventional chest physiotherapy should remain a standard component of therapy in cystic fibrosis.\n4. Comparison of effects of an intrapulmonary percussive ventilator to standard aerosol and chest physiotherapy in treatment of cystic fibrosis: The device was safe and effective, and there was no difference in the use of antibiotics and hospitalizations between the two groups.\n5. Comparison of high frequency chest compression and conventional chest physiotherapy in hospitalized patients with cystic fibrosis: HFCC and CPT are equally safe and effective when used during acute pulmonary exacerbations in CF patients.\n6. Long-term comparative trial of conventional postural drainage and percussion versus positive expiratory pressure physiotherapy in the treatment of cystic fibrosis: For our patients with cystic fibrosis, pulmonary physiotherapy with the PEP technique was superior to conventional physiotherapy with the PD&P technique.\n7. Comparison of a positive expiratory pressure (PEP) mask with postural drainage in patients with cystic fibrosis: PEP mask therapy is an acceptable and effective alternative to postural drainage in interval therapy of patients with cystic fibrosis.\n8. Relative effects of bronchial drainage and exercise for in-",
        "eval": "1"
    },
    "41": {
        "summary": "No clear benefit was shown for open healing over surgical closure. A clear benefit was shown in favour of off-midline rather than midline wound closure. When closure of pilonidal sinuses is the desired surgical option, off-midline closure should be the standard management.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "42": {
        "summary": "In experienced hands, ultrasound provides at least as good success rates as other methods of peripheral nerve location. Individual studies have demonstrated that ultrasound may reduce complication rates and improve quality, performance time, and time to onset of blocks. Due to wide variations in study outcomes we chose not to combine the studies in our analysis.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "43": {
        "summary": "Multiple interventions for upper limb sensory impairment after stroke are described but there is insufficient evidence to support or refute their effectiveness in improving sensory impairment, upper limb function, or participants' functional status and participation. There is a need for more well-designed, better reported studies of sensory rehabilitation.",
        "model_output": "[/INST]  The studies reviewed here investigate the effectiveness of various interventions for improving sensorimotor function in patients with acute hemiplegic upper limb after stroke. The findings can be synthesized as follows:\n\n1. Additional treatment of sensorimotor stimulation in the acute phase after stroke improved motor recovery, which was apparent 1 year later (Study #1).\n2. The functional and sensorimotor integrative approaches to occupational therapy did not show significant differences in improving function in cerebrovascular accident patients (Study #2).\n3. Thermal stimulation significantly enhances the recovery of several aspects of sensory and motor functions in hemiplegic stroke patients (Study #3).\n4. Intermittent pneumatic compression may be of clinical importance for the restoration of sensory function in stroke patients (Study #4).\n5. An outpatient rehabilitation program based on the principles of neuroplasticity can improve upper extremity function and independence in patients stable post-stroke (Study #5).\n6. Electrical stimulation of the wrist and fingers in conjunction with neurodevelopmental exercises improves sensory and functional recovery in acute hemiplegia (Study #6).\n\nOverall, these studies suggest that various interventions can improve sensorimotor function in patients with acute hemiplegic upper limb after stroke. The most effective interventions are those that target the acute phase after stroke and combine different modalities, such as sensorimotor stimulation, functional therapy, and electrical stimulation.",
        "eval": "1"
    },
    "44": {
        "summary": "Behavioural interventions for young women which aim to promote sexual behaviours protective of STI transmission can be effective, primarily at encouraging condom use. Future evaluations should include a greater focus on HPV and its link to cervical cancer, with long-term follow-up to assess impact on behaviour change, rates of HPV infection and progression to cervical cancer. Studies should use an RCT design where possible with integral process evaluation and cost-effectiveness analysis where appropriate. Given the predominance of USA studies in this systematic review evaluations conducted in other countries would be particularly useful.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "45": {
        "summary": "There was no clear evidence of any effect of corticosteroids on substantive clinical outcomes. Those receiving steroids showed significantly greater improvement in platelet counts which was greater for those receiving dexamethasone than those receiving betamethasone. There is to date insufficient evidence of benefits in terms of substantive clinical outcomes to support the routine use of steroids for the management of HELLP. The use of corticosteroids may be justified in clinical situations in which increased rate of recovery in platelet count is considered clinically worthwhile.",
        "model_output": "[/INST] and the group.\n\nstud\nstud \u0409, and theology, and \u0409 and the project.\n\n\n\n\n \u0409.\n \u0409.\n\n\n, \u0409, \u0409, \u0409, \u0409, \u0409, \u0409, \u0409, \u0409,\n \u0409, \n \u0409, and \u0409 \u0409.\n\n\n\n\n\n\n\n\n\n\n\n \u0409, kwiet and a \u0409, kwiet\n \u0409, \u0409, 10 \n \u0409, kwiet\n \u0409, kwiet everybody, kwiet everybody clin sierp sierp sierp sierp sierp clin topics, kwiet everybody clin topics, kwiet\u0435\u0433\u043e, kwiet everybody, kwiet\u0435\u0433\u043e clin, kwiet\u0435\u0433\u043e, kwiet, kwiet, kwiet, and 3, and \n  everybody, and pass,\n,  kwiet,  kwiet, and\n.\n kwiet sierp.\n\n\n\n everybody.\n everybody.\n the  everybody.\n.\niellement.  kwiet everybody.\n.\n.\n,\n,\n,\n,\n,\n,\n,\n\n Hinweis, everybody Hinweis Hinweis Hinweis Hinweis Hinweis\n Hinweis\n kwiet\n everybody\n Hinweis\n Hinweis Hinweis everybody everybody Hinweis Hinweis Einzeln Hinweis Einzeln Einzeln Einzeln Einzeln Einzeln Einzeln Einzeln everybody hopefully, nobody hopefully, everybody hopefully, everybody everybody Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis kwiet kwiet kwiet kwiet kwiet kwiet kwiet kwiet kwiet Hinweis Hinweis Hinweis Hinweis Hinweis Einzeln everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody Hinweis Einzeln Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis,\n\n\n\n.\n.\n\n Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis everybody everybody everybody Hinweis everybody Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis",
        "eval": "0"
    },
    "46": {
        "summary": "To date there is no evidence of effective treatment in preventing malignant transformation of leukoplakia. Treatments may be effective in the resolution of lesion, however relapses and adverse effects are common.",
        "model_output": "[/INST]  The findings from the studies are summarized as follows:\n\n1. Study #1: Chemopreventive potential of vitamin A and beta carotene were evaluated in patients with oral leukoplakia. Vitamin A was more effective than beta carotene in reducing the size of the lesions.\n\n2. Study #2: 13-cis-retinoic acid in the treatment of oral leukoplakia. 13-cis-retinoic acid was effective in treating oral leukoplakia.\n\n3. Study #3: Randomized, double-blind, placebo-controlled phase IIb trial of the cyclooxygenic acid in the treatment of oral leukoplakia.\n\n4. Study #4: The efficacy of oral leukopreductive potential of oral leukin the treatment of oral leukin the treatment of oral leukin the treatment of oral leukin the treatment of oral leukin the treatment of oral leukin the treatment of oral leukin the treatment of oral leukin the treatment of oral leukin the treatment of the treatment of oral leukin the treatment of oral leukin the treatment of the treatment of oral leukin the treatment of oral treatment of oral leukin the treatment of oral leukin the treatment of oral leukin the treatment of oral leukin the treatment of oral leukin the treatment of oral leukin the treatment of oral leuk the treatment of oral leuk the treatment of oral treatment of oral leuk the treatment of oral treatment of oral leuk the treatment of oral treatment of oral leuk the treatment of oral treatment of oral treatment of oral treatment of oral treatment of oral leuk the treatment of oral treatment of oral treatment of oral treatment of oral treatment of oral treatment of treatment of treatment of treatment of treatment of treatment of treatment of the treatment of the treatment of the treatment of the treatment of the treatment of the treatment of the treatment of treatment of the treatment of the treatment of the treatment of the treatment of the treatment of the treatment of the treatment of the treatment of the treatment of the treatment of the treatment of the treatment of the treatment of the treatment of the",
        "eval": "0"
    },
    "47": {
        "summary": "Two intervention types, the specialist epilepsy nurse and self-management education, have some evidence of benefit. However, we did not find clear evidence that other service models substantially improve outcomes for adults with epilepsy. It is also possible that benefits are situation specific and may not generalise to other settings. These studies included only a small number of service providers whose individual competence or expertise may have had a significant impact on outcomes. At present it is not possible to advocate any single model of service provision.",
        "model_output": "[/INST] , , , , , , , \n\n, ,  , , ,,,\n.\n.\n,, , ,      , , , , ,     , , ,,,,,, , ,,,, , , ,,, , , , , , , ,,, , , , , ,,, \n. \u0409 . \u0409, \n,,,,,,,,,,,,,,,,,,,,, , , , ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, , , ,  , , ,   , ,           ,  ,   \n, , , \n,,,,, ,,,,,,,,,,,,,,,,,,,,,,,,,,, ,,,,,,,, ,,,, , \n, \n, \u0409 \u0409,\n\u0409, . . \n, \n\n\n.\n\n\n\n. .\n\u0409 \u0409\n\u0409\n\u0409\n\u0409 \u0409\n\u0409.\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409.\u0409\n\u0409\n\u0409 \u0409,\n\u0409 . \u0409 \u0409.\u0409\u0409\u0409\u0409\u0409.\u0409\n\u0409 \u0409 \u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "48": {
        "summary": "Most active recruitment strategies for breast cancer screening programs examined in this review were more effective than no intervention. Combinations of effective interventions can have an important effect. Some costly strategies, as a home visit and a letter of invitation to multiple screening examinations plus educational material, were not effective. Further reviews comparing the effective interventions and studies that include cost-effectiveness, women's satisfaction and equity issues are needed.",
        "model_output": "[/INST] \n\nThe task is to synthesize the findings from the 13 studies related to identify the main",
        "eval": "0"
    },
    "49": {
        "summary": "In patients with acute gallstone pancreatitis, there is no evidence that early routine ERCP significantly affects mortality, and local or systemic complications of pancreatitis, regardless of predicted severity. Our results, however, provide support for current recommendations that early ERCP should be considered in patients with co-existing cholangitis or biliary obstruction.",
        "model_output": "[/INST]  The studies presented in this summary investigate the use of early endoscopic intervention (EEI) in the treatment of acute gallstone pancreatitis (AGP) and biliopancreatic obstruction. The studies include a randomized clinical trial, a pilot study, and a prospective study. The main findings can be summarized as follows:\n\n1. Early endoscopic intervention may not reduce systemic and local inflammation in patients with AGP and biliopancreatic obstruction. A randomized clinical trial found that early endoscopic intervention did not provide evidence of reduced inflammation in this patient population.\n2. Early endoscopic retrograde cholangiopancreatography (ERCP) and papillotomy may not be beneficial in patients with acute biliary pancreatitis without obstructive jaundice. A prospective study found that early ERCP and papillotomy were not superior to conservative treatment in terms of overall mortality, mortality due to pancreatitis, and complications.\n3. Urgent endoscopic intervention without fluoroscopy may be effective in reducing the severity of acute biliary pancreatitis in the intensive care unit (ICU). A pilot study found that early endoscopic intervention without fluoroscopy was associated with improved efficacy in patients with severe acute biliary pancreatitis in the ICU.\n4. Duodenoscopy may be a feasible and effective treatment option for severe acute gallstone pancreatitis. A prospective study found that duodenoscopy was associated with lower complication rates and shorter hospital stays in patients with severe acute GP.\n\nIn conclusion, the findings of these studies suggest that early endoscopic intervention may not be beneficial in all patients with AGP and biliopancreatic obstruction, and that urgent endoscopic intervention without fluoroscopy may be effective in reducing the severity of acute biliary pancreatitis in the ICU. Duodenoscopy may also be a feasible and effective treatment option for severe acute gallstone pancreatitis. However, further research is needed to confirm these findings and to determine the optimal treatment approach for these conditions.",
        "eval": "0"
    },
    "50": {
        "summary": "The use of ergometrine-oxytocin as part of the routine active management of the third stage of labour appears to be associated with a small but statistically significant reduction in the risk of PPH when compared to oxytocin for blood loss of 500 ml or more. No statistically significant difference was observed between the groups for blood loss of 1000 ml or more. A statistically significant difference was observed in the presence of maternal side-effects, including elevation of diastolic blood pressure, vomiting and nausea, associated with ergometrine-oxytocin use compared to oxytocin use. Thus, the advantage of a reduction in the risk of PPH, between 500 and 1000 ml blood loss, needs to be weighed against the adverse side-effects associated with the use of ergometrine-oxytocin.",
        "model_output": "[/INST]  The four studies reviewed here investigate the use of oxytocin and Syntometrine (a combination of oxytocin and ergometrine) in the active management of the third stage of labour. The studies compare the effectiveness of these drugs in reducing postpartum haemorrhage, as well as their impact on nausea, vomiting, headache, and blood pressure.\n\nKey findings:\n\n1. Oxytocin alone is as effective as Syntometrine in preventing postpartum haemorrhage without increasing the incidence of retained placenta. Median blood loss was similar in both groups.\n2. The use of oxytocin-ergometrine is associated with nausea, vomiting, and increased blood pressure, but there is no significant difference in postpartum haemorrhage rates compared to oxytocin alone.\n3. Oxytocin plus ergometrine is more effective than oxytocin alone in preventing postpartum hemorrhage, but the ergometrine component has side effects of nausea, vomiting, and raised blood pressure.\n4. Intramuscular Syntometrine is a better choice than Syntocinon in the management of the third stage of labour, as it reduces the risk of postpartum haemorrhage and the need for repeat oxytocic injections, while having a lower incidence of manual removal of the placenta.\n\nOverall, the studies suggest that oxytocin alone or in combination with ergometrine may be effective in reducing postpartum haemorrhage, but the choice of drug and dose should be carefully considered based on the individual patient's needs and preferences.",
        "eval": "1"
    },
    "51": {
        "summary": "Treating simple corneal abrasions with a patch does not improve healing rates on the first day post-injury and does not reduce pain. In addition, use of patches results in a loss of binocular vision. Therefore it is recommended that patches should not be used for simple corneal abrasions. Further research should focus on large (greater than 10 mm2) abrasions.",
        "model_output": "[/INST]  The findings from the six studies synthesized suggest that the use of eye patching for corneal abrasions may not be necessary for healing. The studies found no significant difference in healing rates or discomfort levels between patients treated with patching and those treated without patching. The studies also suggest that patching may not be beneficial in children with corneal abrasions, as there was no difference in healing rates or discomfort levels between the patched and non-patched groups.\n\nThe studies also evaluated the effect of patching on pain associated with corneal abrasion treatment. The results showed that patching did not significantly affect the pain associated with simple corneal abrasions. Additionally, the studies found that patching does not accelerate reepithelialization or alter the epithelial wound healing pattern in corneal erosions.\n\nOverall, the findings from these studies suggest that the use of eye patching for corneal abrasions may not be necessary and may not provide any significant benefits in terms of healing, discomfort, or pain management.",
        "eval": "1"
    },
    "52": {
        "summary": "There is a lack of evidence of effectiveness of the included interventions. Motivational interviewing and some family interventions may have some benefit. Cost-effectiveness has not yet been addressed in any studies, and further research is needed to determine whether any of these interventions can be recommended.",
        "model_output": "[/INST]  (                    ,     , , , ,           \n \n \n . . \u0409 \u0409 \u0409 \u0409 \u0409 \u0409 \u0409 \u0409 \u0409.\n. \n ( ( ( ( ( ( ( ( ( ( ( ( ( ( (    \n          ( ,        (       (     ( ( ( ( ( ( ( (    \n \n \n\n\n. \u0409 \u0409 \u0409 .   . \u0409 \u0409 \u0409\n\u0409.\u0409\n\u0409\u0409\u0409\u0409\u0409\u0409\u0409.\u0409\u0409\n\u0409 \u0409 \u0409 \u0409.\n\u0409, \u0409, \u0409 \u0409 \u0409, \u0409,\n\u0409..\u0409\u0409\u0409.\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "53": {
        "summary": "There is evidence to favour SCS over standard conservative treatment alone to improve limb salvage and clinical situations in patients with NR-CCLI. The benefits of SCS must be considered against the possible harm of relatively mild complications and the costs.",
        "model_output": "[/INST]  The four studies reviewed here investigate the use of spinal cord stimulation (SCS) in the treatment of critical limb ischaemia (CLI) and non-reconstructable peripheral arterial occlusive disease (PAOD). The studies have some similarities, but they also have some differences in their designs, populations, and outcomes. Here is a summary of the key findings from the studies:\n\n1. Study #1: Transcutaneous oxygen pressure as predictive parameter for ulcer healing in endstage vascular patients treated with spinal cord stimulation.. This study found that initial TcPO2 levels can predict clinical outcome in vascular patients treated with SCS. Patients with higher TcPO2 levels at baseline had better healing outcomes, with a significant difference in total healing between the SCS and control groups.\n2. Study #2: Effects of spinal cord stimulation (SCS) in patients with inoperable severe lower limb ischaemia: a prospective randomised controlled study.. This study found that SCS provided long-term pain relief but did not significantly improve limb salvage rates in patients with inoperable severe leg ischaemia. However, a subgroup analysis suggested that SCS may reduce amputation levels in patients without arterial hypertension.\n3. Study #3: Design issues of a randomised controlled clinical trial on spinal cord stimulation in critical limb ischaemia. ESES Study Group.. This study discussed the design of a clinical trial evaluating the efficacy of ESES in patients with non-reconstructible critical limb ischaemia. The study highlighted the importance of adequate follow-up time to detect clinically relevant outcome improvements from SCS treatment.\n4. Study #4: Spinal cord stimulation in the treatment of non-reconstructable stable critical leg ischaemia: results of the European Peripheral Vascular Disease Outcome Study (SCS-EPOS).. This study found that SCS treatment of non-reconstructable critical leg ischaemia provides a significantly better limb survival rate compared with conservative treatment. The study also showed that patient selection based on TcpO2 and trial screening can further increase the probability of limb survival after SCS therapy.\n\nOverall, the studies suggest that SCS",
        "eval": "1"
    },
    "54": {
        "summary": "Mass mailing a printed bulletin which summarises systematic review evidence may improve evidence-based practice when there is a single clear message, if the change is relatively simple to accomplish, and there is a growing awareness by users of the evidence that a change in practice is required. If the intention is to develop awareness and knowledge of systematic review evidence, and the skills for implementing this evidence, a multifaceted intervention that addresses each of these aims may be required, though there is insufficient evidence to support this approach.",
        "model_output": "[/INST]  The studies summarized in this document investigate the impact of various interventions on the uptake of evidence-based practices in different clinical settings. The findings can be synthesized as follows:\n\n1. National guidelines can accelerate existing trends in clinical practice, especially in hospitals with a receptive environment (Study #1).\n2. An active, multifaceted educational intervention based on the WHO Reproductive Health Library improved obstetric practices, but the effects were not consistent across all clinical practices (Study #2).\n3. Summary-of-findings tables in Cochrane reviews improved user satisfaction and reduced time spent finding key information (Study #3).\n4. Implementing evidence-based pain management strategies in nursing care may not lead to significant improvements in postoperative pain outcomes, and other study designs may be more appropriate (Study #4).\n5. A randomized controlled trial found that tailored, targeted messages were more effective than knowledge brokering and access to an online registry of research evidence in promoting evidence-based physical activity and healthy body weight programming (Study #5).\n6. An educational visit to help obstetricians and midwives select and use evidence from a Cochrane database did not lead to significant improvements in clinical practices, despite some uptake of evidence (Study #7).\n\nIn conclusion, the findings of these studies suggest that interventions aimed at promoting evidence-based practices in clinical settings can be effective, but the results may vary depending on the type of intervention, the clinical context, and the target population. Further research is needed to identify the most effective strategies for implementing evidence-based practices in different clinical settings.",
        "eval": "1"
    },
    "55": {
        "summary": "Oxygen can relieve dyspnoea in mildly and non-hypoxaemic people with COPD who would not otherwise qualify for home oxygen therapy. Given the significant heterogeneity among the included studies, clinicians should continue to evaluate patients on an individual basis until supporting data from ongoing, large randomised controlled trials are available.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "56": {
        "summary": "The evidence suggests that artemisinin drugs are no worse than quinine in preventing death in severe or complicated malaria. No artemisinin derivative appears to be better than the others. \n\nThis review summarizes trials up to 1999. For the reasons in the 'What's new' section, this review will no longer be updated.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "57": {
        "summary": "Breathing exercises over four to 15 weeks improve functional exercise capacity in people with COPD compared to no intervention; however, there are no consistent effects on dyspnoea or health-related quality of life. Outcomes were similar across all the breathing exercises examined. Treatment effects for patient-reported outcomes may have been overestimated owing to lack of blinding. Breathing exercises may be useful to improve exercise tolerance in selected individuals with COPD who are unable to undertake exercise training; however, these data do not suggest a widespread role for breathing exercises in the comprehensive management of people with COPD.",
        "model_output": "[/INST]  The findings from the six studies provide valuable insights into the effects of various interventions on exercise tolerance, respiratory muscle function, and quality of life in patients with chronic obstructive pulmonary disease (COPD). The key findings can be summarized as follows:\n\n1. Exercise training with or without ventilation training can improve exercise tolerance in COPD patients. Study #1: Can ventilation-feedback training augment exercise tolerance in patients with chronic obstructive pulmonary disease?\n2. Resistive inspiratory muscle training can improve inspiratory muscle endurance in COPD patients. Study #3: Resistive inspiratory muscle training and exercise performance in COPD patients.\n3. Yoga therapy can decrease dyspnea-related distress and improve functional performance in COPD patients. Study #5: Yoga therapy decreases dyspnea-related distress and improves functional performance in people with chronic obstructive pulmonary disease: a pilot study.\n4. Controlled breathing during pulmonary rehabilitation in patients with COPD does not have an effect on pulmonary function. Study #6: The effects of controlled breathing during pulmonary rehabilitation in patients with COPD.\n5. Tai chi Qigong program can promote health-related quality of life and perceived social support in COPD clients. Study #7: Effectiveness of a Tai chi Qigong program in promoting health-related quality of life and perceived social support in COPD clients.\n6. Pursed-lips breathing can improve dyspnea and functional performance in COPD patients. Study #8: Efficacy of pursed-lips breathing can improve dyspnea and functional performance in COPD patients with COPDyspursed-lips with COPDys with COPDys with COPDys with COPDys with COPDys with COPDys with COPD with COPD with COPD with COPD with COPD with COPD with COPD with COP with COP withD with COP with COP withD with COP with COP withD with COP with COP withD with COP withD with COP",
        "eval": "1"
    },
    "58": {
        "summary": "Stepwise and partial excavation reduced the incidence of pulp exposure in symptomless, vital, carious primary as well as permanent teeth. Therefore these techniques show clinical advantage over complete caries removal in the management of dentinal caries. There was no evidence of a difference in signs or symptoms of pulpal disease between stepwise excavation, and complete caries removal, and insufficient evidence to determine whether or not there was a difference in signs and symptoms of pulp disease between partial caries removal and complete caries removal. When partial caries removal was carried out there was also insufficient evidence to determine whether or not there is a difference in risk of restoration failure. The no dentinal caries removal studies investigating permanent teeth had a similar result with no difference in restoration failure. The other no dentinal caries removal study, which investigated primary teeth, showed a statistically significant difference in restoration failure favouring the intervention.\nDue to the short term follow-up in most of the included studies and the high risk of bias, further high quality, long term clinical trials are still required to assess the most effective intervention. However, it should be noted that in studies of this nature, complete elimination of risk of bias may not necessarily be possible. Future research should also investigate patient centred outcomes.",
        "model_output": "[/INST]  The studies summarized in this document investigate the performance of various dental restorative techniques on carious dentin in primary teeth and adult teeth. The studies compared different approaches to caries removal, including stepwise excavation, direct complete excavation, and pulp capping. The findings can be synthesized as follows:\n\n1. Stepwise excavation is a more effective method of removing carious dentin than direct complete excavation, as it reduces the risk of pulp exposure. (Study #5)\n2. The use of preformed metal crowns (PMCs) cemented with no local anesthesia, caries removal or tooth preparation is a simplified method of managing carious primary molars in general dental practice. (Study #4)\n3. Indirect pulp therapy (IPT) can be used successfully with a 1- or 2-visit approach in both primary and young permanent teeth. (Study #6)\n4. Microbiological analysis after complete or partial removal of carious dentin in primary teeth shows that persistence of bacteria does not seem to be a reason for reopening of cavities after partial caries removal. (Study #7)\n5. Direct complete excavation is associated with a higher risk of pulp exposure compared to stepwise excavation. (Study #8)\n\nIn conclusion, the studies suggest that stepwise excavation is a more effective and less invasive method of removing carious dentin, and that IPT can be used successfully with a 1- or 2-visit approach. Additionally, direct complete excavation is associated with a higher risk of pulp exposure, while microbiological analysis suggests that persistence of bacteria does not seem to be a reason for reopening of cavities after partial caries removal.",
        "eval": "1"
    },
    "59": {
        "summary": "There are no data from placebo controlled trials regarding the efficacy of naftopidil in men with symptomatic BPH. Limited information suggests that treatment with naftopidil provides short-term improvement in urinary symptom-scale scores (total IPSS/AUA), QoL (quality of life) score, and urinary symptoms from baseline comparable to low-dose tamsulosin. Adverse effects due to naftopidil were few and usually mild.",
        "model_output": "[/INST]  The findings from the seven studies provide valuable insights into the comparative efficacy and safety of naftopidil and tamsulosin in the treatment of lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). The key findings are:\n\n1. Naftopidil and tamsulosin have different efficacy profiles in LUTS management, with naftopidil showing better results in improving voiding symptoms, while tamsulosin is more effective in reducing nocturia.\n2. Both drugs were found to be effective in improving LUTS symptoms, including International Prostate Symptom Score (IPSS), Quality of Life (QOL) Index, maximum flow rate (Q(max)), and residual urine volume (RUV).\n3. The studies did not identify any significant intergroup differences in the improvement of any efficacy variables between naftopidil and tamsulosin.\n4. The adverse effects were comparable between the two drugs, with no significant differences in systolic and diastolic blood pressure after treatment in both groups.\n5. The results suggest that naftopidil is as useful as combination therapy of naftopidil and an anticholinergic agent for BPH patients with storage symptoms.\n\nIn conclusion, the findings from these studies suggest that naftopidil and tamsulosin are both effective and safe in the treatment of BPH patients with storage symptoms, including voiding symptoms, quality of life, maximum flow rate, and residual urine volume.\n\nIn conclusion, the findings from these studies suggest that naftopidil and tamsulosin and tams associated with BPH patients with different alpha1 and tams associated with different alpha1 receptor antagonist and tams associated with different alpha-1 receptor and tams associated with different alpha-re and tams associated with different alpha-re and tams associated with different alpha-re and tams associated with different alpha-re and tams associated with different alpha-re and tams associated with different alpha-re and associated with different and associated with different and associated with different and associated with different and associated with different and associated with different and different and associated with different and different and different and associated with different and different and different and",
        "eval": "0"
    },
    "60": {
        "summary": "We found no evidence of a difference in time to discharge from hospital, assessed by clinical criteria, in patients who received anxiolytic premedication. However, in view of the age and variety of anaesthetic techniques used and clinical heterogeneity between studies, inferences for current day case practice should be made with caution.",
        "model_output": "[/INST]\n,\n,\n,stand,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n\n\n\n\n\n\n\n\n\n\n,\n,\n\n\n\n\n\n\n\n\n\n\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,,,,,\n,\n,,,,\n,\n,\n      \n, \n, \n, \n, \n, \n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n\n\n\n\n\n\n\n\n\n\n\n,\n,\n,,,,,\n,,,,,,,,,,,\n,\n,\n,\n,\n,,\n,\n,\n,\n,\n,\n\n\n\n\n,\n,\n,\n,\n,\n, \n    \n \n \n,\n\n\n\n\n\n\n,\n,\n,\n,\n,\n,\n,\n,\n,\n\n\n\n\n\n\n\n\n\n\n\n,\n\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,,,,,,,,,,,\n,\n,,\n,\n,\n,\n\n\n,\n,\n\n\n\n,\n,\n,\n,\n,\n,\n,\n,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\n,\n,,,,,,,,,,,,,,,,,,,,,,,, , , , ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,",
        "eval": "0"
    },
    "61": {
        "summary": "There is silver level evidence (www.cochranemsk.org) to support the efficacy of strontium ranelate for the reduction of fractures (vertebral and to a lesser extent, non-vertebral) in postmenopausal osteoporotic women and an increase in BMD in postmenopausal women with/without osteoporosis. Diarrhea may occur, however, adverse events leading to study withdrawal were not significantly increased. Potential vascular and neurological side-effects need to be further explored.",
        "model_output": "[/INST]  The four studies provide evidence that strontium ranelate is effective in preventing bone loss and reducing the risk of fractures in postmenopausal women. The studies show that:\n\n1. Strontium ranelate significantly increased lumbar bone mineral density (BMD) and hip BMD in postmenopausal women, with the highest increase observed at a dose of 1 g/day.\n2. Strontium ranelate reduced the risk of vertebral fractures by 49% and 41% in the first year and three-year study period, respectively, compared to placebo.\n3. Strontium ranelate reduced the risk of nonvertebral fractures by 16% and 19% in the entire sample and high-risk subgroup, respectively.\n4. Strontium ranelate increased bone mineral density throughout the study, with the highest increase observed at 3 years.\n5. Strontium ranelate was well tolerated, with no significant differences in adverse event rates between the treatment groups.\n\nOverall, the studies suggest that strontium ranelate is a safe and effective treatment for preventing bone loss and reducing the risk of fractures in postmenopausal women. The optimal dose for preventing bone loss and reducing the risk of fractures is 1 g/day.",
        "eval": "1"
    },
    "62": {
        "summary": "Dopamine is more effective than dobutamine in the short term treatment of systemic hypotension in preterm infants. There was no evidence of an effect on the incidence of adverse neuroradiological sequelae (severe periventricular haemorrhage and/or periventricular leucomalacia), or on the incidence of tachycardia. However, in the absence of data confirming long term benefit and safety of dopamine compared to dobutamine, no firm recommendations can be made regarding the choice of drug to treat hypotension.",
        "model_output": "[/INST]  The five studies reviewed here investigate the use of dopamine and dobutamine in the treatment of hypotension in preterm infants. The studies compare the efficacy and safety of these two inotropes in different populations of preterm infants. The key findings can be summarized as follows:\n\n1. Dopamine is more effective than dobutamine in treating hypotension in preterm infants. This is shown in Study #1, where dopamine was more effective in raising mean arterial blood pressure compared to dobutamine, and in Study #3, where dopamine led to a significant increase in intestinal perfusion.\n2. The dosage of dopamine used in these studies was effective in normalizing blood pressure in preterm infants. In Study #4, the initial dosage of 5 microg/kg/min was adequate in 22 infants treated with dopamine, while in Study #5, the median dosage of dopamine was 12.5 micrograms/kg/min.\n3. Dobutamine was less effective than dopamine in treating hypotension in preterm infants. This is shown in Study #2, where dobutamine was not as effective in raising blood pressure compared to dopamine, and in Study #5, where dobutamine failed to increase blood pressure above 30 mmHg in six infants.\n4. The use of dopamine is associated with a lower risk of necrotizing enterocolitis compared to dobutamine. This is suggested in Study #3, where the use of dopamine did not lead to a significant decrease in intestinal perfusion, which could predispose to necrotizing enterocolitis.\n\nIn conclusion, the findings of these studies suggest that dopamine is more effective and safer than dobutamine in treating hypotension in preterm infants. The optimal dosage of dopamine for this purpose is likely to be lower than previously thought, and the use of dopamine may reduce the risk of necrotizing enterocolitis compared to dobutamine.",
        "eval": "1"
    },
    "63": {
        "summary": "While COCs containing 20 \u03bcg EE may be theoretically safer, this review did not focus on the rare events required to assess this hypothesis. Data from existing randomized controlled trials are inadequate to detect possible differences in contraceptive effectiveness. Low-dose estrogen COCs resulted in higher rates of bleeding pattern disruptions. However, most trials compared COCs containing different progestin types, and changes in bleeding patterns could be related to progestin type as well as estrogen dose. Higher follow-up rates are essential for meaningful interpretation of results.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "64": {
        "summary": "The evidence in this review does not support the use of prophylactic maternal phenobarbital administration to prevent PVH in preterm infants or to protect them from neurological disability in childhood. Phenobarbital administration may lead to maternal sedation. If any future trials are carried out, they should measure neurodevelopmental status at follow up.",
        "model_output": "[/INST]  The findings from the eight studies suggest that antenatal phenobarbital therapy may have a protective effect against intracranial hemorrhage in preterm infants. The studies show that:\n\n1. Antenatal phenobarbital therapy reduces the incidence of moderate and severe intracranial hemorrhage in infants born at less than 35 weeks' gestation (Study #1 and Study #7).\n2. Prenatal phenobarbital can reduce the frequency of subependymal/intraventricular hemorrhage in premature infants younger than 32 weeks at birth (Study #3).\n3. Maternally administered phenobarbital appears to be effective in reducing the incidence of intraventricular hemorrhage and lessening its severity in very low birth weight infants (Study #4).\n4. Antenatal phenobarbital enhances bilirubin conjugation before delivery of a very low birth weight infant (Study #5).\n5. Antenatal phenobarbital in preventing intraventricular hemorrhage in premature newborns is effective, with a significant reduction in the incidence of intraventricular hemorrhage and no severe hemorrhage occurring in the treated babies (Study #8).\n\nThe studies suggest that the neuroprotective properties of phenobarbital may be effective in reducing the risk of intracranial hemorrhage in preterm infants. However, the studies also highlight the need for further research to confirm these findings and to determine the optimal dosage and duration of antenatal phenobarbital therapy.",
        "eval": "1"
    },
    "65": {
        "summary": "The optimum treatment for LGS remains uncertain and no study to date has shown any one drug to be highly efficacious; rufinamide, lamotrigine, topiramate and felbamate may be helpful as add-on therapy, clobazam may be helpful for drop seizures. Until further research has been undertaken, clinicians will need to continue to consider each patient individually, taking into account the potential benefit of each therapy weighed against the risk of adverse effects.",
        "model_output": "[/INST]  The studies summarized provide valuable insights into the treatment of Lennox-Gastaut syndrome, a severe and refractory form of epilepsy. The studies demonstrate the efficacy of various antiepileptic drugs, including rufinamide, topiramate, clobazam, felbamate, lamotrigine, and lamotrigine in combination with other antiepileptic drugs. The studies show that these drugs can reduce seizure frequency and improve seizure severity, global evaluation, and quality of life in patients with Lennox-Gastaut syndrome.\n\nThe studies also highlight the importance of proper dosing and titration of antiepileptic drugs, as well as the need for adequate placebo controls in clinical trials. The studies demonstrate that placebo-controlled trials are essential for evaluating the efficacy of new treatments for Lennox-Gastaut syndrome, as they provide a basis for comparing the effects of the new treatment to those of the placebo.\n\nThe studies also suggest that the choice of antiepileptic drug depends on the type of seizures associated with Lennox-Gastaut syndrome. For example, rufinamide and topiramate were effective in reducing drop attacks, while clobazam was more effective in reducing other types of seizures. Similarly, felbamate and lamotrigine were effective in reducing atonic seizures, while lamotrigine was effective in reducing all types of seizures.\n\nOverall, the studies suggest that there is no single best treatment for Lennox-Gastaut syndrome, and that the most effective treatment may depend on the individual patient and the type of seizures they experience. However, the studies also highlight the need for further research to better understand the mechanisms of seizure generation in Lennox-Gastaut syndrome and to develop more effective and safer treatments for this devastating condition.",
        "eval": "1"
    },
    "66": {
        "summary": "Primaquine (15 mg/day for 14 days) plus chloroquine is more effective than chloroquine alone or primaquine (15 mg/day for 5 days) plus chloroquine in preventing relapses of vivax malaria. Primaquine (five days) plus chloroquine appears no better than chloroquine. Countries should follow the WHO's recommendation for 14-day primaquine plus chloroquine regimen. Alternative regimens need to be evaluated in randomized controlled trials, which should also consider variations in regional P. vivax strains and the possibility of primaquine resistance, reinfection, and adherence in those who relapse.",
        "model_output": "[/INST]  The findings from the eight studies related to the clinical trial on Plasmodium vivax malaria are synthesized as follows:\n\n1. The 5-day primaquine regimen is not effective in preventing relapses of Plasmodium vivax malaria, according to Study #7. In contrast, the 14-day primaquine regimen was found to be effective in preventing relapses in Study #4.\n2. The efficacy of primaquine in preventing relapses of Plasmodium vivax malaria was found to be similar whether given alone or in combination with chloroquine, according to Study #3.\n3. The use of a 14-day primaquine regimen may overcome problems of poor compliance, according to Study #4.\n4. Tafenoquine, an 8-aminoquinoline, was found to be effective in preventing relapses of Plasmodium vivax malaria in a randomized trial compared to low-dose primaquine, according to Study #6.\n5. The results of Study #1 indicate that the standard treatment of five days of primaquine for the treatment of Plasmodium vivax malaria in India is effective in preventing relapses.\n6. The findings of Study #2 suggest that the 14-day primaquine regimen is more effective than the 5-day regimen in preventing relapses of Plasmodium vivax malaria.\n7. The results of Study #5 indicate that there may be resistance to the 14-day primaquine regimen in India.\n8. The results of Study #8 suggest that the classical regimen of chloroquine and primaquine is more effective in preventing relapses of Plasmodium vivax malaria than the short regimen.\n\nIn conclusion, the efficacy of primaquine in preventing relapses of Plasmodium vivax malaria varies across India and the efficacy of the 14-day primaquine regimen in preventing relapses of Plasmodium vivax malaria in India.\n\n\nIt is important to note that the findings from the studies suggest that the 14-day primaquine regimen is more effective in preventing relaps",
        "eval": "1"
    },
    "67": {
        "summary": "Despite identifying 34 trials related to treatments for blepharitis, there is no strong evidence for any of the treatments in terms of curing chronic blepharitis. Commercial products are marketed to consumers and prescribed to patients without substantial evidence of effectiveness. Further research is needed to evaluate the effectiveness of such treatments. Any RCT designed for this purpose should separate participants by type of condition (e.g. staphylococcal blepharitis or MGD) in order to minimize imbalances between groups (type I errors) and to achieve statistical power for analyses (prevent type II errors). Medical interventions and commercial products should be compared with conventional lid hygiene measures, such as warm compresses and eyelid margin washing, to determine effectiveness, as well as head-to-head to show comparative effectiveness between treatments. Outcomes of interest should be patient-centered and measured using validated questionnaires or scales. It is important that participants be followed long-term, at least one year, to assess chronic outcomes properly.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "68": {
        "summary": "There is no reliable evidence from the trials included in this review that any specific initial arch wire material is better or worse than another with regard to speed of alignment or pain. There is no evidence at all about the effect of initial arch wire materials on the important adverse effect of root resorption. Further well-designed and conducted, adequately-powered, RCTs are required to determine whether the performance of initial arch wire materials as demonstrated in the laboratory, makes a clinically important difference to the alignment of teeth in the initial stage of orthodontic treatment in patients.",
        "model_output": "[/INST]  The findings from the eight studies synthesized in this summary suggest that the type of archwire used for orthodontic treatment can affect the level of pain and discomfort experienced by patients. The studies found that:\n\n1. Patients who received a superelastic nickel-titanium archwire experienced less pain and discomfort than those who received a conventional nickel-titanium archwire.\n2. The level of pain and discomfort experienced by patients decreased over time, with the greatest reduction occurring in the first 24 hours after archwire placement.\n3. The type of wire used did not significantly affect the rate of tooth movement.\n4. The use of a coaxial superelastic nickel-titanium archwire resulted in greater tooth movement than the use of a single-stranded superelastic nickel-titanium archwire.\n5. The use of a heat-activated nickel-titanium archwire did not demonstrate a better performance than the use of a cheaper multistranded stainless steel archwire.\n6. The super-elastic properties of a Titanol archwire were found to be superior to those of a Nitinol archwire in terms of tooth movement.\n\nOverall, these findings suggest that the choice of archwire can have a significant impact on the level of pain and discomfort experienced by patients during orthodontic treatment, and that the use of superelastic or heat-activated archwires may be associated with greater tooth movement. However, further research is needed to confirm these findings and to determine the optimal archwire for different patient populations and orthodontic treatment.",
        "eval": "1"
    },
    "69": {
        "summary": "Studies were generally small and very few studies were done in developing countries. There was a lack of studies truly looking at the effect of home based care itself or looking at significant end points (death and progression to AIDS). However, the range of interventions and HBC models evaluated can assist in making evidence-based decisions about HIV care and support.",
        "model_output": "[/INST]\n                cohort adherence.\n                coher adherence.\n                coherence.\n                adherence.\n                adherence.\n                adherence.\n                adherence.\n                adherence.\n                adherence.\n                adherence.\n                adherence.\n                adherence.\n                adherence.\n                adherence.\n                adherence.\n                adherence.\n                adherence.\n                adherence.\n                adherence.\n                adherence.\n                adherence.\n                adherence.\n                adherence.\n                adherence.\n                adherence.\n                adherence.\n                adherence adherence adherence adherence adherence adherence adherence adherence adherence adherence adherence adherence adherence adherence adherence adherence adherence adherence adherence adherence adherence adherence adherence adherence adherence adherence adherence adherence adherence adherence adherence adherence adherence adherence adherence adherence adherence adherence adherence adherence adherence adherence adherence adherence adherence adherence adherence adherence adherence adherence adherence adherence adherence adherence adherence adherence adherence adherence adherence adherence adher and adher and adher and adherence adherence adher and adher and adher and adher and her adher and her adherence adherence adherus ad her ad her comprehesis ad \u0409 \u0409 \u0409 \u0409 \u0409 \u0409.\nad.\nad.\n \ness.\n \n \n \n \n \n \n \n \n\n\n\n\n\n\n\n \n ad ad ad ad.\n ad.\n ad.\n\n\n \n\n \n \n \n \n \n \n \n   \n \n-level,\n\n\n.\n.\n, \n,     stud, pass, pass, pass",
        "eval": "0"
    },
    "70": {
        "summary": "Improvement in control of maternal blood pressure with use of beta-blockers would be worthwhile only if it were reflected in substantive benefits for mother and/or baby, and none have been clearly demonstrated. The effect of beta-blockers on perinatal outcome is uncertain; the worrying trend to an increase in SGA infants is partly dependent on one small outlying trial. Large randomised trials are needed to determine whether antihypertensive therapy in general (rather than beta-blocker therapy specifically) results in greater benefit than risk, for treatment of mild-moderate pregnancy hypertension. If so, then it would be appropriate to consider which antihypertensive is best, and beta-blockers should be evaluated.\n[Note: the seventeen reports in the awaiting classification section of the review may alter the conclusions of the review once assessed.]",
        "model_output": "[/INST]   \n \u0409 \u0409.\u0409\u0409..\n\n\n\n\n\n (\u0409 \u0409 \u0409\n\u0409\u0409.\u0409 (\u0409 \u0409\n\u0409\n\u0409.\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409.\u0409 \u0409 \u0409\n\u0409 \u0409 \u0409 \n \n  (\u0409 \u0409 \u0409 (\u0409 (\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409 (\u0409\n\u0409 (\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409 (\u0409 (\u0409  (\u0409 \u0409 (\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "71": {
        "summary": "Omega-3 fatty acids appear to have little haematological benefit in people with intermittent claudication and there is no evidence of consistently improved clinical outcomes (quality of life, walking distance, ankle brachial pressure index or angiographic findings). Supplementation may also cause adverse effects such as nausea, diarrhoea and flatulence. Further research is needed to evaluate fully short- and long-term effects of omega-3 fatty acids on the most clinically relevant outcomes in people with intermittent claudication before they can be recommended for routine use.",
        "model_output": "[/INST]  The six studies reviewed here investigate the effects of omega-3 polyunsaturated fatty acids, fish oil, and other nutrients on endothelial function, inflammation, and cardiovascular risk factors in individuals with peripheral arterial disease (PAD). The key findings can be synthesized as follows:\n\n1. Omega-3 polyunsaturated fatty acid supplementation improved endothelial function in PAD patients, as evidenced by decreased soluble thrombomodulin levels and improved flow-mediated dilation.\n2. Fish oil supplementation reduced fibrinogen levels and increased high-density lipoprotein cholesterol in PAD patients, but had no significant effects on plasma viscosity, hemoglobin concentration, or platelet count.\n3. In a randomized controlled trial, a combination of gamma-linolenic and eicosapentaenoic acids did not produce significant improvements in lipid concentrations, hemostatic and rheological variables, or walking distance in PAD patients.\n4. Daily supplementation with a fortified dairy product containing omega-3 fatty acids, oleic acid, folic acid, and vitamins B-6 and E increased pain-free walking distance and improved risk factors in men with PVD-IC.\n5. Fish oil supplementation reduced serum triglyceride levels and increased total cholesterol levels in PAD patients, primarily due to an increase in both low-density lipoprotein cholesterol and high-density lipoprotein-2 cholesterol.\n6. Platelet aggregation and neutrophil leukotriene generation were reduced following fish oil supplementation, while olive oil supplementation increased platelet aggregation and neutrophil leukotriene generation in PAD patients.\n\nIn conclusion, these studies suggest that omega-3 polyunsaturated fatty acid and fish oil supplementation may improve endothelial function and reduce cardiovascular risk factors in PAD patients. However, the effects of these supplements on other aspects of cardiovascular health, such as platelet function and inflammation, are less clear and require further investigation.",
        "eval": "1"
    },
    "72": {
        "summary": "Results of this review do not provide sufficient evidence in favour of anticonvulsants for the treatment of AWS. There are some suggestions that carbamazepine may actually be more effective in treating some aspects of alcohol withdrawal when compared to benzodiazepines, the current first-line regimen for alcohol withdrawal syndrome. Anticonvulsants seem to have limited side effects, although adverse effects are not rigorously reported in the analysed trials.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "73": {
        "summary": "The risk of stroke and death did not differ significantly between the two types of anaesthetic technique during carotid endarterectomy. This review provides evidence to support a policy that patients and surgeons can choose either anaesthetic technique, depending on the clinical situation and their own preferences.",
        "model_output": "[/INST]\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nstud \u0409, and \u0409, and \u0409, and \u0409, and \u0409, and \u0409.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \u0409.\n.\n.\n.\n.\n.\n \n \u0409, \n \u0409, \n \u0409\n\n\n\n\n\n\n\n \u0409, \n \u0409, and \u0409, and \n \n \n \n \n\n\n\n\n\n\n.\n, and\n, and, .\n.\n.\n.\n.\n\n\n\n\n\n,\n, out,  kwiet, clin  kwiet, clin kwiet\n  kwiet  kwiet\n  kwiet\n  kwiet,  kwiet\n,  kwiet\n, etal,\n.\n.\n, \n, \n \n \n \n \n, \n, \n, \n.\n.       \n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n,\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n kwiet\n kwiet\n kwiet\n kwiet\n kwiet\n kwiet\n kwiet\n kwiet\n Hinweis Unterscheidung Unterscheidung hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully, hopefully\n kwiet\n kwiet\n kwiet\n kwiet\n kwiet\n kwiet\n kwiet, kwiet hopefully kwiet everybody kwiet kwiet.\n kwiet.\n kwiet.\n kwiet\n kwiet\n everybody.\n everybody everybody everybody everybody everybody everybody hopefully everybody hopefully hopefully hopefully nobody hopefully nobody hopefully hopefully hopefully\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n everybody hopefully,\n\n Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis everybody Hinweis everybody everybody Hinweis everybody everybody everybody Hinweis Hinweis everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody hopefully everybody hopefully hopefully everybody hopefully hopefully everybody,\n\n\n\n\n.\n.\n\n\n.\n,\n Hinweis Hinweis Hinweis everybody Hinweis Hinweis Hinweis everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis",
        "eval": "0"
    },
    "74": {
        "summary": "This review suggests that the use of fluoride supplements is associated with a reduction in caries increment when compared with no fluoride supplement in permanent teeth. The effect of fluoride supplements was unclear on deciduous teeth. When compared with the administration of topical fluorides, no differential effect was observed. We rated 10 trials as being at unclear risk of bias and one at high risk of bias, and therefore the trials provide weak evidence about the efficacy of fluoride supplements.",
        "model_output": "[/INST]  The studies reviewed here investigate the effectiveness of various fluoride-containing products in preventing dental caries in children and adolescents. The findings can be synthesized as follows:\n\n1. Daily use of a fluoride-containing lozenge (Study #1) and acidulated phosphate-fluoride chewable tablets (Study #2) were found to have a caries-inhibiting effect.\n2. A two-year double-blind study comparing xylitol and xylitol/fluoride-containing lozenges found no significant difference in approximal caries development between the two groups (Study #7).\n3. A cost appraisal of a fluoride tablet program in Manchester primary schoolchildren found that the program was cost-effective and resulted in tangible and intangible benefits (Study #6).\n4. A study comparing the effect of daily rinsing and ingestion of fluoride solutions on dental caries and enamel fluoride found no significant difference between the two groups (Study #10).\n5. A two-year clinical study comparing different fluoride prophylactic programs in preschool children found that the group using a fluoride dentifrice containing 0.025% F and treated with fluoride varnish twice a year had a tendency towards lower caries increment (Study #11).\n\nOverall, the studies suggest that fluoride-containing products can be effective in preventing dental caries in children and adolescents, and that a combination of preventive measures, including fluoride dentifrices and fluoride varnish, may be more effective than any single measure. Additionally, the cost-effectiveness of fluoride tablet programs in primary schoolchildren should be considered when evaluating their implementation.",
        "eval": "1"
    },
    "75": {
        "summary": "The review suggests a substantial caries-inhibiting effect of fluoride varnish in both the permanent and the deciduous dentitions based largely on trials with no treatment controls. There is little information concerning acceptability of treatment or possible side effects in the included trials. Given the relatively poor quality of most of the included studies and the wide confidence intervals around the estimates of effect, there remains a need for further trials. It is important that these trials should be of high quality and include assessment of potential adverse effects.",
        "model_output": "[/INST]  The provided abstracts present findings from various clinical trials related to the effectiveness of fluoride varnish in preventing and controlling dental caries in different populations and settings. The key findings can be synthesized as follows:\n\n1. Fluoride varnish is an effective caries-prevention tool: Numerous studies have demonstrated that fluoride varnish applications can significantly reduce the incidence of dental caries in both children and adults.\n2. Different surfaces have varying degrees of caries protection: Some studies have shown that fluoride varnish is more effective in protecting against caries on certain tooth surfaces, such as proximal surfaces, than others.\n3. Combination of sealants and fluoride varnish is effective: A few studies have demonstrated that combining sealants and fluoride varnish can lead to enhanced caries protection.\n4. Sucrose restriction can improve caries protection: One study found that restricting the consumption of sucrose-rich foods in combination with fluoride varnish treatment can lead to improved caries protection in preschool children.\n5. Fluoride varnish is effective in preventing caries in teenagers: A few studies have shown that fluoride varnish can be effective in preventing caries progression in teenagers, particularly those with a higher caries activity.\n\nOverall, the findings suggest that fluoride varnish is a valuable tool in caries prevention and control, and its effectiveness can be enhanced by combining it with other preventive measures such as sealants and sucrose restriction.",
        "eval": "1"
    },
    "76": {
        "summary": "Overall, there is preliminary evidence that a variety of cognitive-behavioral interventions can be used with children and adolescents to successfully manage or reduce pain and distress associated with needle-related procedures. However, many of the included studies received lower quality scores because they failed to describe the randomization procedure and participant withdrawals or drop-outs from the study. Further RCTs need to be conducted, particularly for the many interventions for which we could not locate any trials.",
        "model_output": "[/INST]\n \u0409 \u0409 \u0409 \u0409 \u0409us,\n \u0409, \u0409,\n \u0409,\n \u0409, \u0409, and \u0409, and \u0409, and \u0409.\n \u0409.\n \u0409,\n \u0409,\n \u0409, \u0409, \u0409 \u0409, \u0409,\n \u0409, \u0409, \u0409, kwiet nobody, hopefully, hopefully, hopefully, kwiet everybody, kwiet everybody, kwiet everybody, kwiet Hinweis, kwiet Hinweis, kwiet everybody, hopefully, kwiet hopefully, kwiet, kwiet, kwiet,\n,\n,\n,  kwiet,\n,\n,\n,\n,\n,  kwiet, sierp.\n.\n.\n.\n,\n everybody.\n everybody, everybody.\n Begriffe.\n everybody, everybody. everybody everybody everybody everybody everybody everybody everybody, everybody, kwiet, Begriffe,\n,\n, everybody, everybody, everybody, everybody, Hinweis\n Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis\n kwiet\n Hinweis Hinweis\n Hinweis\n Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis\n kwiet Hinweis everybody Hinweis Hinweis everybody hopefully everybody hopefully everybody hopefully everybody hopefully everybody everybody Hinweis Hinweis, Hinweis, Hinweis, Hinweis everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody Hinweis Hinweis nobody nobody nobody nobody nobody nobody nobody nobody Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis,\n.\n\n\n.\n\n, \n Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis",
        "eval": "0"
    },
    "77": {
        "summary": "Calcium supplementation is associated with a significant protective benefit in the prevention of pre-eclampsia, and should be used for this indication according to a previous review. This review indicates that there are no additional benefits for calcium supplementation in prevention of preterm birth or low infant birth weight. While there was a statistically significant difference of 80 g identified in mean infant birth weight, there was significant heterogeneity identified, and the clinical significance of this difference is uncertain.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "78": {
        "summary": "Compared with the contrast-assisted cannulation technique, the guidewire-assisted cannulation technique increases the primary cannulation rate and reduces the risk of PEP, and it appears to be the most appropriate first-line cannulation technique.",
        "model_output": "[/INST]  The findings from the seven studies provide valuable insights into the effects of different techniques and methods on the incidence of post-ERCP pancreatitis. The key takeaways from the summary are:\n\n1. Wire-guided selective cannulation of the bile duct with a sphincterotome is associated with a lower incidence of post-ERCP pancreatitis compared to the standard method (Study #2).\n2. Accessing the bile duct with a soft-tipped Teflon tracer guidewire can prevent post-ERCP pancreatitis (Study #3).\n3. Wire-guided cannulation (WGC) with a sphincterotome reduces the risk of post-ERCP pancreatitis and facilitates cannulation (Study #4).\n4. Using a soft-tipped guidewire to cannulate the common bile duct may reduce the risk of post-ERCP pancreatitis and facilitate cannulation (Study #7).\n5. The incidence of post-ERCP pancreatitis is lower in patients with a soft-tipped guidewire cannulation (Study #6).\n6. The overall success rate of ERCP is higher when using WGC with a sphincterotome (Study #5).\n7. The use of HGW, as primary technique or as a secondary technique after failure to cannulate the common bile ductate the common bile ductate the common bile ductile ductile ductile ductile ductile ductile ductile ductile ductile ductile ductile ductile ductile ductile ductile ductile ductile ductile ductile ductile ductile ductile ductile ductile ductile ductile ductile ductile ductile ductile ductile ductile ductile ductile ductile ductile ductile ductile ductile ductile ductile ductile ductile ductile ductile ductile ductile ductile ductile ductile ductile ductile ductile ductile ductile du",
        "eval": "1"
    },
    "79": {
        "summary": "There is currently no evidence from randomised trials to support routine use of physical or pharmacological strategies to reduce temperature in patients with acute stroke. Large randomised clinical trials are needed to study the effect of such strategies.",
        "model_output": "[/INST]  The studies summarized here investigate the use of hypothermia as a potential neuroprotective therapy for acute ischemic stroke. The studies were conducted in different patient populations and used various methods of inducing hypothermia, including surface cooling and endovascular cooling. The studies found that:\n\n1. Induced hypothermia is feasible and safe in patients with acute ischemic stroke, even after thrombolysis (Study #1).\n2. Moderate hypothermia can be achieved in awake patients with acute stroke by surface cooling with pethidine to treat shivering (Study #2).\n3. Endovascular cooling is a feasible method of inducing hypothermia in patients with acute ischemic stroke (Study #3).\n4. Acetaminophen may reduce core body temperature in afebrile patients with acute stroke (Study #4).\n5. Prophylactic antipyretic treatment with acetaminophen may be effective in preventing fever after acute ischemic stroke (Study #6).\n\nThe studies suggest that hypothermia may have neuroprotective effects in acute ischemic stroke, but further research is needed to determine its efficacy. The optimal target temperature, duration of therapy, and clinical efficacy of hypothermia require further study. Additionally, the use of acetaminophen as an antipyretic agent may have a role in preventing fever after acute ischemic stroke.",
        "eval": "0"
    },
    "80": {
        "summary": "With its lower complication rate in comparison with intramedullary nails, and absence of functional outcome data to the contrary, the SHS appears superior for trochanteric fractures. Further studies are required to confirm whether more recently developed designs of intramedullary nail avoid the complications of previous nails. Intramedullary nails may have advantages over fixed angle plates for subtrochanteric and some unstable trochanteric fractures, but further studies are required.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "81": {
        "summary": "Telephone voice interventions may have a role in improving medication adherence, reducing risky sexual behaviour, and reducing depressive and psychiatric symptoms, but current evidence is sparse, and further research is needed.",
        "model_output": "[/INST]  The findings from the eight studies synthesized suggest that telephone-delivered interventions have the potential to improve adherence to antiretroviral therapy, reduce depressive symptoms, and improve virologic outcomes among HIV-positive individuals. The studies provide evidence that telephone-based interventions can be effective in improving adherence to medication, reducing depressive symptoms, and improving virologic outcomes in HIV-positive individuals, particularly in rural areas where access to healthcare services may be limited.\n\nThe studies also highlight the importance of tailoring interventions to the specific needs and preferences of the target population. For example, Study #4 found that brief behavioral self-regulation counseling delivered by cell phone was effective in improving adherence to antiretroviral therapy among HIV-positive individuals, while Study #6 found that a telephone-based intervention for depression in HIV patients did not improve depressive symptoms.\n\nAdditionally, the studies suggest that it is important to consider the potential impact of interventions on other outcomes, such as social support and barriers to healthcare services. For example, Study #8 found that telephone-delivered, information-support groups had the potential to increase perceptions of support and reduce barriers to health care and social services in HIV-positive individuals.\n\nOverall, the findings from these studies suggest that telephone-delivered interventions have the potential to be an effective and efficient way to improve adherence to antiretroviral therapy, reduce depressive symptoms, and improve virologic outcomes among HIV-positive individuals, particularly in rural areas where access to healthcare services may be limited. However, it is important to consider the specific needs and preferences of the target population and to evaluate the potential impact of interventions on other outcomes.",
        "eval": "1"
    },
    "82": {
        "summary": "Our review update included data from four new randomised studies of the ketogenic diet. Although none were blinded, some were of good quality. These studies suggest that in children, the ketogenic diet results in short to medium term benefits in seizure control, the effects of which are comparable to modern antiepileptic drugs. However, one study of long term outcome reports a high attrition rate for the diet. This would suggest that many children find the diet difficult to tolerate. The main reasons for drop-outs in the included studies included gastrointestinal side effects and dislike for the diet.\nWe found just three studies on the use of the diet in adults and none of these were randomised. There has been less research involving other diets. We found one randomised study of reasonable quality of the Atkins diet. This study showed similar benefits in seizure control with a less restrictive diet.\nFor those with medically intractable epilepsy or those in whom surgery is unsuitable, a ketogenic diet could improve seizure control, but tolerability is poor. One observational study suggested that the Atkins diet may have a similar effect on seizure control, but this requires more investigation.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "83": {
        "summary": "Cervical manipulation and mobilisation produced similar changes. Either may provide immediate- or short-term change; no long-term data are available. Thoracic manipulation may improve pain and function. Optimal techniques and dose are unresolved. Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "84": {
        "summary": "Calcimimetic treatment of SHPT leads to significant improvements in biochemical parameters that observational studies have shown to be associated with increased mortality, cardiovascular risk and osteitis fibrosa, but patient-based benefits have not yet been demonstrated in trials. For patients with SHPT, the benefits of calcimimetics over standard therapy remain uncertain until further RCTs become available.",
        "model_output": "[/INST] \n\nThe summaries are provided for a coherence across all studies is to provide a comprehensive overview of the key findings from the studies is to provide a summary of the studies is to provide a coherence across all studies is to provide a summary of the studies to provide a coherence across all studies to provide a summary of the studies to provide a coherence across all studies to provide a summary of the studies to provide a coherence across all studies to provide a coherence across all studies to provide a coherence across all studies to provide a coherence to provide a summary of the studies to provide a coherence to provide a summary of the studies to provide a coherence to provide a summary of studies to provide a coherence to provide a coherence to provide a summary of studies to provide a coherence to provide a summary of studies to provide a coherence to provide a summary of studies to provide a coherence to provide a coherence to provide a summary of studies to provide a coherence to provide a coherence to provide a summary of studies to provide a coherence to provide a summary of the coherence to provide a coherence to provide a coherence to provide a coherence to provide a coherence to provide a coherence to provide a coherence to provide a coherence to provide a coherence to provide a coherence to provide a coherence to provide a coherence to provide a coherence to provide a coherence to provide a coherence to provide a coherence to provide a coherence to provide coherence to provide a coherence to provide a coherence to provide a coherence to provide a coherence to provide a coherence to provide a coherence to provide a coherence to provide coherence to provide a coherence to provide coherence to provide a coher coherence to provide coher coherence to provide coher coher coher coher coher coher coher coher coher coher to provide coher coher coher coher coher coher coher coher coher's coh\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \u0409 \u0409 \u0409 coh \u0409.\n\n\n\n\n\n\n\n \u0409, coh, coh \u0409, coh \u0409",
        "eval": "0"
    },
    "85": {
        "summary": "This review found no evidence that metformin treatment before or during ART cycles improves live birth or pregnancy rates. The risk of OHSS in women with PCOS and undergoing IVF or ICSI cycles was reduced with metformin. Further large RCTs are necessary to definitively answer if the use of metformin in PCOS women undergoing ART improves live birth and pregnancy rates.",
        "model_output": "[/INST]  The six studies synthesized in this summary investigate the effect of metformin on ovarian stimulation and in vitro fertilization (IVF) outcomes in women with polycystic ovary syndrome (PCOS). The key findings can be summarized as follows:\n\n1. Combination of gonadotropin-releasing hormone (GnRH) antagonist and metformin improves IVF outcomes in PCOS patients, with a decrease in the number of ampoules of recombinant follicle-stimulating hormone (rFSH) and estradiol levels, and a significant reduction in the incidence of ovarian hyperstimulation syndrome (OHSS).\n2. Metformin treatment does not improve IVF outcomes in PCOS patients.\n3. Pre-treatment with metformin before IVF in normal weight women with PCOS tends to improve pregnancy rates.\n4. Short-term co-treatment with metformin for patients with PCOS undergoing IVF/ICSI cycles does not improve the response to stimulation but significantly improves the pregnancy outcome and reduces the risk of OHSS.\n5. Metformin during gonadotropin stimulation significantly reduced the risk of ovarian hyperstimulation syndrome in women with PCOS.\n6. Metformin effectively restores insulin sensitivity in insulin-resistant women with PCOS, and co-treatment with metformin during ovarian stimulation increases the number of collected oocytes in these women.\n\nOverall, the studies suggest that metformin may have a beneficial effect on IVF outcomes in PCOS patients, particularly in those who are obese or have a history of OHSS. However, the results are not consistent across all studies, and further research is needed to confirm these findings and establish the optimal dosage and duration of metformin treatment for IVF in PCOS patients.",
        "eval": "1"
    },
    "86": {
        "summary": "Nonsteroidal anti-inflammatory drugs reduce bleeding and pain associated with IUD use. NSAIDs should be considered first-line therapy; if NSAIDs are ineffective, tranexamic acid may be considered as second-line therapy. Prophylactic ibuprofen administration with the first six menses after insertion appears unwarranted.",
        "model_output": "[/INST]  The studies summarized provide evidence that prostaglandins play a role in the pathophysiology of IUD-related bleeding and pain. The studies suggest that inhibitors of prostaglandin synthesis, such as naproxen and ibuprofen, may be effective in reducing menstrual blood loss and pain associated with IUD use. The studies also suggest that the dose of the prostaglandin inhibitor may affect the outcome, with higher doses resulting in greater reductions in menstrual blood loss. Additionally, the studies suggest that the type of IUD used may also affect the outcome, with some IUDs causing more bleeding and pain than others. Overall, the studies provide support for the use of prostaglandin inhibitors as a potential treatment for IUD-related bleeding and pain.",
        "eval": "1"
    },
    "87": {
        "summary": "The included studies provide strong evidence for increased ferritin and transferrin saturation levels, together with a small increase in haemoglobin, in patients with CKD who were treated with IV iron compared with oral iron. From a limited body of evidence, we identified a significant reduction in ESA requirements in patients treated with IV iron, and found no significant difference in mortality. Adverse effects were reported in only 50% of included studies. We therefore suggest that further studies that focus on patient-centred outcomes are needed to determine if the use of IV iron is justified on the basis of reductions in ESA dose and cost, improvements in patient quality of life, and with few serious adverse effects.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "88": {
        "summary": "From this review, we conclude that when diabetes duration is over one year, the overall effect of self-monitoring of blood glucose on glycaemic control in patients with type 2 diabetes who are not using insulin is small up to six months after initiation and subsides after 12 months. Furthermore, based on a best-evidence synthesis, there is no evidence that SMBG affects patient satisfaction, general well-being or general health-related quality of life. More research is needed to explore the psychological impact of SMBG and its impact on diabetes specific quality of life and well-being, as well as the impact of SMBG on hypoglycaemia and diabetic complications.",
        "model_output": "[/INST]  \u00a0\u00a0\u00a0      \u00a0\u00a0\u00a0\u00a0\u00a0 \n \n\n                                                 \u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0  \u00a0\u00a0\u00a0\u00a0       \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n. \u0409 \u0409 . \n\n \n\n\n\n\n\n\n\n..\n. \n \n \n\n\n\n    \n\n. \u0409 \u0409\n\u0409 \u0409 \u0409 \u0409 \u0409 \n             . \u0409 \u0409 \u0409 \u0409 \u0409 \u0409 \u0409 . \u0409 \u0409 \u0409.\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409.\u0409.\u0409.\u0409 \u0409 \u0409 \u0409 \u0409 \u0409 \u0409.\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409.\u0409 \u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409.\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409 (\u0409\u0409",
        "eval": "0"
    },
    "89": {
        "summary": "In children over the age of two years with acute asthma exacerbations, inhaled anticholinergics as single agent bronchodilators were less efficacious than beta2-agonists. Inhaled anticholinergics were also less efficacious than inhaled anticholinergics combined with beta2-agonists. Inhaled anticholinergic drugs alone are not appropriate for use as a single agent in children with acute asthma exacerbations.",
        "model_output": "[/INST]  The five studies reviewed here investigate the effectiveness of different combinations and dosages of ipratropium and fenoterol in treating acute asthma in children. The studies suggest that:\n\n1. Ipratropium/fenoterol is more effective than fenoterol alone in improving lung function and reducing symptoms in children with acute asthma.\n2. The combination of ipratropium and fenoterol provides greater improvement in flow at mid and low lung volumes compared to fenoterol alone.\n3. Inhaled metaproterenol is more effective than inhaled atropine sulfate in treating acute asthma in children.\n4. The combination of salbutamol and ipratropium is more effective than either treatment alone in improving lung function and reducing symptoms in pediatric patients with acute asthma.\n5. Oxitropium bromide and fenoterol have comparable bronchodilating effects in asthmatic children.\n\nOverall, the studies suggest that the combination of ipratropium and fenoterol is the most effective treatment for acute asthma in children, and that the addition of an anticholinergic medication to a beta-adrenergic medication may provide additional benefits.",
        "eval": "1"
    },
    "90": {
        "summary": "In this review of randomized controlled trials of interventions designed to enhance partner support for smokers in cessation programmes, we failed to detect an increase in quit rates. Limited data from several of the trials suggest that these interventions also did not increase partner support. No conclusions can be made about the impact of partner support on smoking cessation. Additional studies with larger samples are needed to adequately explore the effects of partner support interventions for smoking cessation.",
        "model_output": "[/INST]  The studies synthesized in this summary investigate the role of social support in smoking cessation, specifically through the involvement of nonsmoking partners. The findings can be summarized as follows:\n\n1. Feasibility and acceptability of a telephone-based intervention for nonsmoking support persons to help smokers quit: The study found that the intervention was feasible and acceptable to both support persons and smokers, with high retention rates and motivation to quit among smokers.\n2. Effects of social support and relapse prevention training as adjuncts to a televised smoking-cessation intervention: This study showed that social support and relapse prevention training can improve smoking abstinence rates in addition to a televised smoking-cessation intervention.\n3. The effects of a multiple treatment program and maintenance procedures on smoking cessation: The study found that a combination of multiple treatments and maintenance procedures can lead to higher smoking abstinence rates compared to a single treatment approach.\n4. Randomized controlled trial of a social support ('buddy') intervention for smoking cessation: This study found that a buddy system intervention did not significantly improve smoking abstinence rates among smokers, suggesting that the high level of social support already achieved through group treatments may have mitigated the effectiveness of the buddy system.\n5. Web-based intervention for adolescent nonsmokers to help parents stop smoking: The study found that adolescents can be engaged to help parents stop smoking, but further research is needed to determine the most effective intervention approach.\n6. Programming social support for smoking modification: The study found that social support from significant others can be an important factor in smoking cessation, but the level of negative social interactions can negatively impact treatment success.\n7. Self-help quit smoking interventions: The study found that telephone counseling can increase adherence to a quitting protocol and improve quit rates.\n8. Co-worker social support in a worksite smoking control program: The study found that adding a social support component to a worksite smoking control program can be effective in producing significant reductions in smoking behavior.\n9. Partner support, psychological treatment, and nicotine gum in sm",
        "eval": "1"
    },
    "91": {
        "summary": "GTR has a greater effect on probing measures of periodontal treatment than open flap debridement, including improved attachment gain, reduced pocket depth, less increase in gingival recession and more gain in hard tissue probing at re-entry surgery. However there is marked variability between studies and the clinical relevance of these changes is unknown. As a result, it is difficult to draw general conclusions about the clinical benefit of GTR. Whilst there is evidence that GTR can demonstrate a significant improvement over conventional open flap surgery, the factors affecting outcomes are unclear from the literature and these might include study conduct issues such as bias. Therefore, patients and health professionals need to consider the predictability of the technique compared with other methods of treatment before making final decisions on use. Since trial reports were often incomplete, we recommend that future trials should follow the CONSORT statement both in their conduct and reporting. \nThere is therefore little value in future research repeating simple, small efficacy studies. The priority should be to identify factors associated with improved outcomes as well as investigating outcomes relevant to patients. Types of research might include large observational studies to generate hypotheses for testing in clinical trials, qualitative studies on patient-centred outcomes and trials exploring innovative analytic methods such as multilevel modelling. Open flap surgery should remain the control comparison in these studies.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "92": {
        "summary": "Although antibiotic treatment is effective for children with UTI, there are insufficient data to answer the question of which type of antibiotic or which duration is most effective to treat symptomatic lower UTI. This review found that 10-day antibiotic treatment is more likely to eliminate bacteria from the urine than single-dose treatments. No differences were observed for persistent bacteriuria, recurrence or re-infection between short and long-course antibiotics where the antibiotic differed between groups. This data adds to an existing Cochrane review comparing short and long-course treatment of the same antibiotic who also reported no evidence of difference between short and long-course antibiotics.",
        "model_output": "[/INST]  The studies summarized provide valuable insights into the treatment of urinary tract infections (UTIs) in children. The findings can be synthesized as follows:\n\n1. Single-dose amoxicillin therapy is as effective as conventional therapy in treating uncomplicated UTIs in children.\n2. The response to single-dose therapy is lower in patients with structural abnormalities or history of recurrent infections.\n3. The use of single-dose amoxicillin is associated with a lower risk of selecting resistant organisms compared to conventional therapy.\n4. The cure rates of single-dose and conventional therapy are similar, but the relapse and reinfection rates are lower in the single-dose group.\n5. The data suggest that single-dose therapy may be a reasonable alternative in children with acute lower UTI when commonly used medications are less well tolerated.\n6. The antibody-coated bacteria assay had no predictive value in separating upper and lower tract disease, although it may predict underlying radiologic abnormalities.\n7. The findings have not been previously reported in single-dose trials.\n8. Candida vaginitis occurred in 20% of the conventional-dose group and none of the single-dose group.\n9. The efficacy of single-dose treatment of acute urinary tract infections with sulfamethizole for 3 days, sulfamethizole for 10 days, and pivmecillinam for 3 days was compared in a randomized multicentre study comprising 264 children.\n10. The cure, defined as sterile urine after treatment was achieved in 740% of the treatment of uncomplicated urinary tract infections in children with a multicurinary tract infections in children with a multiclinical symptoms in children with a multiclinical symptoms in children with a multiclinical symptoms in children with a multiclinical symptoms in children with a multiclinical sympt and multiclinical multiclinical multicurinary multicurinal multiclinical multiclinical multic multiclinical multic multiclinical mult",
        "eval": "0"
    },
    "93": {
        "summary": "This review shows a trend towards greater effectiveness with dual chamber pacing compared to single chamber ventricular pacing, which supports the current British Pacing and Electrophysiology Group's Guidelines regarding atrioventricular block. Additional randomised controlled trial evidence from ongoing trials in this area will further inform the debate.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "94": {
        "summary": "There is some evidence to suggest that ibuprofen dressings may offer pain relief to people with painful venous leg ulcers. EMLA (5%) appears to provide effective pain relief during the debridement of venous leg ulcers. Further research should consider standardised pain assessment methods and assess both the effect on ulcer healing and the impact of long term use of these treatments.",
        "model_output": "[/INST]  The studies presented in this summary investigate the use of topical anesthetics, specifically EMLA cream, for the management of venous leg ulcers. The studies show that EMLA cream is effective in reducing pain during debridement of leg ulcers, shortening the time to a clean ulcer, and providing analgesia for surgical debridement. The studies also suggest that repeated treatment with EMLA cream is safe and effective in reducing pain from cleansing of venous leg ulcers.\n\nThe studies compare EMLA cream to placebo or local best practice (LBP) and show that EMLA cream produces significant pain relief during debridement and cleansing of leg ulcers. The studies also demonstrate that EMLA cream is well-tolerated and does not cause any serious adverse events.\n\nThe studies suggest that EMLA cream may be a useful addition to the management of venous leg ulcers, particularly for patients who experience pain during debridement or cleansing. However, the studies also highlight the need for further research to fully understand the efficacy and safety of EMLA cream in this context.\n\nKey findings:\n\n* EMLA cream reduces pain during debridement of leg ulcers (Study #1)\n* EMLA cream shortens the time to a clean ulcer during debridement (Study #1)\n* EMLA cream produces effective pain relief for surgical debridement of leg ulcers (Study #2)\n* EMLA cream is well-tolerated and safe for repeated treatment in leg ulcers (Study #5)\n* EMLA cream may be a useful addition to the management of venous leg ulcers, particularly for patients who experience pain during debridement or cleansing (Studies #1-5)\n\nIn conclusion, the studies suggest that EMLA cream is a promising topical anesthetic for the management of venous leg ulcers, particularly for patients who experience pain during debridement or cleansing. However, further research is needed to fully understand the efficacy and safety of EMLA cream in this context.",
        "eval": "1"
    },
    "95": {
        "summary": "We included 25 RCTs and found no compelling evidence to support any one psychosocial treatment over another to reduce substance use (or improve mental state) by people with serious mental illnesses. Furthermore, methodological difficulties exist which hinder pooling and interpreting results; high drop out rates, varying fidelity of interventions, varying outcome measures, settings and samples and comparison groups may have received higher levels of treatment than standard care. Further studies are required which address these concerns and improve the evidence in this important area.",
        "model_output": "[/INST] and \u0409, \u0409, \u0409, .\n, \n, \n, \n, \n, \n, 2, and \n, \n, \n, \n,                 \n.\n.\n.\n,\n,\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n,\n,\n,\n,\n,\n,\n,\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n  Hinweis,\n           \n \n \n  kwiet,  kwiet,\n,\n,  kwiet,  kwiet,  kwiet\n- Einzeln,\n-\n-\n,\n,\n,\n, Begriffe,\n,      \n, \n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n, kwiet\n, Hinweis, Hinweis, Hinweis,, Hinweis, Hinweis, Hinweis, Hinweis, Hinweis, Hinweis, Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Einzeln Hinweis Einzeln Hinweis Einzeln Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis,\n.\n.\n.\n, , Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis \n   kwiet Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis hopefully hopefully    \n, \n,  Begriffe Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis everybody everybody everybody everybody everybody Hinweis everybody Hinweis everybody Hinweis Hinweis Hinweis Hinweis hopefully hopefully everybody Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis,\n,\n,\n, Begriffe, Begriffe Hinweis Hinweis Hinweis Hinweis Hinweis\n,\n,\n,\n,\n,\n, Begriffe, Begriffe, Begriffe Hinweis Hinweis Hinweis Hinweis Hinweis,\n,\n,\n,\n,\n, Hinweis Hinweis Hinweis,\n,\n, , ,\n,\n, Hinweis,\n,\n,\n\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n\n Hinweis Hinweis,\n,\n,\n,\n,\n,\n,\n,",
        "eval": "0"
    },
    "96": {
        "summary": "Overall, we found neither evidence that the addition of pTE to antineoplastic treatment reduced the risk of death or disease progression nor that it improved the rate of tumour responses to antineoplastic treatment. For thymosin \u03b11, there was a trend for a reduced risk of dying and of improved DFS. There was preliminary evidence that pTE lowered the risk of severe infectious complications in patients undergoing chemotherapy or radiotherapy.",
        "model_output": "[/INST] in  in in  in  in  in  in  in \n\n\n\n in  in     T\n\n\n.\n.....\n\n\n\n\n\n\n\n\n T\n. T. T\n T. T T\n\n\n\n\n\n\n\n\n T\n T\n          T         \n\n\n\n\n\n\n T\n\n\n\n T\n T\n\n\n\n\n\n\n\n T\n\n\n\n\n\n\n\n\n T T T T T T T T T T T T T\n\n\n.\n...\u0409..\u0409.\u0409\u0409.\u0409..\u0409.\u0409.....\n\n\n T T T T T T T T\n\u0409 .\n\n T  T\n\u0409 \u0409 \u0409 \u0409 \u0409 \u0409.\u0409\u0409.\u0409\u0409\u0409\u0409\u0409.\u0409\n\u0409 .\n.\n\n\n\n\n\n....\u0409.\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\n\u0409\n\u0409\n\u0409\n\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\n.\n\n T T T T T T T\n..\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409.\n. T\n\n T T\n\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "97": {
        "summary": "There is no evidence that community-based screening of asymptomatic older people results in improvements in vision.",
        "model_output": "[/INST]  The provided abstracts discuss various clinical trials related to screening and interventions for elderly people. The key findings can be synthesized as follows:\n\n1. Screening for visual impairment in older people: A cluster randomized trial found that including a vision screening component by a practice nurse in a pragmatic trial of multidimensional screening for older people did not lead to improved visual outcomes. (Study #2)\n2. Preventing disability and falls in older adults: A randomized controlled trial found that a modest, one-time prevention program appeared to confer short-term health benefits on ambulatory HMO enrollees, although benefits diminished by the second year of follow-up. (Study #3)\n3. Can health visitors prevent fractures in elderly people? A randomized controlled trial found that health visitors visiting a group of people aged 70 and over and using simple preventive measures had no effect on the incidence of fractures. (Study #4)\n4. Effect of health visitors working with elderly patients in general practice: A randomized controlled trial found that health visitors employed specifically to care for two years for a random sample of patients in general practice who were aged over 70 had some impact on their caseload of patients, reducing their mortality and improving their quality of life. (Study #5)\n5. Effects of preventive home visits to elderly people: A randomized controlled trial found that preventive home visits by public health nurses had no effect on the health of the subjects, but were effective for subjects who initially rated their health as poor. (Study #6)\n\nIn summary, these studies suggest that while some interventions may have short-term benefits, there is no evidence to suggest that universal screening or preventive measures can significantly improve visual outcomes, prevent disability and falls, or prevent fractures in elderly people. However, targeted interventions for individuals with poor health may be more effective.",
        "eval": "1"
    },
    "98": {
        "summary": "Compared to no intervention or minimal interventions (pamphlets, usual care), interactive computer-based interventions are an effective intervention for weight loss and weight maintenance. Compared to in-person interventions, interactive computer-based interventions result in smaller weight losses and lower levels of weight maintenance. The amount of additional weight loss, however, is relatively small and of brief duration, making the clinical significance of these differences unclear.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "99": {
        "summary": "Although acute bacterial conjunctivitis is frequently self limiting, the findings from this updated systematic review suggest that the use of antibiotic eye drops is associated with modestly improved rates of clinical and microbiological remission in comparison to the use of placebo. Use of antibiotic eye drops should therefore be considered in order to speed the resolution of symptoms and infection.",
        "model_output": "[/INST]                                    \n \n \n \n \n    \n \n \n\n\n\n \n \n\n\n     \n    \n    \n\n\n\n                           \n\n\n\n   \n\n\n\n\n\n........................ \n\n ....................    \n  ....  \n \n................                                   ............   .......                              .\n\u0409 \u0409 \u0409 .                   \n. \u0409   \n          ..\u0409 \u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409.\u0409 \u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409.\u0409.\u0409.\u0409\n\u0409.\u0409 \u0409 \u0409\n\u0409.\u0409\u0409\u0409\u0409\u0409.\u0409\n\u0409 \u0409 \u0409 .\n\n\n.\n\u0409\n\u0409\n.\n.\n\u0409\n\u0409.\u0409.\u0409\u0409\u0409\u0409.....\n.\u0409.\u0409\u0409\u0409\n\u0409\u0409\u0409\u0409\u0409\u0409.\u0409.\u0409 . \n\n\n\n          \n.\n\n   \n\n\n\n\n\n\n                   \n\n\u0409\n\u0409\u0409\u0409\u0409\u0409.\u0409",
        "eval": "0"
    },
    "100": {
        "summary": "There is no convincing evidence to support the use of either atorvastatin\u00a0or simvastatin as an adjunctive therapy in MS.",
        "model_output": "[/INST]  The three studies discussed in this summary investigate the use of statins (simvastatin and atorvastatin) as add-on therapy to interferon beta-1a for patients with relapsing-remitting multiple sclerosis (RRMS). The studies aim to determine the safety and efficacy of this combination in reducing disease activity and improving clinical outcomes.\n\nKey Findings:\n\n1. Simvastatin treatment in patients with RRMS receiving interferon beta-1a: A double-blind randomized controlled trial found that simvastatin treatment significantly reduced the total attack number in patients with RRMS compared to placebo (moderate effect size r = 0.29, p = 0.01). The final Expanded Disability Status Scale scores were lower in the simvastatin group, but this difference was not significant after controlling for baseline Expanded Disability Status Scale score (p = 0.07).\n2. Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis: A study found that high-dose atorvastatin can be administered safely to persons with RRMS taking thrice weekly interferon beta-1a, but resulted in increased MRI and clinical disease activity compared to placebo (p = 0.019).\n3. Atorvastatin combined to interferon to verify the efficacy (ACTIVE) in relapsing-remitting active multiple sclerosis patients: A longitudinal controlled trial found that low-dose atorvastatin plus high-dose interferon beta-1a may be beneficial as add-on therapy in poor responders to high-dose interferon beta-1a alone, with significantly fewer contrast-enhanced lesions and relapses in the atorvastatin group compared to the interferon alone group (p < 0.001 and p = 0.053, respectively).\n4. Simvastatin as add-on therapy to interferon \u03b2-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): A placebo-controlled randomized phase 4 trial found that simvastatin",
        "eval": "1"
    },
    "101": {
        "summary": "Varenicline and behavioural interventions may help ST users to quit. Behavioural interventions incorporating telephone counselling or an oral examination are likely to increase abstinence rates.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409.11 Bedeut.1 Bedeut.\n\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "102": {
        "summary": "There is some evidence to suggest that CSII may be better than MI for glycaemic control in people with type 1 diabetes. Non-severe hypoglycaemic events do not appear to be reduced with CSII. There is insufficient evidence regarding adverse events, mortality, morbidity and costs.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "103": {
        "summary": "Some outcomes may be amenable to psychosocial treatments; however, there is insufficient evidence to recommend practice changes. Further research on interventions described in this review is required, including attention to timing, duration, setting and administering discipline(s), as well as treatment across care settings. To facilitate future evaluations, a core outcome set, including patient-reported outcomes such as quality of life and compliance, should be established for hip fracture trials.",
        "model_output": "[/INST]  The findings from the eight studies related to clinical trial research on postacute care coordination for hip fracture patients are synthesized as follows:\n\n1. GAPN postacute care coordination improves function and return-home outcomes in elderly patients with hip fracture (Study #1).\n2. Treatment and prevention of depression after surgery for hip fracture in older people: randomized, controlled trials (Study #2) showed that a psychiatric intervention did not significantly benefit depressed older people, while a psychological intervention did not significantly prevent incident depression.\n3. Testing the effectiveness of the exercise plus program in older women post-hip fracture (Study #3) demonstrated that the program increased exercise levels in all three treatment groups.\n4. Methodological challenges of multiple-component intervention: lessons learned from a randomized controlled trial of functional recovery after hip fracture (Study #4) highlighted the difficulties in implementing and assessing complex interventions in a population that proved difficult to follow up.\n5. A randomized clinical trial of the effectiveness of a discharge planning intervention in hospitalized elders with hip fracture due to falling (Study #5) showed that the intervention decreased length of stay, rate of readmission, and repeat falls, and improved activities of daily living.\n6. Postoperative mental impairment in hip fracture patients: a randomized study of reorientation measures (Study #6) found that attributes were less important than the psychological environment for postoperative mental deterioration.\n7. Early individualized postoperative occupational therapy training in 100 patients improves ADL after hip fracture: a randomized trial (Study #7) demonstrated that individualized postoperative occupational training improved patients' ability to perform ADL and IADL.\n8. Home-based multicomponent rehabilitation program for older persons after hip fracture: a randomized trial (Study #8) found that a home-based systematic multicomponent rehabilitation strategy did not lead to improved outcomes compared to usual care.\n\nIn summary, the studies suggest that postacute care coordination, discharge planning, and",
        "eval": "1"
    },
    "104": {
        "summary": "Complications for surgical first trimester abortion are rare. The included studies do not indicate overall benefits of one over the other method. MVA can be used for early first trimester surgical abortion, but maybe more difficult when used later in the first trimester. Duration of procedure is shorter with VA compared to D&C, which may be of importance when using local anaesthetics or for busy clinics. Outcomes such as women's satisfaction, the need for pain relief or surgeons preference for the instrument have been inadequately addressed. No long-term outcomes, such as fertility after surgical abortion, are available.",
        "model_output": "[/INST]  The studies presented in this summary compare and contrast manual vacuum aspiration (MVA) and electric vacuum aspiration (EVA) for first trimester abortion. The studies found that:\n\n1. MVA and EVA are equally effective in emptying the uterine cavity, with no significant differences in the rate of complete abortion between the two groups.\n2. Complications rates were similar for both methods, with no case of ongoing pregnancy occurring in either group.\n3. Patients did not report significant differences in pain levels or satisfaction between MVA and EVA.\n4. Physicians found MVA to be as acceptable as EVA for elective abortions performed at less than 10 weeks gestation.\n5. Women's perceptions and experiences with MVA and EVA were similar, with no significant differences in their reports of pain, anxiety, or bleeding.\n6. D & C is less convenient and cost-effective than vacuum aspiration, and should therefore be accepted as the standard method for first trimester abortion.\n7. Residents took longer than faculty to perform both procedures, with electric vacuum curettage taking less time than manual vacuum aspirator.\n8. Patient pain perception with aspiration by MVA and EVA is not different.\n\nOverall, the studies suggest that MVA and EVA are safe and effective alternatives for first trimester abortion, with similar complication rates and patient satisfaction. However, MVA may be more convenient and cost-effective than EVA, and D & C is less convenient and cost-effective than vacuum aspiration.",
        "eval": "1"
    },
    "105": {
        "summary": "There is insufficient evidence to assess the effectiveness of interventions for domestic violence on pregnancy outcomes. There is a need for high-quality, RCTs with adequate statistical power to determine whether intervention programs prevent or reduce domestic violence episodes during pregnancy, or have any effect on maternal and neonatal mortality and morbidity outcomes.",
        "model_output": "[/INST]  The studies summarized in this document focus on the prevention and management of intimate partner violence (IPV) during pregnancy. The studies provide insights into the effectiveness of various interventions, including provider cueing, home visits by paraprofessionals and nurses, empowerment interventions, integrated interventions, and nurse case management. The findings suggest that these interventions can be effective in reducing IPV during pregnancy and improving outcomes for both mothers and children.\n\nKey findings include:\n\n1. Provider cueing can significantly reduce IPV discussions among providers.\n2. An interpersonally based intervention for low-income pregnant women with IPV showed moderate effects for reducing symptoms of PTSD and depression during pregnancy.\n3. Paraprofessional-visited women were less likely to be married and to live with the biological father of the child, but worked more and reported a greater sense of mastery and better mental health.\n4. Nurse-visited women reported greater sensitivity and responsiveness toward one another and, in cases where mothers had low levels of psychologic resources at registration, had home environments that were more supportive of children's early learning.\n5. Simply asking pregnant women about abuse and offering referral could potentially interrupt and prevent further abuse.\n6. A relatively brief intervention during pregnancy had discernible effects on intimate partner violence and pregnancy outcomes.\n7. Abused pregnant women may focus on basic needs and their pregnancies rather than the abuse, although all received safety planning.\n\nThese findings suggest that interventions aimed at preventing and managing IPV during pregnancy can be effective in improving outcomes for both mothers and children. However, more research is needed to determine the most effective interventions and to identify the populations that may benefit the most from these interventions.",
        "eval": "1"
    },
    "106": {
        "summary": "IVIG administration results in a 3% reduction in sepsis and a 4% reduction in one or more episodes of any serious infection but is not associated with reductions in other clinically important outcomes, including mortality. Prophylactic use of IVIG is not associated with any short-term serious side effects.\nThe decision to use prophylactic IVIG will depend on the costs and the values assigned to the clinical outcomes. There is no justification for conducting additional RCTs to test the efficacy of previously studied IVIG preparations in reducing nosocomial infections in preterm and/or LBW infants.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409..\n..\n\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "107": {
        "summary": "People with mild, moderate or severe dementia due to Alzheimer's disease treated for periods of 12, 24 or 52 weeks with donepezil experienced benefits in cognitive function, activities of daily living and behaviour. Study clinicians rated global clinical state more positively in treated patients, and measured less decline in measures of global disease severity. There is some evidence that use of donepezil is neither more nor less expensive compared with placebo when assessing total health care resource costs. Benefits on the 10 mg/day dose were marginally larger than on the 5 mg/day dose. Taking into consideration the better tolerability of the 5 mg/day donepezil compared with the 10 mg/day dose, together with the lower cost, the lower dose may be the better option. The debate on whether donepezil is effective continues despite the evidence of efficacy from the clinical studies because the treatment effects are small and are not always apparent in practice.",
        "model_output": "[/INST] \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \n                 \u0409 \u0409\n                 \u0409\n                   \n                   \n                   \n                   \n                    \u0409 sierp sierp everybody's \u0409 \u0409 \u0409\n                 \u0409\n                   \n                 \u0409 \u0409 \u0409 \u0409 \u0409 \u0409 repeat\n\n\n\n\n\n \u0409 \u0409 \u0409   \u0409 sierp sierp sierp sierp sierp sierp \u0409 \u0409  kwiet sierp.\n \n sierp sierp sierp sierp sierp sierp sierp sierp sierp \u0409 \u0409\n sierp\n\n\n\n\n sierp\n\n\n\n\n\n\n \n \n \n  kwiet sierp\n  kwiet sierp\n \n  \n \n\n\n\n\n\n\n\n\n\n\n\n \n\n\n \n \n \n\n\n\n\n\n\n\n\n\n\n\n\n hopefully hopefully hopefully hopefully Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis everybody Hinweis clin Hinweis clin kwiet everybody\n kwiet everybody hopefully, hopefully,\n kwiet Hinweis,\n  kwiet sierp  kwiet sierp 3,\n  kwiet sierp  kwiet sierp\n kwiet everybody,\n sierp sierp sierp sierp sierp sierp sierp sierp sierp\n kwiet sierp\n kwiet sierp everybody\n sierp everybody\n the the the the everybody\n everybody\n kwiet everybody  sierp everybody nobody everybody everybody",
        "eval": "0"
    },
    "108": {
        "summary": "There is no evidence from RCTs that supplementation with antioxidant vitamins (beta-carotene, vitamin C or vitamin E) prevents or slows the progression of age-related cataract. We do not recommend any further studies to examine the role of antioxidant vitamins beta-carotene, vitamin C and vitamin E in preventing or slowing the progression of age-related cataract. Costs and adverse effects should be weighed carefully with unproven benefits before recommending their intake above recommended daily allowances.",
        "model_output": "[/INST]\n010.\n010.\n010.\n010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010101010.\n1010101.\n1010101010101010, and \u0409\nind\nstud\nind010101010101010101010101.\n1 and1,101010101,10,10 \u0409, \u0409, \u0409, \u0409, \u0409, clin \u0409 \u0409 \u0409 \u0409 \u0409 clin sierp topics, kwietion, including clin study clin clin clin clin \u0409 \u0409, and \u0409, and \n \u0409, 1 pass, and 1 1 pass, pass, and  sierp, sierp.\n kwiet everybody.\n kwiet everybody.\n everybody. \n  everybody.  kwiet  kwiet  kwiet everybody, kwiet, kwiet, kwiet, kwiet.\n,\n, kwiet\n\n\n\n\n kwiet kwiet kwiet Hinweis\n kwiet Hinweis kwiet Hinweis Hinweis kwiet Hinweis kwiet\n kwiet\n kwiet\n kwiet\n kwiet  kwiet Hinweis Hinweis Hinweis  kwiet Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis\n kwiet\n kwiet\n kwiet\n kwiet Hinweis Hinweis Hinweis everybody everybody  kwiet everybody kwiet kwiet kwiet kwiet kwiet kwiet kwiet kwiet kwiet kwiet Hinweis kwiet Hinweis Einzeln Hinweis Einzeln everybody Einzeln everybody everybody everybody everybody everybody everybody everybody everybody",
        "eval": "0"
    },
    "109": {
        "summary": "Caring for people in acute day hospitals is as effective as inpatient care in treating acutely ill psychiatric patients. However, further data are still needed on the cost effectiveness of day hospitals.",
        "model_output": "[/INST]  The studies reviewed here investigate the effectiveness of day hospital treatment for acutely ill psychiatric patients compared to inpatient care. The findings can be synthesized as follows:\n\n1. Day hospital treatment is a feasible and effective alternative to inpatient care for acutely ill psychiatric patients.\n2. The clinical, functional, social adjustment, quality of life, and satisfaction outcomes of day hospital patients are similar to those of inpatient patients.\n3. Day hospital treatment is more cost-effective than inpatient treatment, with savings of up to 2165 pounds per patient over 12 months.\n4. Day hospital care is more effective on social functioning outcomes at discharge and at follow-up assessments.\n5. The study by van Os et al. (2009) found that day hospital care is as effective as conventional inpatient care on psychopathologic symptoms, treatment satisfaction, and quality of life.\n6. The study by Killaspy et al. (2010) found that day hospital patients were more satisfied with their treatment than inpatient patients.\n7. The study by Sondij (2011) found that day hospital treatment is a realistic alternative for 33% of all patients admitted for inpatient treatment.\n8. The study by van der Feltz-Cornelis et al. (2015) found that day hospital care is more effective on social functioning outcomes at discharge and at follow-up assessments.\n\nOverall, the studies suggest that day hospital treatment is a viable and effective alternative to inpatient care for acutely ill psychiatric patients, with potential cost savings and improved social functioning outcomes. However, the studies also highlight the need for further research to determine which patients are most suitable for day hospital treatment and to identify the optimal treatment approach.",
        "eval": "1"
    },
    "110": {
        "summary": "Inhaled antibiotic treatment probably improves lung function and reduces exacerbation rate, but a pooled estimate of the level of benefit is not possible. The best evidence is for inhaled tobramycin. More evidence, from trials of longer duration, is needed to determine whether this benefit is maintained and to determine the significance of development of antibiotic-resistant organisms.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "111": {
        "summary": "Evidence suggests that risperidone and olanzapine are useful in reducing aggression and risperidone reduces psychosis, but both are associated with serious adverse cerebrovascular events and extrapyramidal symptoms. Despite the modest efficacy, the significant increase in adverse events confirms that neither risperidone nor olanzapine should be used routinely to treat dementia patients with aggression or psychosis unless there is severe distress or risk of physical harm to those living and working with the patient. Although insufficient data were available from the considered trials, a meta-analysis of seventeen placebo controlled trials of atypical neuroleptics for the treatment of behavioural symptoms in people with dementia conducted by the Food and Drug Administration suggested a significant increase in mortality (OR 1.7). A peer-reviewed meta-analysis (Schneider 2005) of 15 placebo controlled studies (nine unpublished) found similarly increased risk in mortality (OR=1.54, 95% CI 0.004 to 0.02, p=0.01) for the atypical neuroleptics.",
        "model_output": "[/INST]  The provided abstracts discuss various clinical trials related to the effectiveness of different medications in treating psychosis and associated behavioral disturbances in patients with dementia. The studies compare the efficacy of olanzapine, risperidone, and placebo in improving neuropsychiatric functioning, reducing aggression and agitation, and managing psychosis in dementia patients.\n\nKey findings from the abstracts include:\n\n1. Olanzapine and risperidone were compared in Study #1, with both medications showing significant improvement in neuropsychiatric functioning compared to placebo. However, olanzapine had a higher incidence of adverse events, particularly extrapyramidal symptoms.\n2. In Study #2, no significant differences in efficacy were observed among olanzapine, risperidone, and placebo groups in terms of improving neuropsychiatric functioning.\n3. Study #3 found that risperidone was effective in reducing aggression and agitation in dementia patients, with a significant improvement in the CMAI total aggression score and the BEHAVE-AD total and psychotic symptoms subscale.\n4. In Study #4, olanzapine was found to be more effective than placebo in reducing psychotic symptoms and behavioral disturbances in patients with Alzheimer's disease, with a significant improvement in the NPI/NH Psychosis Total scores. However, olanzapine was associated with a higher incidence of adverse events, including weight gain, anorexia, and urinary incontinence.\n\nOverall, the studies suggest that both olanzapine and risperidone can be effective in improving neuropsychiatric functioning and reducing aggression and agitation in dementia patients. However, the optimal dosage and tolerability of these medications need to be carefully evaluated in future studies.",
        "eval": "1"
    },
    "112": {
        "summary": "Behavioral interventions reduce self-reported unprotected anal sex among MSM. These results indicate that HIV prevention for this population can work and should be supported. \nResults of previous studies provide a benchmark for expectations in new studies. Meta-analysis can inform future design and implementation in terms of sample size, target populations, settings, goals for process measures, and intervention content.\nWhen effects differ by design variables, which are deliberately selected and planned, awareness of these characteristics may be beneficial to future designs. Researchers designing future small group and individual-level studies should keep in mind that to date, effects of the greatest magnitude have been observed in studies that used count outcomes and a shorter intervention span (up to 1 month).\nAmong small group and individual-level studies, effects were also greatest when the comparison condition included minimal to no HIV prevention content. Nevertheless, statistically significant favorable effects were also seen when the comparison condition included standard or other HIV prevention content. Researchers choosing the latter option for new studies should plan for larger sample sizes based on the smaller expected net intervention effect noted above.\nWhen effects differ by implementation variables, which become evident as the study is conducted but are not usually selected or planned, caution may be advised so that future studies can reduce bias. Because intervention effects were somewhat stronger (though not statistically significantly so) in studies with a greater attrition in the comparison condition, differential retention may be a threat to validity. Extra effort should be given to retaining participants in comparison conditions.\nAmong community-level interventions, intervention effects were strongest among studies with random assignment of groups or communities. Therefore the inclusion of studies where assignment of groups or communities was by convenience did not exaggerate the summary effect. The greater effectiveness of interventions including more than 25% non-gay identifying MSM suggests that when they can be reached, these men may be more responsive than gay-identified men to risk reduction efforts. Non-gay identified MSM may have had less exposure to previous prevention messages, so their initial exposure may have a greater impact.\nThe greater effectiveness of interventions that include efforts to promote personal skills such as keeping condoms available and behavioral self-management indicates that such content merits strong consideration in development and delivery of new interventions for MSM. And the finding that interventions were most effective for majority white populations underscores the critical need for effective interventions for MSM of African and Latino descent.\nFurther research measuring the incidence of HIV and other STDs is needed. Because most studies were conducted among mostly white men in the US and Europe, more evaluations of interventions are needed for African American and Hispanic MSM as well as MSM in the developing world. More research is also needed to further clarify which behavioral strategies (e.g., reducing unprotected anal sex, having oral sex instead of anal sex, reducing number of partners, avoiding serodiscordant partners, strategic positioning, or reducing anal sex even with condom use) are most effective in reducing transmission among MSM, the messages most effective in promoting these behaviors, and the methods and settings in which these messages can be most effectively delivered.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "113": {
        "summary": "The range of proven effective interventions for chronic pelvic pain remains limited and recommendations are based largely on single studies. Given the prevalence and healthcare costs associated with chronic pelvic pain in women, randomised controlled trials of other medical, surgical and psychological interventions are urgently required.Chronic pelvic pain is common in women in the reproductive and older age groups and it causes disability and distress that result in significant costs to health services. The pathogenesis of chronic pelvic pain is poorly understood. Often investigation by laparoscopy reveals no obvious cause for the pain. There are several possible explanations for chronic pelvic pain including undetected irritable bowel syndrome, and central sensitisation of the nervous system. A vascular hypothesis proposes that pain arises from dilated pelvic veins in which blood flow is markedly reduced. As the pathophysiology of chronic pelvic pain is not well understood, its treatment is often unsatisfactory and limited to symptom relief. Currently the main approaches to treatment include counselling or psychotherapy, attempts to provide reassurance using laparoscopy to exclude serious pathology, progestogen therapy such as with medroxyprogesterone acetate and surgery to interrupt nerve pathways.",
        "model_output": "[/INST]  The studies summarized in this collection relate to the clinical trial research question of identifying effective interventions for chronic pelvic pain. The findings suggest that:\n\n1. Written emotional disclosure may be beneficial for women with chronic pelvic pain, as it can lead to lower evaluative pain intensity ratings and improved affective outcomes. However, the main effects of disclosure are limited, and individual differences in ambivalence towards emotional expression or negative affect moderate the intervention's effectiveness.\n2. An integrated approach to treating chronic pelvic pain, which addresses both organic and non-organic factors, is more likely to result in pain reduction than a standard approach that focuses solely on organic causes.\n3. Laparoscopic adhesiolysis for chronic abdominal pain is not evidence-based and does not lead to substantial pain relief or improvement in quality of life compared to diagnostic laparoscopy alone.\n4. Medroxyprogesterone acetate (MPA) and psychotherapy are effective treatments for pelvic congestion syndrome, with MPA showing a significant benefit in reducing pain scores and psychotherapy improving pain, functional disability, and psychological function.\n5. Sertraline is not effective as an analgesic for chronic pelvic pain, as there were no significant improvements in pain or functional disability noted in the double-blind crossover trial.\n6. Goserelin acetate is more effective than medroxyprogesterone acetate in improving pelvic venographic scores, symptom resolution, improvement of psychological status, and sexual functioning in patients with pure pelvic congestion syndrome.\n7. Adhesiolysis may be beneficial for women with severe, vascularized, and dense adhesions involving the bowel, as it can lead to significant improvements in pelvic pain. However, adhesiolysis is not indicated for women with light or moderate degree pelvic adhesions.\n\nIn summary, the studies suggest that a multifaceted approach to treating chronic pelvic pain, which addresses both organic and non-organic factors, may be more effective than a standard approach. Additionally, certain interventions, such as written emotional disclosure and goserelin acetate, may",
        "eval": "1"
    },
    "114": {
        "summary": "There is insufficient evidence of efficacy of individual antioxidants, or antioxidants in general, in the treatment of people with amyotrophic lateral sclerosis. One study reported a mild positive effect but this was not supported in our analysis. If future trials of antioxidant medications are performed, careful attention should be given to sample size, outcome measures, and duration of the trials. The high tolerance and safety, and relatively low cost of vitamins C and E, explain the continuing use of these vitamins by physicians and people with amyotrophic lateral sclerosis. While there is no substantial clinical trial evidence to support their clinical use, there is no clear contraindication.",
        "model_output": "[/INST]  The six studies reviewed here investigate the effects of various interventions on the clinical course of amyotrophic lateral sclerosis (ALS). The findings can be synthesized as follows:\n\n1. Glutathione peroxidase activity and oxidative stress: Study #1 found that ALS patients had decreased activity of glutathione peroxidase and cuz Zn superoxide dismutase, indicating oxidative stress.\n2. Antioxidant effects of selenium: Study #2 found that exogenous administration of selenium did not enhance the activity of glutathione peroxidase or plasma vitamin E levels in ALS patients.\n3. Acetylcysteine treatment: Study #3 found that treatment with the free radical scavenger acetylcysteine did not result in a major increase in 12-month survival or reduction in disease progression in ALS patients.\n4. Vitamin E supplementation: Study #4 found that alpha-tocopherol (vitamin E) supplementation did not affect survival or motor function in ALS patients.\n5. CoQ10 trial: Study #5 found that CoQ10 supplementation did not show sufficient promise to warrant Phase III testing in ALS patients.\n6. Serial studies of free radical and antioxidant activity: Study #6 investigated the serial changes in free radical and antioxidant activity in ALS patients, but the results were not provided.\n7. Deprenyl treatment: Study #7 found that deprenyl treatment did not result in any obvious retardation in the progress of ALS disease.\n\nIn summary, these studies suggest that while some interventions may have potential antioxidant effects, there is currently no evidence to support their use in the treatment of ALS. Further research is needed to determine the most effective strategies for managing this devastating disease.",
        "eval": "0"
    },
    "115": {
        "summary": "The evidence from this updated review supports the use of KMC in LBW infants as an alternative to conventional neonatal care mainly in resource-limited settings. Further information is required concerning effectiveness and safety of early onset continuous KMC in unstabilized LBW infants, long term neurodevelopmental outcomes, and costs of care.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "116": {
        "summary": "Cyproterone acetate combined with estradiol results in a subjective improvement in hirsutism compared to placebo. Clinical differences in outcome between cyproterone acetate and other medical therapies were not demonstrated in the studies included in this review. This may be because of the small size of the studies, lack of standardized assessment and lack of objective determinants of improvement in hirsutism. The endocrinological effects of the different drug therapies reflect the mode of action. Larger carefully designed studies are needed to compare efficacy and safety profiles between drug therapies for hirsutism.",
        "model_output": "[/INST]  The summary of the provided abstracts is as follows:\n\n1. Study #1: Comparison of four different treatment regimens for hirsutism related to polycystic ovary syndrome. The study found that ketoconazole was the most effective treatment, followed by cyproterone acetate, spironolactone, and flutamide.\n2. Study #2: Treatment of hirsutism: comparisons between different antiandrogens with central and peripheral effects. The study compared the efficacy of cyproterone acetate, flutamide, and finasteride in treating hirsutism and found that they were equally effective despite different mechanisms of action.\n3. Study #3: Comparison of flutamide and cyproterone acetate in the treatment of hirsutism: a randomized controlled trial. The study found that both flutamide and cyproterone acetate were effective in treating hirsutism, but there was a trend towards better response with flutamide.\n4. Study #4: Comparison of spironolactone-oral contraceptive versus cyproterone acetate-estrogen regimens in the treatment of hirsutism. The study found that both spironolactone and cyproterone acetate were effective in treating hirsutism, but there was a trend towards better response with spironolactone.\n5. Study #5: Comparison of sequential cyproterone acetate/estrogen versus spironolactone/oral contraceptive in the treatment of hirsutism. The study found that both spironolactone and cyproterone acetate were effective in treating hirsutism, but there was no difference between the two drugs in terms of efficacy.\n6. Study #6: Prospective randomized study comparing the long-acting gonadotropin-releasing hormone agonist triptorelin, flutamide, and cyproterone acetate, used in combination with an oral contraceptive, in the treatment of hirsutism. The study found that all three drugs were effective in treating hirsutism, but flutamide was the most effective.",
        "eval": "1"
    },
    "117": {
        "summary": "MAO-B inhibitors (more specifically selegiline which contributes most of the data) do not appear to delay disease progression in terms of improved survival but may reduce later motor fluctuations. At present, we do not feel these drugs can be recommended for routine use in the treatment of early Parkinson's disease.",
        "model_output": "[/INST] everybody Hinweis Hinweis,\n,\n,\n Hinweis Hinweis\n\n Hinweis\n\n,\n\n\n\n\n\n\n\n, \n,  , , , , \n,\n,\n,\n,\n,\n,,,,,,,,, ,         , , , , , , , , , ,\n,\n, \n, \n, \n, , , , ,     \n \n\n,\n,\n,\n,\n,\n,\n,\n, \n, \n, \n, \n, 0,\n,\n,\n,\n,\n,,\n,\n,,,, , , \n,\n,\n,\n,\n,\n, , \n, ,\n,\n\n,\n\n\n\n\n\n\n\n\n\n\n\n\n,\n,\n,\n,\n,\n,, ,\n, , \n,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\n,,,,,\n,,,,,,,,,,,,\n,,,,,,,,,,,,,,,,,,,,,,,,,\n,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, ,  , , ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\u00a0,,,,,,,,,,,,,,,,,,,,,,, , \u00a0,\u00a0,\u00a0,\u00a0,\u00a0,,,,,,,,,,,, clearly, clearly,",
        "eval": "0"
    },
    "118": {
        "summary": "There are few trials that have directly compared the antipyretic properties of paracetamol against placebo or physical methods. Data on adverse events are limited. Establishing standard outcomes will help comparisons between studies and better meta-analysis.",
        "model_output": "[/INST]  The provided abstracts present the results of various studies on the management of fever in children. The studies compare the effectiveness of different medications, including ibuprofen, acetaminophen, and paracetamol, in reducing fever in children. The studies also evaluate the safety and efficacy of these medications in different age groups, dosages, and in combination with other treatments. The findings suggest that ibuprofen is a safe and effective antipyretic agent in children, while acetaminophen may have a dose-response relationship for 5 and 10 mg/kg) was minimally effective in children less than 6 years of age who had an initial temperature of at least 104 degrees F). All treatments were well tolerated, and in terms of their efficacy, and safety. The studies also evaluate the potential clinical or laboratory abnormalities were not significant clinical or laboratory abnormalities were not significant. The findings suggest that ibuprofen is a safe and effective in children with feveral studies suggest that ibuprofen is a safe and effective in children with acetemedication was not significant clinical or laboratory abnormal or placebo-significal or placebo-signific or laboratory or placebo-signific or laboratory or placebo-signific or laboratory or placebo-signific or laboratory or placebo-signific or laboratory or placebo-signific or laboratory or placebo-signific or laboratory or placebo-sign or placebo-sign or laboratory or placebo-sign or placebo-sign or placebo-sign or laboratory or placebo-sign or placebo-sign or placebo-sign or placebo-sign or laboratory or placebo-sign or placebo-sign or placebo-sign or placebo-sign or placebo-sign or placebo-sign or placebo-sign or placebo-sign or placebo-sign or placebo-sign or placebo-sign or placebo-sign or placebo-place-sign or placebo-place-sign or placebo-sign-placebo-place-place-place-sign-place-placebo-place-place-place-place-place-place-place-place-place-place-place-place-place-place-place-place",
        "eval": "0"
    },
    "119": {
        "summary": "Active chest compression-decompression in patients with cardiac arrest is not associated with clear benefit.",
        "model_output": "[/INST] everybody Hinweis Einzeln Hinweis Einzeln Hinweis Einzeln Einzeln Einzeln Hinweis Einzeln Hinweis Einzeln Einzeln\n\n\n.\n everybody everybody everybody Hinweis everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Bedeut Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis obviously obviously (emer Hinweis Hinweis Hinweis Einzeln (emer Einzeln obviously obviously obviously obviously obviously everybody Begriffe Einzeln Begriffe Begriffe obviously everybody obviously everybody Einzeln everybody obviously obviously obviously obviously everybody Hinweis Hinweis Hinweis Einzeln obviously everybody Hinweis Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Hinweis Hinweis Hinweis Begriffe Begriffe\n\n Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe obviously Begriffe Begriffe Begriffe obviously obviously obviously\n Begriffe Begriffe\n Begriffe\n Begriffe hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully ( ( ( ( ( ( ( ( ( ( ( Begriffe Begriffe ( ( ( ( ( Begriffe Begriffe Begriffe (\n (\n Begriffe Begriffe hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis ( sierp Hinweis Hinweis Hinweis Hinweis Hinweis Begriffe ( kwiet Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe ( Begriffe (\n Begriffe Begriffe (\n (\n (\n ( Begriffe Begriffe Begriffe Begriffe (\n Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe ( (emer Einzeln Einzeln Einzeln Einzeln Einzeln Einzeln Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe\n\n\n\n\n,\n.\n\n Begriffe\n\n.\n ( emer Begriffe Begriffe Begriffe (\n\n\n\n ( ( ( ( ( ( ( ( ( ( (, (\n\n into into emer,\n\n\n\n\n.\n... (. ( ( ( ( ( ( ( ( ( emer ( emer ( emer\n\n\n\n ( ( (\n\n (\n\n\n\n\n\n\n\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,,\n,\n,\n,,\n,\n,\n,\n,\n,\n, (, (, (, (, (, (, (, ( ( ( ( (\n,\n,\n,\n,\n,\n ( ( ( ( ( ( ( ( ( ( ( ( (",
        "eval": "0"
    },
    "120": {
        "summary": "There is limited evidence on which to base clinical decisions regarding the prescription of custom-made foot orthoses for the treatment of foot pain. Currently, there is gold level evidence for painful pes cavus and silver level evidence for foot pain in JIA, rheumatoid arthritis, plantar fasciitis and hallux valgus.",
        "model_output": "[/INST]  The findings from the nine studies provide valuable insights into the effectiveness of foot orthotics in managing various foot-related conditions. The key takeaways from the summary are:\n\n1. Custom foot orthoses are more effective than sham orthoses in managing pain and disability associated with cavus foot type (Study #1).\n2. Surgery is more effective than orthosis or waiting list for treating hallux valgus (Study #3).\n3. Mechanical treatment of plantar fasciitis is effective (Study #4).\n4. Custom-made foot orthoses are more effective than prefabricated or supportive athletic shoes in reducing pain and improving function in children with juvenile idiopathic arthritis (Study #8).\n5. Semi-rigid orthoses worn in supportive shoes are an effective treatment for metatarsalgia (Study #9).\n\nOverall, the studies suggest that custom-made foot orthoses are more effective than prefabricated or off-the-shelf orthoses in managing foot-related conditions. Additionally, the studies highlight the importance of proper fitting and comfortable orthoses to ensure compliance.",
        "eval": "1"
    },
    "121": {
        "summary": "Active management is associated with small reductions in the CS rate, but it is highly prescriptive and interventional. It is possible that some components of the active management package are more effective than others. Further work is required to determine the acceptability of active management to women in labour.",
        "model_output": "[/INST]  The findings from the seven studies suggest that active management of labor can reduce the rate of cesarean section without increasing maternal or neonatal morbidity. The studies were conducted in different settings, with varying populations and interventions, but they consistently showed that active management of labor can shorten labor duration and reduce the risk of cesarean section.\n\nThe studies also highlight some limitations and variations in the implementation of active management of labor. For example, some studies used different criteria for diagnosing labor, and some used different doses of oxytocin. However, the overall findings suggest that active management of labor is a promising strategy for reducing the rate of cesarean section without compromising maternal or neonatal outcomes.\n\nThe key findings from the studies can be summarized as follows:\n\n1. Active management of labor reduces the rate of cesarean section: Six of the seven studies found that active management of labor reduced the rate of cesarean section, with a combined relative risk reduction of 39% (95% CI 22-66%).\n2. Active management of labor shortens labor duration: Five of the seven studies found that active management of labor shortened labor duration, with a combined mean reduction of 2.7 hours (95% CI 2.1-3.3 hours).\n3. Active management of labor does not increase maternal or neonatal morbidity: None of the studies found a significant increase in maternal or neonatal morbidity associated with active management of labor.\n4. The effect of active management of labor may vary depending on the setting and population: The studies were conducted in different settings and populations, and the effect of active management of labor may vary depending on the specific context and population.\n\nIn conclusion, the findings from these studies suggest that active management of labor is a promising strategy for reducing the rate of cesarean section without compromising maternal or neonatal outcomes. However, the effect of active management of labor may vary depending on the setting and population, and further research is needed to optimize the implementation of this strategy.",
        "eval": "1"
    },
    "122": {
        "summary": "We conclude that there is no evidence of difference between rhCG or rhLH and uhCG in achieving final follicular maturation in IVF, with equivalent pregnancy rates and OHSS incidence. According to these findings uHCG is still the best choice for final oocyte maturation triggering in IVF and ICSI treatment cycles.",
        "model_output": "[/INST]  The findings from the seven studies on the use of recombinant human chorionic gonadotropin (r-hCG) in assisted reproductive technology are synthesized in the following key points:\n\n1. R-hCG is as effective and safe as urinary hCG in inducing final follicular maturation and luteinization in women undergoing assisted reproductive technology.\n2. The two doses of r-hCG administered subcutaneously (s.c.) or intramuscularly (i.m.) were as effective as the lowest dose of r-hCG (500 microg) administered s.c.\n3. The safety and efficacy of r-hCG were comparable to that of u-hCG in terms of oocytes retrieved per patient receiving the highest number of oocytes retrieved per patient.\n4. The two studies show that r-hCG and u-hCG and ually (safety and efficacy and safety and efficacy and safety and lute-hCG and lute.\n\n5.\n5.\n5.\n6.\n7.\n\n7.\n8.\n8.\n9.\n9.\n10.\n10.\n110.\n111.\n11.\n2.\n\n2.\n\n3.\n\n\n4.\n\n3.\n\n1.\n1.\n1.\n1.\n2.\n2.\n3.\n1.\n1.\n2.\n4.\n3.\n1.\n1.\n1.\n1.\n2.\n1.\n3.\n1.\n1.\n2.\n1.\n1.\n1.\n2.\n1.\n1.\n2.\n1.\n1.\n1.\n1.\n1.\n1.\n1.\n1.\n2.\n1.\n1.\n1.\n1.\n1.\n1.\n1.\n1.\n1.\n1.\n1.\n1.\n1.\n1.\n1.\n1.\n1.\n1.\n1.\n1.\n1.\n1.\n1.\n1.\n1.\n1.\n1.",
        "eval": "1"
    },
    "123": {
        "summary": "The most likely effective treatment to slow myopia progression thus far is anti-muscarinic topical medication. However, side effects of these medications include light sensitivity and near blur. Also, they are not yet commercially available, so their use is limited and not practical. Further information is required for other methods of myopia control, such as the use of corneal reshaping contact lenses or bifocal soft contact lenses (BSCLs) with a distance center are promising, but currently no published randomized clinical trials exist.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "124": {
        "summary": "Generally, fluoroquinolones performed well in treating typhoid, and maybe superior to alternatives in some settings. However, we were unable to draw firm general conclusions on comparative contemporary effectiveness given that resistance changes over time, and many studies were small. Policy makers and clinicians need to consider local resistance patterns in choosing a fluoroquinolone or alternative.\nThere is some evidence that the newest fluoroquinolone, gatifloxacin, remains effective in some regions where resistance to older fluoroquinolones has developed. However, the different fluoroquinolones have not been compared directly in trials in these settings.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\n.\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "125": {
        "summary": "The evidence suggests that a discharge plan tailored to the individual patient probably brings about reductions in hospital length of stay and readmission rates for older people admitted to hospital with a medical condition. The impact of discharge planning on mortality, health outcomes and cost remains uncertain.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "126": {
        "summary": "Increasing the pH of lidocaine decreased pain on injection and augmented patient comfort and satisfaction.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "127": {
        "summary": "Updated evidence is of low quality, and potential differences between early and late tracheostomy need to be better investigated by means of randomized controlled trials. At present there is no specific information about any subgroup or individual characteristics potentially associated with better outcomes with either early or late tracheostomy.",
        "model_output": "[/INST]  The four studies discussed in this summary investigate the timing of tracheotomy in critically ill patients requiring mechanical ventilation. The studies suggest that the timing of tracheotomy does not significantly impact the length of ventilator dependence, frequency of pneumonia, or length of intensive care unit (ICU) stay.\n\nStudy #1 found that early tracheotomy (before day 8) did not reduce the number of days of mechanical ventilation, frequency of pneumonia, or ICU length of stay compared to a strategy of tracheotomy after day 28.\n\nStudy #2 found that there was no significant difference in the complication incidence between early (34 patients) and late (40 patients) tracheotomy groups, with 15% of patients developing major laryngotracheal pathology and 54% developing respiratory infections.\n\nStudy #3 found that early percutaneous dilational tracheotomy resulted in significantly less mortality (31.7% vs. 61.7%), pneumonia (5% vs. 25%), and accidental extubations compared to delayed tracheotomy (0 vs. 6) in critically ill medical patients. The early tracheotomy group also spent less time in the ICU (4.8 +/- 1.4 vs. 16.2 +/- 3.8 days) and on mechanical ventilation (7.6 +/- 2.0 vs. 17.4 +/- 5.3 days).\n\nStudy #4 found that early tracheotomy (after 6-8 days of laryngeal intubation) did not result in statistically significant improvement in incidence of ventilator-associated pneumonia compared to late tracheotomy (after 13-15 days of laryngeal intubation) in mechanically ventilated adult ICU patients.\n\nIn summary, the studies suggest that the timing of tracheotomy does not significantly impact the outcomes of critically ill patients requiring mechanical ventilation. Early tracheotomy may have potential benefits in reducing complications and improving outcomes, but further research is needed to confirm these findings.",
        "eval": "0"
    },
    "128": {
        "summary": "The conclusion is that the choice of drug must be made based on consideration of drug-specific side effect properties.",
        "model_output": "[/INST]  The studies reviewed here investigate the effectiveness of various antidepressants in treating dysthymia, a chronic and often undertreated form of depression. The findings can be synthesized as follows:\n\n1. Different antidepressants have varying degrees of efficacy in treating dysthymia. For example, imipramine and sertraline were found to be more effective than placebo in reducing symptoms of dysthymia, while minaprine was better tolerated than imipramine.\n2. The choice of antidepressant may depend on the individual patient's needs and preferences. For example, patients with dysthymia may benefit more from the tolerability of ritanserin than from the efficacy of imipramine.\n3. The timing of treatment is crucial in dysthymia. Early intervention with antidepressants may lead to better outcomes, as seen in the study where patients who received imipramine early in the trial had better response rates than those who received it later.\n4. The severity of dysthymia may impact treatment response. For example, patients with early-onset dysthymia may respond better to treatment than those with late-onset dysthymia.\n5. Combination therapy may be necessary in some cases. For example, the study found that the combination of moclobemide and imipramine was more effective than either drug alone in treating dysthymia.\n6. The side effect profile of antidepressants should be taken into account when selecting a treatment. For example, ritanserin was found to have a better tolerability profile than imipramine, which may make it a more attractive option for patients with dysthymia.\n\nIn conclusion, the studies suggest that a variety of antidepressants can be effective in treating dysthymia, and that the choice of medication and timing of treatment may play a crucial role in achieving optimal outcomes. Further research is needed to determine the optimal treatment approach for this chronic and often undertreated form of depression.",
        "eval": "1"
    },
    "129": {
        "summary": "The results suggest that iodised salt is an effective means of improving iodine status. No conclusions can be made about improvements in other, more patient-oriented outcomes, such as physical and mental development in children and mortality. None of the studies specifically investigated development of iodine-induced hyperthyroidism, which can be easily overlooked if just assessed on the basis of symptoms. High quality controlled studies investigating relevant long term outcome measures are needed to address questions of dosage and best means of iodine supplementation in different population groups and settings.",
        "model_output": "[/INST]  The five studies discussed in this summary investigate the effectiveness of different iodine interventions in preventing iodine deficiency disorders (IDD) in various populations. The studies include comparing different iodine interventions in school children, the effect of voluntary intake of iodinated salt on goitre prevalence, the effects of iodoprophylaxis on thyroid size during pregnancy, the effectiveness of iodized salt in delivering iodine to young children in rural areas, and the use of iodized salt to prevent Himalayan endemic goitre.\n\nThe studies show that:\n\n1. In school children, receiving iodized salt with an iodine concentration of 25 ppm was effective in preventing IDD, as evidenced by the decline in the prevalence of abnormal thyroid volumes and goitre.\n2. Voluntary intake of iodinated salt can also be effective in preventing goitre and increasing iodine excretion in urine.\n3. Iodoprophylaxis during pregnancy can significantly reduce the risk of maternal and fetal hypothyroidism by preventing the increase in thyroid size.\n4. Iodized salt may not be an effective vehicle for delivering iodine to young children in rural areas, as urinary iodine excretion remained unchanged in these children.\n5. Fortifying salt with potassium iodide or potassium iodate can significantly reduce the prevalence of goitre in areas where goitre is endemic.\n\nOverall, these studies suggest that a combination of iodine interventions, including iodized salt, voluntary intake of iodinated salt, and fortification of salt with potassium iodide or potassium iodate, can be effective in preventing IDD in various populations. However, the optimal approach may depend on the specific population and context, and further research is needed to determine the most effective strategies for IDD control in different settings.",
        "eval": "1"
    },
    "130": {
        "summary": "In elective liver resection, hepatic vascular occlusion cannot be recommended over portal triad clamping. Intermittent portal triad clamping seems to be better than continuous portal triad clamping at least in patients with chronic liver disease. There is no evidence to support selective inflow occlusion over portal triad clamping. The optimal method of intermittent portal triad clamping is not clear. There is no evidence for any difference between the ischaemic preconditioning followed by vascular occlusion and intermittent vascular occlusion for liver resection in patients with non-cirrhotic livers. Further randomised trials of low risk of bias are needed to determine the optimal technique of vascular occlusion.",
        "model_output": "[/INST] to\n,\n, \n, \n,\n, \n, \n,\n, pass, pass,\n,\n,\n,\n.\n.\n....\n\n\n\n,\n,\n, Hinweis,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n, Begriffe, hopefully,,, Hinweis, Hinweis, Hinweis, hopefully, hopefully, hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully, hopefully, hopefully, \n, hopefully, hopefully, hopefully, hopefully, hopefully, hopefully, hopefully, hopefully,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n\n\n\n\n\n\n\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n\n\n,   \n, \n, \n, \n, \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n,\n,\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n,\n\n\n,\n,\n,\n,\n\n\n\n\n\n\n\n\n\n\n\n\n\n,\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n to\n\n\n\n\n\n\n\n\n\n,\n,\n,\n,\n,\n,\n,\n,\n\n\n\n\n\n\n\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,,,,,,,,,,,,,,,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n, #, #, #,\n,\n,\n\n,\n,\n,\n,\n,\n\n\n,",
        "eval": "0"
    },
    "131": {
        "summary": "Although antibiotic treatment is effective for the cure of urinary tract infections, there are insufficient data to recommend any specific drug regimen for treatment of symptomatic urinary tract infections during pregnancy. All the antibiotics studied were shown to be very effective in decreasing the incidence of the different outcomes. Complications were very rare. All included trials had very small sample sizes to reliably detect important differences between treatments. Future studies should evaluate the most promising antibiotics, in terms of class, timing, dose, acceptability, maternal and neonatal outcomes and costs.",
        "model_output": "[/INST]  The six studies reviewed above investigate the treatment of lower urinary tract infections (UTIs) and acute pyelonephritis during pregnancy. The findings can be synthesized as follows:\n\n1. Treatment of lower UTI in pregnancy:\n\t* Fosfomycin trometamol and ceftibuten are equally effective in treating acute cystitis in pregnant women.\n\t* Escherichia coli is the most common pathogen in both groups.\n\t* Therapeutic success was achieved in 95.2% of patients treated with fosfomycin-trometamol and 90.0% of those treated with ceftibuten.\n2. Comparison of second-generation cephalosporins and cefuroxime:\n\t* Cefuroxime is more effective than cephradine in treating acute pyelonephritis during pregnancy.\n\t* Cefuroxime has a lower rate of resistance to isolated uropathogens compared to cephradine.\n3. Randomized clinical trial of antibiotic therapy for antenatal pyelonephritis:\n\t* Completion of a 10-day course of oral antibiotics does not significantly reduce the risk of recurrent pyelonephritis immediately post-parenteral treatment.\n\t* Women in the no oral treatment group had a non-significant increase in positive urine cultures at the 2-week follow-up visit.\n4. Acute cystourethritis during pregnancy:\n\t* Nitrofurantoin or ampicillin is safe and effective therapy for acute uncomplicated urinary tract infections in pregnant women.\n\t* Escherichia coli is the most common pathogen in acute cystitis during pregnancy.\n5. A randomized trial of three antibiotic regimens for the treatment of pyelonephritis in pregnancy:\n\t* There are no significant differences in clinical response to antimicrobial therapy or birth outcomes among subjects treated with ampicillin and gentamicin, cefazolin, or ceftriaxone for",
        "eval": "1"
    },
    "132": {
        "summary": "Metered-dose inhalers with spacer produced outcomes that were at least equivalent to nebuliser delivery. Spacers may have some advantages compared to nebulisers for children with acute asthma.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "133": {
        "summary": "A comparison of the effects of human and animal insulin as well as of the adverse reaction profile did not show clinically relevant differences. Many patient-oriented outcomes like health-related quality of life or diabetes complications and mortality were never investigated in high-quality randomised clinical trials. The story of the introduction of human insulin might be repeated by contemporary launching campaigns to introduce pharmaceutical and technological innovations that are not backed up by sufficient proof of their advantages and safety.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "134": {
        "summary": "Further research is needed on the comparison of different types of low vision aids. It will be also necessary to delineate patient's characteristics that predict performance with costly electronic devices as well as their sustained use in the long term compared to simpler and cheaper optical devices.",
        "model_output": "[/INST]  The studies summarized in this document investigate the effects of various interventions on reading performance in individuals with age-related macular degeneration (AMD) or other low vision conditions. The findings can be synthesized as follows:\n\n1. Coloured light filter overlays may not improve reading rates in AMD patients associated with a relative scotoma and central fixation.\n2. Reading performance with prism spectacles is similar to that with conventional spectacles for people with AMD.\n3. Electronic vision enhancement systems (EVES) provide objective benefits in reading speed and acuity compared to optical magnification for visually impaired individuals.\n4. Head-mounted video magnifiers can support good low-vision reading performance, but the restricted range of magnification may limit their usefulness for people with very low acuity.\n5. CCTVs are more effective than optical devices for low vision patients with central field loss, and handheld CCTVs are less expensive and provide equal performance compared to stand-mounted systems.\n6. Four new ergonomically designed stand magnifiers were preferred by low vision patients compared to a commercial stand magnifier.\n7. The Virtual Retinal Display (VRD) may be a promising alternative computer visual interface for low-vision use, particularly for individuals with predominantly optical causes of low vision.\n\nThese findings suggest that the most effective interventions for improving reading performance in individuals with low vision may vary depending on the specific condition and individual factors. Further research is needed to determine the optimal interventions for different populations and to improve the design and functionality of low-vision aids.",
        "eval": "1"
    },
    "135": {
        "summary": "While brief counselling interventions have been identified as successful ifor adults when delivered by physicians, this cannot be extrapolated to adults as parents in child health settings. However, there is limited support for more intensive counselling interventions for parents in such contexts. There is no clear evidence of differences between the respiratory, non-respiratory ill child, well child and peripartum settings as contexts for reduction of children's ETS exposure.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "136": {
        "summary": "Long acting inhaled beta-agonists have advantages across a wide range of physiological and clinical outcomes for regular treatment.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "137": {
        "summary": "Available evidence nevertheless suggests that compared with standard care or no intervention, behavioral interventions are effective in reducing HIV and the incidence of STIs amongst female sex workers (FSWs). Given the benefits of social cognitive theory and the promotion of condom use in reducing HIV/STI and the public health need to control transmission amongst FSWs, there is a clear finding in favour of behavioral interventions. However, it should be recognized that there is a lack of information about most other outcomes and target populations, and that all of the trials were conducted in low- and middle-income countries.",
        "model_output": "[/INST]\n Hinweis Hinweis\n\n\n\n\n\n\n Hinweis\n Hinweis Hinweis Hinweis Hinweis obviously\n\n Hinweis\n\n\n\n\n\n Hinweis Hinweis Hinweis Hinweis Hinweis everybody everybody everybody everybody Hinweis everybody Hinweis everybody everybody\n,\n,\n,\n,\n,\n, Begriffe,\n\n\n\n\n\n\n  \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n,\n,\n,\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n,\n,\n, 0, \n,\n,\n,\n,\n,\n\n\n\n,\n,\n,\n,\n,\n,\n, Begriffe Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung everybody,\n, \n\n\n\n\n Begriffe\n\n\n\n\n\n,\n,\n,\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n,\n\n\n\n\n\n\n\n\n, , ,,,,\n,,,,,\n, and and,\n,\n,,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n,\n\n\n\n\n\n,\n,\n,\n,\n,\n,\n,\n,\n\n\n\n\n\n\n,\n,\n,\n,\n,\n,\n,\n,\n,,,,,,,,,,,,, , , , ,,,,, , ,,,,, ,,,,,,,,,,,,,\n,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,",
        "eval": "0"
    },
    "138": {
        "summary": "This review demonstrated that there is insufficient evidence to draw definitive conclusions regarding the impact of educational or behavioural interventions on TTR in AF patients receiving OAT. Thus, more trials are needed to examine the impact of interventions on anticoagulation control in AF patients and the mechanisms by which they are successful. It is also important to explore the psychological implications for patients suffering from this long-term chronic condition.",
        "model_output": "[/INST]  The abstracts provide insights into the effectiveness of various interventions in improving the decision-making process and the quality of antithrombotic therapy in patients with atrial fibrillation. The findings suggest that decision aids can improve the understanding of treatment options and reduce the uncertainty associated with the decision-making process. Additionally, the use of enhanced follow-up and self-management practices can improve the quality of oral anticoagulant therapy. However, the long-term effectiveness of these interventions and their cost-effectiveness require further evaluation.\n\nStudy #1: The use of an audiobooklet (AB) decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation was evaluated. The AB included information on the benefits and risks of different treatment options, and participants were asked to make a decision based on this information. The study found that participants who used the AB decision aid were more likely to make a decision about antithrombotic therapy than those who did not use the aid.\n\nStudy #2: This study evaluated the effectiveness of enhanced follow-up and the need for larger studies to delve into the cost-effectiveness of these interventions in patients with atrial fibrillation. The study found that enhanced follow-up resulted in improved knowledge of safe warfarin practices early in treatment.\n\nStudy #3: This study aimed to evaluate the use of a decision aid in patients with non-valvular atrial fibrillation (SMAAF Study). The study found that the use of enhanced follow-up and the need for larger studies to evaluate the cost-up and the use of enhanced follow-up and the use of enhanced follow-up and the use of enhanced follow-up and the use of the use of the use of the use of the use of the use of the use of the use of the use of the use of the use of the use of the use of the use of the use of the use of the use of the use of the use of the use of the use of the use of the use of the use of the use of the use of the use of the use of the use of the use of the use of the use of the use of the use of the use of the use of the use of the use of the use of",
        "eval": "0"
    },
    "139": {
        "summary": "Although numerous studies have been undertaken, there is a noticeable inconsistency of the findings of the available studies and this is confounded by serious methodological issues within the included studies. The body of evidence in this review does not support the hypothesis that multi-component community wide interventions effectively increase population levels of physical activity. There is a clear need for well-designed intervention studies and such studies should focus on the quality of the measurement of physical activity, the frequency of measurement and the allocation to intervention and control communities.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "140": {
        "summary": "Benefits of screening include a modest reduction in colorectal cancer mortality, a possible reduction in cancer incidence through the detection and removal of colorectal adenomas, and potentially, the less invasive surgery that earlier treatment of colorectal cancers may involve.Harmful effects of screening include the psycho-social consequences of receiving a false-positive result, the potentially significant complications of colonoscopy or a false-negative result, the possibility of overdiagnosis (leading to unnecessary investigations or treatment) and the complications associated with treatment.",
        "model_output": "[/INST]  The six studies reviewed here provide evidence that biennial screening for colorectal cancer using fecal occult blood tests can reduce mortality from the disease. The studies were conducted in different populations and used different screening tests, but they all found a significant reduction in colorectal cancer mortality among individuals who were screened compared to those who were not. The reduction in mortality ranged from 11% to 43%, with an average reduction of 29%. The studies also found that screening was associated with improved survival in those with colorectal cancer and a shift to detection at an earlier stage of cancer. However, the studies also noted some limitations and potential biases, such as the impact of compliance on mortality from colorectal cancer and the need for further follow-up to determine the long-term effectiveness of screening. Overall, the findings of these studies suggest that biennial screening for colorectal cancer using fecal occult blood tests is a promising strategy for reducing mortality from this disease.",
        "eval": "1"
    },
    "141": {
        "summary": "There appears to be little basis for offering CSE over epidurals in labour, with no difference in overall maternal satisfaction despite a slightly faster onset with CSE and conversely less pruritus with low-dose epidurals. There was no difference in ability to mobilise, maternal hypotension, rate of caesarean birth or neonatal outcome. However, the significantly higher incidence of urinary retention, rescue interventions and instrumental deliveries with traditional techniques would favour the use of low-dose epidurals. It is not possible to draw any meaningful conclusions regarding rare complications such as nerve injury and meningitis.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "142": {
        "summary": "NO donors are superior to placebo or no treatment, but inferior to prostaglandins for first-trimester cervical ripening, and associated with more side effects.",
        "model_output": "[/INST]  The findings from the eight studies are synthesized as follows:\n\n1. Study #1: Isosorbide mononitrate for cervical ripening before surgical termination of pregnancy in the first trimester: Isosorbide mononitrate was evaluated for its efficacy in cervical priming before surgical termination of pregnancy in the first trimester. The study found that isosorbide mononitrate was not significantly different from placebo in terms of cervical resistance, but it was associated with fewer side effects.\n2. Study #2: Comparison of isosorbide mononitrate and misoprostol for cervical priming before first-trimester surgical termination of pregnancy: This study compared the efficacy and safety of isosorbide mononitrate and misoprostol for cervical priming before first-trimester surgical termination of pregnancy. The study found that isosorbide mononitrate was more effective and safe than misoprostol for cervical priming before first-trimester surgical termination of pregnancy.\n3. Study #4. Study #4. Study #5.",
        "eval": "0"
    },
    "143": {
        "summary": "Repetitive task training resulted in modest improvement in lower limb function, but not upper limb function. Training may be sufficient to impact on daily living function. However, there is no evidence that improvements are sustained once training has ended. The review potentially investigates task specificity rather more than repetition. Further research should focus on the type and amount of training, and how to maintain functional gain.",
        "model_output": "[/INST]\n,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, \u00a0,\u00a0, ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, , , ,   ,    , , , , , , , , , , , ,                         fully  fully     after                , ,                    , , ,             ,                                                                                                               , , , \n, \n, \n, \n. \n. \n. . \n. . . \n, ,                                       , , ,                                                       .",
        "eval": "0"
    },
    "144": {
        "summary": "There is insufficient evidence either for or against the use of stabilisation splint therapy for the treatment of temporomandibular pain dysfunction syndrome. This review suggests the need for further, well conducted RCTs that pay attention to method of allocation, outcome assessment, large sample size, and enough duration of follow up. A standardisation of the outcomes of the treatment of PDS should be established in the RCTs .",
        "model_output": "[/INST]  The studies reviewed provide insights into the effectiveness of various treatments for temporomandibular disorders (TMD), including intraoral appliances, biofeedback/stress management, occlusal splints, acupuncture, and hypnorelaxation. The findings suggest that:\n\n1. Intraoral appliances and biofeedback/stress management are equally effective in treating pain and depression in patients with TMD.\n2. Oral splints are effective in reducing pain and improving quality of life in patients with myofascial pain of the jaw muscles.\n3. Mandibular movement feedback and occlusal appliances are effective in improving clinical and electromyographic outcomes in patients with mandibular dysfunction.\n4. Widespread pain may affect the effectiveness of oral splints in treating myofascial face pain.\n5. Acupuncture is an alternative method to conventional stomatognathic treatment for individuals with craniomandibular disorders of muscular origin.\n6. Occlusal splint therapy is more effective than relaxation procedures in reducing pain and improving mandibular function in patients with TMD.\n7. Hypnorelaxation is an effective mode of treatment in MPD, especially regarding some subjective pain parameters.\n8. Therapeutic jaw exercises and interocclusal appliance therapy are equally effective in treating TMD.\n9. Acupuncture seems to be a useful early form of therapy in patients with TMJ disorders that are expected to be largely functional and reversible and with evidence of psychophysiologic or neuromuscular disturbances but not of any marked occlusal interference or joint damage.\n\nThese findings suggest that a comprehensive approach to treating TMD, incorporating various treatment modalities, may lead to the best outcomes. It is important to consider the individual patient's needs and comorbidities when selecting a treatment plan.",
        "eval": "1"
    },
    "145": {
        "summary": "The results of this systematic review indicate that virtual reality endoscopy training can be used to effectively supplement early conventional endoscopy training (apprenticeship model) in diagnostic oesophagogastroduodenoscopy, colonoscopy and/or sigmoidoscopy for health professions trainees with limited or no prior endoscopic experience. However, there remains insufficient evidence to advise for or against the use of virtual reality simulation-based training as a replacement for early conventional endoscopy training (apprenticeship model) for health professions trainees with limited or no prior endoscopic experience. There is a great need for the development of a reliable and valid measure of endoscopic performance prior to the completion of further randomised clinical trials with high methodological quality.",
        "model_output": "[/INST] , \n\n\n\n............\n\n\n\n\n                          in  in  \n \n\n...........................\n,\n              \n\n\n\n \n............\n\n\n          a . \u0409 \u0409 \u0409 \u0409 \u0409\n\u0409\n.\n  both.\n\n\n\n\n\n....\n..... \u0409. . \n \n   \n. \u0409 \u0409, \u0409.\u0409.\u0409.\u0409.\u0409..\n.\n.\n. . \u0409 . .\n\u0409 \u0409 \u0409\u0409\u0409\u0409\u0409.\u0409 \u0409 \u0409 \u0409 \u0409 \u0409 \u0409 \u0409 \u0409\n\u0409 \u0409.\u0409.\u0409.\u0409\n\u0409\n\u0409 \u0409 \u0409 \u0409.\u0409 \u0409\n\u0409.\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409.\u0409.\u0409.\u0409.\u0409.\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "146": {
        "summary": "The findings of this review suggest that oral naltrexone did not perform better than treatment with placebo or no pharmacological agent with respect to the number of participants re-incarcerated during the study period. If oral naltrexone is compared with other pharmacological treatments such as benzodiazepine and buprenorphine, no statistically significant difference was found. The percentage of people retained in treatment in the included studies is however low (28%). The conclusion of this review is that the studies conducted have not allowed an adequate evaluation of oral naltrexone treatment in the field of opioid dependence. Consequently, maintenance therapy with naltrexone cannot yet be considered a treatment which has been scientifically proved to be superior to other kinds of treatment.",
        "model_output": "[/INST]  The findings from the provided abstracts suggest that naltrexone can be an effective pharmacotherapy for opioid dependence, with a significant reduction in opioid use and relapse rates observed in several studies. The studies also highlight the importance of integrating naltrexone into the Federal Probation/Parole system, as well as the potential benefits of combining naltrexone with psychotherapeutic measures. However, the studies also note limitations and potential drawbacks of naltrexone use, such as the need for careful dosing and monitoring, as well as the potential for side effects and withdrawal symptoms. Overall, the findings suggest that naltrexone can be a useful tool in the treatment of opioid dependence, but further research is needed to fully understand its efficacy and potential risks.",
        "eval": "1"
    },
    "147": {
        "summary": "The addition of corticosteroids reduces the incidences of acute GvHD grade I to IV and II to IV. This reduction, however, did not show any effect on overall survival and disease-free survival. Further randomised controlled studies are needed to evaluate if the timing of steroid administration has a significant influence on the outcome; data on quality of life should be assessed systematically.",
        "model_output": "[/INST]  The studies summarized in this collection relate to the prevention and treatment of graft-versus-host disease (GVHD) in patients undergoing bone marrow transplantation. The studies compare different regimens of cyclosporine, methotrexate, and prednisolone for preventing GVHD, and investigate the addition of prednisolone to the standard regimen of methotrexate and cyclosporine.\n\nThe findings from the studies can be synthesized as follows:\n\n1. Equivalence of 2 effective graft-versus-host disease prophylaxis regimens: The first study found that the addition of methotrexate to cyclosporine and prednisolone did not result in a higher incidence of acute GVHD in patients undergoing bone marrow transplantation.\n2. Cyclosporine or CSP plus methylprednisolone for graft-versus-host disease prophylaxis: The second study found that the addition of methylprednisolone to cyclosporine did not result in a lower incidence of acute GVHD, but did increase the incidence of chronic GVHD.\n3. Cyclosporine, methotrexate, and methylprednisolone compared with cyclosporine and methotrexate for the prevention of graft-versus-host disease: The third study found that the addition of methylprednisolone to the standard regimen of cyclosporine and methotrexate resulted in a lower incidence of acute GVHD.\n4. What role for prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants: The fourth study found that the addition of prednisone to the standard regimen of methotrexate and cyclosporine resulted in a significant increase in acute and chronic GVHD in HLA-identical recipients, but did not result in a significant increase in transplant-related mortality.\n5. A prospective randomised trial of cyclosporin and methotrexate versus cyclosporin, methotrexate and prednisolone for prevention of graft-",
        "eval": "1"
    },
    "148": {
        "summary": "There is insufficient evidence to evaluate the effectiveness of sustained-release naltrexone for treatment of opioid dependence.For naltrexone injections, administration site-related adverse effects appear to be frequent, but of moderate intensity and time limited. For a harm-benefit evaluation of naltrexone implants, more data on side effects and adverse events are needed.",
        "model_output": "[/INST]                                         .                              \n . . \n . \u0409 \n                       \n        \n\n\u0409 \u0409 \u0409 \u0409 \u0409 . \u0409 .                . \u0409 \u0409.\u0409 \u0409 \u0409.\u0409.\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409.\u0409 abstract \u0409   \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n \n \n \n                .\n. \u0409 . . . .\n.....\n.\n.\n. \n   . .",
        "eval": "0"
    },
    "149": {
        "summary": "The use of ddI and, to a lesser extent, ddC delayed both HIV disease progression and death, at least when added to AZT.",
        "model_output": "[/INST]  The five studies reviewed here investigate the use of combination therapy with zidovudine and other nucleosides in treating HIV-infected patients. The studies found that:\n\n1. Combination therapy with zidovudine and either didanosine or zalcitabine is not superior to zidovudine monotherapy in patients with advanced HIV disease, as shown in Study #1 and Study #3.\n2. Combination therapy with zidovudine plus didanosine or zalcitabine delays disease progression or death more effectively than zidovudine monotherapy in patients with little or no previous zidovudine treatment, as shown in Study #3.\n3. The addition of didanosine to participants already treated with zidovudine improves survival, although the benefit appears less, as shown in Study #3.\n4. Combination therapy with zidovudine and either didanosine or zalcitabine results in a significant increase in CD4 cells and a greater and more sustained decline in serum HIV-1 RNA compared with zidovudine monotherapy, as shown in Study #5.\n5. Combination therapy with zidovudine plus didanosine or zalcitabine delays the emergence of zidovudine-resistant virus isolates, as shown in Study #5.\n\nOverall, the studies suggest that combination therapy with zidovudine and other nucleosides may be more effective than monotherapy in treating HIV-infected patients, particularly those with little or no previous zidovudine treatment. However, the findings also suggest that the benefits of combination therapy may be limited to certain patient populations, and further research is needed to determine the optimal treatment strategies for HIV-infected patients.",
        "eval": "1"
    },
    "150": {
        "summary": "The retinoids studied are not effective in causing regression of CIN3 but may have some effect on CIN2. The data on CIN1 are inadequate. Retinoids are not effective in preventing progression of CIN of any grade. At the doses given for the duration of treatment studied, the retinoids were reasonably well tolerated.",
        "model_output": "[/INST]  The findings from the five studies suggest that topical retinoids, including all-trans-retinoic acid (ATRA) and 9-cis-retinoic acid (aliretinoin), are effective in reversing cervical intraepithelial neoplasia (CIN) II and III. The studies show that locally applied ATRA can increase the complete histologic regression rate of CIN II from 27% to 43% (Study #1), and that lower concentrations of ATRA applied with a cervical cap for 4 days were no more effective than placebo (Study #2). Study #3 found that isotretinoin was not associated with longer time to progression of low-grade squamous intraepithelial lesions (SIL) in human immunodeficiency virus (HIV)-positive women, and Study #4 showed that aliretinoin at high doses and schedules does not result in significant regression rates in CIN 2/3 patients when compared with placebo. Study #5 found that 4-hydroxyphenylretinamide (4-HPR) at 200 mg/day with a 3-day/month drug holiday is not active compared with placebo in the treatment of high-grade squamous intraepithelial lesions (HGSIL).\n\nThe studies highlight the importance of having a placebo arm and an adequate sample size in cervical dysplasia chemoprevention studies, as well as the potential for side effects to thwart efforts to increase the dose or duration of treatment. The findings suggest that topical retinoids may be a promising approach for the treatment and prevention of cervical dysplasia, but further research is needed to determine the optimal dosage and schedule for treatment.",
        "eval": "1"
    },
    "151": {
        "summary": "Although strong evidence supports the use of magnesium sulphate for prevention and treatment of eclampsia, trials comparing alternative treatment regimens are too small for reliable conclusions.",
        "model_output": "[/INST]  The findings from the five studies suggest that magnesium sulfate therapy during antepartum and postpartum periods has a positive impact on reducing the levels of prostacyclin and thromboxane in women with severe preeclampsia. Specifically, the study abstracts indicate that:\n\n1. Administration of magnesium sulfate does not affect prostacyclin and thromboxane levels in the maternal circulation in women with preeclampsia during antepartum and postpartum periods (Study #1).\n2. Twelve hours of postpartum magnesium sulfate therapy for mild preeclampsia is associated with infrequent disease progression and a clinical course similar to that with 24-hour therapy (Study #2).\n3. Only loading dose of magnesium sulfate is effective in controlling convulsion in eclampsia (Study #3).\n4. Low-dose magnesium sulphate regimens are safe and effective in the treatment of eclampsia (Study #4).\n5. Intramuscular magnesium sulphate regimens produce similar average serum magnesium concentrations as intravenous regimens, with greater fluctuations in magnesium levels observed with the IM regimen (Study #5).\n\nOverall, the studies suggest that magnesium sulfate therapy can be effective in managing preeclampsia and eclampsia, with different regimens having varying effects on prostacyclin and thromboxane levels. However, further research is needed to fully understand the optimal dosing and administration regimens for magnesium sulfate in these conditions.",
        "eval": "0"
    },
    "152": {
        "summary": "Postoperative platinum based chemotherapy is associated with a small benefit in progression-free survival and overall survival irrespective of radiotherapy treatment. It reduces the risk of developing a metastasis, could be an alternative to radiotherapy and has added value when used with radiotherapy.",
        "model_output": "[/INST]  The studies summarized above investigate the use of chemotherapy and radiation therapy in the treatment of endometrial cancer. The findings can be synthesized as follows:\n\n1. In Study #1, whole-abdominal irradiation (WAI) was compared to doxorubicin and cisplatin chemotherapy in patients with advanced endometrial carcinoma. The study found that WAI was associated with a higher risk of bowel complications, but did not improve overall survival or recurrence rates.\n2. In Study #2, surgically staged high-risk endometrial cancer patients were randomized to receive adjuvant radiotherapy alone or sequential chemotherapy and radiotherapy. The study found that sequential chemotherapy and radiotherapy did not improve progression-free survival or overall survival in high-risk endometrial cancer patients.\n3. In Study #3, the Japanese Gynecologic Oncology Group conducted a randomized phase III trial of adjuvant pelvic radiation therapy (PRT) versus cyclophosphamide-doxorubicin-cisplatin (CAP) chemotherapy in patients with intermediate- and high-risk endometrial cancer. The study found that CAP chemotherapy was associated with a higher progression-free survival rate and higher overall survival rate in patients with intermediate-risk endometrial cancer.\n4. In Study #4, the use of adjuvant chemotherapy versus radiotherapy in high-risk endometrial cancer patients was evaluated. The study found that both treatments were well tolerated, but failed to show any improvement in survival.\n5. In Study #5, sequential adjuvant chemotherapy and radiotherapy in endometrial cancer were evaluated. The study found that the combination of chemotherapy and radiotherapy improved progression-free survival and overall survival in high-risk endometrial cancer patients.\n6. In Study #6, doxorubicin was evaluated as an adjuvant following surgery and radiation therapy in patients with high-risk endometrial carcinoma, stage I and occult stage II. The study found that doxorubicin did not improve survival or progression-free interval of the endometrial cancer study",
        "eval": "0"
    },
    "153": {
        "summary": "Information on all comparisons are of limited quality, are incomplete and problematic to apply clinically. Aripiprazole is an antipsychotic drug with a variant but not absent adverse effect profile. Long-term data are sparse and there is considerable scope for another update of this review as new data emerges from the many Chinese studies as well as from ongoing larger, independent pragmatic trials.",
        "model_output": "[/INST] and \u0409, highly, highly, highly, and \u0409,\n\n\n\n\n\n\n\n\n \u0409, \u0409, and \u0409 and \u0409.\n\n\n\n\n\n\n\n\n\n\n\n\n \u0409\n \u0409, and the clin, \u0409,\n\n\n\n,\n,\n\n\n\n, \u0409, \u0409, \u0409,\n,\n,\n, \u0409,\n, \n, \n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,  kwiet,\n,  kwiet,\n,  sierp,  sierp,\n,\n,\n everybody,\n everybody,\n everybody, everybody,\n,\n, everybody,\n,\n\n\n\n\n\n,\n,\n,\n,\n,\n,\n,\n\n\n\n\n\n kwiet\n\n\n\n\n kwiet\n\n\n\n\n\n\n\n\n Hinweis\n Hinweis hopefully hopefully hopefully hopefully hopefully hopefully hopefully Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis\n Hinweis\n kwiet\n kwiet\n kwiet everybody, everybody hopefully everybody everybody everybody everybody everybody everybody everybody everybody Einzeln Einzeln Einzeln everybody everybody everybody\n everybody.\n everybody,\n, everybody everybody everybody everybody everybody everybody everybody Hinweis everybody Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis\n\n\n Hinweis Hinweis Hinweis,\n Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis everybody Hinweis everybody Hinweis everybody Hinweis everybody everybody everybody Hinweis everybody Hinweis everybody Hinweis Hinweis Hinweis everybody everybody everybody everybody everybody everybody everybody Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Einzeln Hinweis Einzeln Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis,\n\n\n.\n.\n.\n,\n Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis everybody everybody everybody Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis everybody everybody everybody everybody everybody everybody Hinweis everybody everybody everybody everybody everybody everybody everybody everybody Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe Begriffe everybody everybody everybody Hinweis everybody Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis",
        "eval": "0"
    },
    "154": {
        "summary": "Telephone consultation appears to reduce the number of surgery contacts and out-of-hours visits by general practitioners. However, questions remain about its affect on service use and further rigorous evaluation is needed with emphasis on service use, safety, cost and patient satisfaction.",
        "model_output": "[/INST]  The findings from the provided abstracts suggest that telephone triage for same-day appointments in general practice can reduce the number of appointments with general practitioners but result in busier routine surgeries, increased nursing time, and a small but significant increase in out-of-hours and accident and emergency attendance. The use of telephone consultations for managing requests for same-day appointments in general practice can save time and did not result in lower patient satisfaction. An alternate method of handling telephone complaints in a large emergency room through a randomized clinical trial of pediatric protocols demonstrated an alternate method of handling telephone complaints in a large emergency room. The effect of an out-of-hours reform on attendance at casualty wards in Denmark was analyzed, and it was found that the decrease in the total number of contacts with the out-of-hours primary health care after the reform was not met by a corresponding increase in casualty ward contacts.\n\nNurse telephone consultation in out-of-hours primary care was found to be safe and effective, reducing overall workload of general practitioners by 50% while allowing callers faster access to health information and advice, without being associated with an increase in the number of adverse events.\n\nIn summary, telephone triage for same-day appointments in general practice can result in busier routine surgeries and increased nursing time, but does not reduce overall costs per patient. The use of telephone consultations for managing requests for same-day appointments can save time and did not result in lower patient satisfaction. The out-of-hours reform in Denmark did not lead to an increase in attendance at casualty wards. Finally, nurse telephone consultation in out-of-hours primary care is safe and effective in reducing overall workload of general practitioners while allowing callers faster access to health information and advice without increasing adverse events.",
        "eval": "1"
    },
    "155": {
        "summary": "This review provides no clear evidence for the treatment of cirrhotic patients with spontaneous bacterial peritonitis. In practice, third generation cephalosporins have already been established as the standard treatment of spontaneous bacterial peritonitis, and it is clear, that empirical antibiotic therapy should be provided in any case. However, until large, well-conducted trials provide more information, practice will remain based on impression, not evidence.",
        "model_output": "[/INST] everybody Hinweis Hinweis Hinweis everybody Hinweis everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody,\n\n\n\n.\n\n.\n,\n Hinweis Unterscheidung Hinweis Unterscheidung Hinweis Unterscheidung Hinweis everybody everybody everybody everybody everybody everybody hopefully everybody everybody everybody everybody everybody everybody hopefully everybody everybody Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis, Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis obviously obviously, obviously, obviously obviously obviously Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis hopefully obviously obviously obviously obviously obviously obviously obviously, pass obviously obviously everybody everybody everybody everybody everybody everybody everybody everybody obviously obviously obviously obviously obviously, obviously, obviously, pass, pass, pass,\n,\n,\n,\n,\n\n\n\n\n\n\n\n\n\n\n\n,\n\n\n\n\n\n\n\n\n\n, \n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,,,,,,,,,,\n,\n,\n,\n,\n, \n, \n,\n, \n, \n,\n,\n,\n,\n,\n,\n\n\n,\n, \n,\n,\n,\n,\n, Hinweis,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n, \n,,,\n,\n,\n,\n,\n,\n,\n, Hinweis Hinweis Hinweis, Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis,\n,\n,\n,\n,\n,\n\n\n\n,\n,\n,\n,\n,\n,\n,\n\n\n\n\n\n\n\n\n\n\n\n\n\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,,,,,,,,,,,,,,,\n,\n,,,,,,,,,,,,,,,,,\n,\n,\n,\n\n\n\n\n\n\n\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,,\n,\n,\n,,,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,,,,,,,,,,",
        "eval": "0"
    },
    "156": {
        "summary": "In view of methodological deficiencies and limited number of individual studies, we have found no reliable evidence to support the routine use of vitamins in patients with epilepsy. Further trials are needed, especially to assess the utility of vitamin D supplementation to prevent osteomalacia and the role of vitamin E on seizures and thiamine in improving cognitive functions.",
        "model_output": "[/INST]  The findings from the provided abstracts suggest that folic acid supplementation may have a positive impact on epilepsy treatment. The studies suggest that folic acid can:\n\n1. Reduce seizure frequency: Studies #1, #2, #4, #6, #8, #10, and #12 suggest that folic acid supplementation can lead to a decrease in seizure frequency in epileptic patients.\n2. Improve neurological function: Studies #3, #7, #9, and #11 suggest that folic acid supplementation can improve neurological function in epileptic patients, particularly in terms of visuo-spatial analysis, visuo-motor speed, and verbal abstracting ability.\n3. Reduce gingival hyperplasia: Studies #5, #7, #10, and #15 suggest that folic acid supplementation can reduce gingival hyperplasia in epileptic patients, particularly when treated with phenytoin.\n4. Normalize folate levels: Studies #1, #2, #4, #6, #8, #10, and #12 suggest that folic acid supplementation can normalize folate levels in epileptic patients, particularly when treated with anticonvulsant drugs.\n\nIt is important to note that the studies have some limitations, such as small sample sizes, lack of control groups, and short follow-up periods. Therefore, further large-scale, well-designed studies are needed to confirm these findings and establish the efficacy of folic acid supplementation in epilepsy treatment.",
        "eval": "1"
    },
    "157": {
        "summary": "We detected no difference in the effect on parasites and clinical illness for intrarectal quinine, but most trials were small. Pain may be less with intrarectal proprietary, buffered quinine preparations (made less acidic by adjustment of the pH to 4.5). Further larger trials in patients with severe malaria and in adults are required before the intrarectal route can be recommended.",
        "model_output": "[/INST] Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis, Begriffe, Hinweis Hinweis, Begriffe, Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis\n\n\n\n\n\n Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis obviously\n\n\n\n\n Hinweis Hinweis Hinweis Hinweis Hinweis, Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis, Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis\n\n\n\n\n\n\n Hinweis Hinweis Hinweis Hinweis\n\n\n\n\n\n\n Begriffe Hinweis Hinweis everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody Hinweis Hinweis to\n to\n\n\n\n to Begriffe Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n,\n,\n,\n,\n,\n,\n\n\n\n\n,\n,\n,\n,\n,\n,\n,\n,\n,\n\n\n,\n,\n\n\n\n\n\n\n\n\n\n\n\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n\n\n,\n,\n,\n,\n,\n,\n\n,\n, #, #, #, \n, \n, , \n, \n, \n, \n,       \n           \n, \n, \n, \n, \n,\n,\n,\n, \n, , , ,,,,,,,, ,   \n,  , , ,,,, , , , , , , , , , , ,,,, ,,,, , , ,                , . , , ,           , ,   \n,  ,",
        "eval": "0"
    },
    "158": {
        "summary": "As a result of the few available studies, no convincing conclusions can be formulated about the effectiveness of workplace interventions on work-related outcomes and health outcomes regardless of the type of work disability. The pooled data for the musculoskeletal disorders subgroup indicated that workplace interventions are effective in the reduction of sickness absence, but they are not effective in improving health outcomes. The evidence from the subgroup analysis on musculoskeletal disorders was rated as moderate-quality evidence. Unfortunately, conclusions cannot be drawn on the effectiveness of these interventions for mental health problems and other health conditions due to a lack of studies.",
        "model_output": "[/INST]  The provided abstracts present findings from five studies related to clinical trial research on back pain management, work-related upper-extremity disorders, early workplace intervention, occupational health management, and multidisciplinary rehabilitation for subacute low back pain. The key findings can be synthesized as follows:\n\n1. Early intervention by occupational physicians in managing back pain did not show a significant positive effect on return to work or other health outcomes (Study #4).\n2. A more active role for insurance case managers and workplace ergonomic interventions were found to significantly reduce sickness absenteeism due to musculoskeletal disorders (MSDs) (Study #3).\n3. Workplace intervention was effective in reducing time until return to work for workers with subacute low back pain, with work modifications and case management involving all stakeholders being the most effective components (Study #5).\n4. Graded activity had a negative effect on return to work and functional status, while combined intervention had no effect (Study #5).\n5. Patient satisfaction was significantly associated with greater positive outcomes in terms of symptom severity, functional limitations, and return to work in the integrated case management (ICM) approach for work-related upper-extremity disorders (Study #2).\n6. Allowing case managers a more active role and involving an ergonomist in workplace adaptation meetings may be beneficial in managing MSDs (Study #3).\n\nIn conclusion, the studies suggest that early intervention, workplace intervention, and a more active role for insurance case managers are effective in reducing sickness absenteeism and improving outcomes for workers with musculoskeletal disorders. Graded activity may have a negative effect on return to work and functional status, while combined intervention had no effect. Patient satisfaction is also an important factor in determining the effectiveness of interventions.",
        "eval": "1"
    },
    "159": {
        "summary": "The quantity and especially quality of data are low. Analysis shows a reduction in overall complications, but major complications were not reduced. Length of stay was reduced significantly. We state that ERAS seems safe, but the quality of trials and lack of sufficient other outcome parameters do not justify implementation of ERAS as the standard of care. Within ERAS protocols included, no answer regarding the role for minimally invasive surgery (i.e. laparoscopy) was found. Furthermore, protocol compliance within ERAS programs has not been investigated, while this seems a known problem in the field. Therefore, more specific and large RCT's are needed.",
        "model_output": "[/INST]  The six studies reviewed here investigate the use of fast-track surgical recovery protocols, multimodal optimization of surgical care, and standard perioperative surgical care in patients undergoing open intestinal surgery. The key findings from these studies are as follows:\n\n1. Fast-track surgical recovery protocols can significantly reduce postoperative stay and improve physical function in patients undergoing open intestinal surgery.\n2. Multimodal optimization of surgical care can reduce hospital stay and improve physical function in patients undergoing colonic resection.\n3. Standard perioperative surgical care can also reduce hospital stay and improve physical function in patients undergoing colonic resection.\n4. Fluid restriction and early ambulation are key factors in determining the outcome of fast-track surgical recovery protocols.\n5. Multimodal optimization of surgical care can reduce the number of complications and length of hospital stay after open colonic surgery.\n6. A prospective randomized controlled trial of a multimodal perioperative management protocol in patients undergoing elective colorectal resection for cancer can significantly reduce postoperative stay and improve independence milestones.\n\nOverall, these studies suggest that the use of fast-track surgical recovery protocols, multimodal optimization of surgical care, and standard perioperative surgical care can improve outcomes in patients undergoing open intestinal surgery. However, the optimal approach may depend on the specific patient population and surgical procedure being used.",
        "eval": "1"
    },
    "160": {
        "summary": "ESA treatment in cancer patients increased on study mortality and worsened overall survival. For patients undergoing chemotherapy the increase was less pronounced, but an adverse effect could not be excluded.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "161": {
        "summary": "Use of either doxycycline 200 mg or azithromycin 500 mg by mouth before IUD insertion confers little benefit. While the reduction in unscheduled visits to the provider was marginally significant, the cost-effectiveness of routine prophylaxis remains questionable. A uniform finding in these trials was the low risk of IUD-associated infection, with or without use of antibiotic prophylaxis.",
        "model_output": "[/INST]  The five studies reviewed here investigate the use of prophylactic antibiotics before IUD insertion to reduce the risk of upper genital tract infection and pelvic inflammatory disease (PID). The studies were conducted in various settings, including Africa and southern California, and involved different populations of women.\n\nThe key findings from the studies can be summarized as follows:\n\n1. The use of prophylactic antibiotics before IUD insertion did not significantly reduce the risk of post-insertion PID infection in two studies conducted in Africa (Study #1 and Study #2).\n2. The use of prophylactic doxycycline at the time of IUD insertion was associated with a lower incidence of PID infection in a study conducted in Kenya (Study #4).\n3. The use of prophylactic antibiotics before IUD insertion did not significantly reduce the rate of IUD removal for any reason within 90 days in a randomized controlled trial conducted in southern California (Study #3).\n4. The overall infection rates for both groups were low in a study that evaluated the effectiveness of prophylactic doxycycline at the time of IUD insertion (Study #5).\n\nOverall, the findings of these studies suggest that the use of prophylactic antibiotics before IUD insertion may not significantly reduce the risk of PID infection, but further research is needed to confirm these findings. The use of prophylactic antibiotics may also affect the retention rate of IUDs, with some studies showing a lower retention rate in the antibiotic-treated groups. Further research is needed to determine the optimal dosage and type of antibiotic for use in preventing PID infection and to determine the long-term effects of prophylactic antibiotics on IUD retention.",
        "eval": "0"
    },
    "162": {
        "summary": "Methotrexate may have a small steroid sparing effect in adults with asthma who are dependent on oral corticosteroids. However, the overall reduction in daily steroid use is probably not large enough to reduce steroid-induced adverse effects. This small potential to reduce the impact of steroid side-effects is probably insufficient to offset the adverse effects of methotrexate.",
        "model_output": "[/INST]  The findings from the 10 studies provide valuable insights into the effectiveness and safety of methotrexate in the treatment of severe asthma that requires high-dose corticosteroid therapy. The studies have some similarities and differences, which are summarized below:\n\n1. Study #1: The study found that methotrexate has a marginal steroid reduction in the steroid dose in patients with severe asthma who require high-dose methotrexate.\n\n2. Study #2: The study found that methotrexate significantly reduced the steroid dose in patients with severe corticosteroid-dependent asthma.\n\n3. Study #3: The study found that low-dose methotrexate significantly reduced the steroid dose in patients with severe chronic asthma.\n\n4. Study #4: The study found that low-dose methotrexate did not have a significant benefit of methotrexate did not have a steroid dose in patients with severe asthma therapy.\n\n5. Study #5. Study #6.\n\n\nstudy found that methotrecommendotrequently.\n\n\nrecommendations and conclusions and\n\n\nrecommendations and conclusions and\n\n\nrecommendations and\n\n\nrecommendations and",
        "eval": "0"
    },
    "163": {
        "summary": "Quetiapine may not differ from typical antipsychotics in the treatment of positive symptoms and general psychopathology. There are no clear differences in terms of the treatment of negative symptoms. However, it causes fewer adverse effects in terms of abnormal ECG, extrapyramidal effects, abnormal prolactin levels and weight gain.",
        "model_output": "[/INST] \n.\n.\n the the the the the the the the the the the the the the the the the the \n\n\n\n\n\n\n\n\n\n\n\n,\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n pass,\n-pass\n\n\n\n pass\n \n\n\n\n \n \n \n \n \n, \n, \n, \n. \n.\n.\n\n\n\n\n\n\n\n,\n,\n,\n, \n \n  \n \n \n \n, \n, \n,\n,\n,-\n,\n, \n,-\n,-\n,\n,\n,\n,\n,\n hopefully, hopefully, hopefully,\n, , ,, , , , \n,   sup, group,,, and,\n..........\n....,,,,- everybody,- of- of-\n..-\n,,,\n,\n, hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully everybody Hinweis Hinweis Hinweis hopefully hopefully everybody hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully\n\n\n\n\n,\n\n\n\n\n Hinweis Hinweis hopefully\n\n\n\n\n\n\n\n,\n,\n,\n,\n\n\n\n\n\n,\n\n\n\n\n, \n Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis hopefully everybody Hinweis hopefully hopefully hopefully hopefully hopefully everybody hopefully everybody everybody everybody Hinweis Hinweis hopefully everybody Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis, Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully Hinweis Hinweis hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully\n\n\n\n\n Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis hopefully hopefully hopefully everybody hopefully everybody everybody everybody hopefully everybody everybody everybody everybody everybody everybody everybody hopefully everybody hopefully everybody hopefully everybody everybody everybody hopefully",
        "eval": "0"
    },
    "164": {
        "summary": "Interventions to improve water quality are generally effective in preventing diarrhoea, and interventions to improve water quality at the household level are more effective than those at the source. Significant heterogeneity among the trials suggests that the actual level of effectiveness may depend on a variety of conditions that research to date cannot fully explain. Rigorous, blinded, multi-arm randomized controlled trials conducted over a longer duration in a variety if settings may help clarify the potential effectiveness.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "165": {
        "summary": "Implications for practice \u00a0\n\nOral borage oil and evening primrose oil lack effect on eczema; improvement was similar to respective placebos used in trials. Oral BO and EPO are not effective treatments for eczema.\nIn these studies, along with the placebos, EPO and BO have the same, fairly common, mild, transient adverse effects, which are mainly gastrointestinal.\nThe short-term studies included here do not examine possible adverse effects of long-term use of EPO or BO. A case report warned that if EPO is taken for a prolonged period of time (more than one year), there is a potential risk of inflammation, thrombosis, and immunosuppression; another study found that EPO may increase bleeding for people on Coumadin\u00ae (warfarin) medication.\n\nImplications for research \n\nNoting that the confidence intervals between active and placebo treatment are narrow, to exclude the possibility of any clinically useful difference, we concluded that further studies on EPO or BO for eczema would be hard to justify.\nThis review does not provide information about long-term use of these products.",
        "model_output": "[/INST]  The studies reviewed suggest that evening primrose oil (EPO) and borage oil may have some benefits in managing atopic eczema, but the results are inconsistent and inconclusive. The studies found that:\n\n1. EPO did not improve atopic eczema symptoms in Study #1, Study #2, and Study #3.\n2. Borage oil improved atopic eczema symptoms in Study #4, but the study was small and had limited scope.\n3. EPO did not improve atopic eczema symptoms in Study #5 and Study #6, despite a significant increase in gamma-linolenic acid levels.\n4. Borage oil may have some benefits in managing atopic eczema, but the study was small and had limited scope (Study #11).\n5. Gamma-linolenic acid supplementation did not improve atopic eczema symptoms in Study #12.\n\nThe studies highlight the need for further research to determine the efficacy and safety of EPO and borage oil in managing atopic eczema. The inconsistent results may be due to differences in study design, patient population, and dosage of the supplements used. Additionally, the studies suggest that other factors, such as individual patient responses and the presence of comorbidities, may also play a role in the effectiveness of these supplements.",
        "eval": "0"
    },
    "166": {
        "summary": "Longitudinal studies consistently suggest that exposure to tobacco advertising and promotion is associated with the likelihood that adolescents will start to smoke. Based on the strength and specificity of this association, evidence of a dose-response relationship, the consistency of findings across numerous observational studies, temporality of exposure and smoking behaviours observed, as well as the theoretical plausibility regarding the impact of advertising, we conclude that tobacco advertising and promotion increases the likelihood that adolescents will start to smoke.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "167": {
        "summary": "Stapled hemorrhoidopexy is associated with a higher long-term risk of hemorrhoid recurrence and the symptom of prolapse. It is also associated with a higher likelihood of long-term symptom recurrence and the need for additional operations compared to conventional excisional hemorrhoid surgeries. Patients should be informed of these risks when being offered the stapled hemorrhoidopexy as surgical therapy. If hemorrhoid recurrence and prolapse are the most important clinical outcomes, then conventional excisional surgery remains the \"gold standard\" in the surgical treatment of internal hemorrhoids.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "168": {
        "summary": "We cannot make any definite statements on the efficacy and clinical usefulness of electrotherapy modalities for neck pain. Since the quality of evidence is low or very low, we are uncertain about the estimate of the effect. Further research is very likely to change both the estimate of effect and our confidence in the results. Current evidence for PEMF, rMS, and TENS shows that these modalities might be more effective than placebo but not other interventions. Funding bias should be considered, especially in PEMF studies.\u00a0 Galvanic current, iontophoresis, electric muscle stimulation(EMS), and static magnetic field did not reduce pain or disability. Future trials on these interventions should have larger patient samples and include more precise standardization and description of all treatment characteristics.",
        "model_output": "[/INST] , , ,,,,,,,,,,,,\u00a0, \u00a0, \u00a0, \u00a0, \u00a0,\u00a0,,,,,,,,,,, , , \u00a0, , ,,,,, ,,,,,,,,,,,,,,,,, , , , , , , , , ,  ,                                                                     , , , , ,                      , ,              . .      , , \n\n,  the        in  in                       .      . .         , , , ,        , , , 0 0. 3   0 . 0. 0. 3 0,  , ,\n,\n    \n,\n,\n\n\n\n, \n, 0, 3 3,0. 3. 3. .  . 3, , , ,                              \n  \n . \n    \n        .  in\n  ,\n,\n. , , . . , .            \n. \n . . \u0409.\n\u0409.\u0409...\u0409 \u0409 \u0409 \u0409 \u0409 \u0409 \u0409 \u0409 .",
        "eval": "0"
    },
    "169": {
        "summary": "There is insufficient evidence to claim or refute a benefit for any antifungal agent in treating candidiasis. Further well designed, placebo-controlled trials assessing the effectiveness of old and new interventions for treating oral candidiasis are needed. Clinicians need to make a decision on whether to prevent or treat oral candidiasis in patients receiving treatment for cancer.",
        "model_output": "[/INST]  The studies reviewed here investigate the effectiveness of various antifungal agents in treating oropharyngeal candidiasis (OPC) in patients with cancer. The findings can be synthesized as follows:\n\n1. Fluconazole is a more effective treatment than ketoconazole for OPC in cancer patients, with a significantly higher clinical cure rate (Study #1).\n2. Miconazole 50-mg mucoadhesive buccal tablets (MBT) are more effective than miconazole 500-mg gel in treating OPC in cancer patients (Study #2).\n3. The 50-mg dose of clotrimazole is more effective than the 10-mg dose in treating OPC in cancer patients (Study #3).\n4. Ketoconazole is less effective than fluconazole in treating OPC in cancer patients (Study #4).\n5. Fluconazole has a significantly better clinical and mycological cure rate than itraconazole in treating OPC in non-neutropenic cancer patients (Study #5).\n6. Oropharyngeal candidiasis in immunocompromised children can be effectively treated with fluconazole suspension, which is more effective than nystatin (Study #6).\n7. Amphotericin B is less effective than fluconazole in treating OPC in patients undergoing radiotherapy for head and neck tumors (Study #7).\n8. Clotrimazole is effective in treating oral candidiasis in patients with neoplastic disease (Study #8).\n\nOverall, the studies suggest that fluconazole is the most effective antifungal agent for treating OPC in cancer patients, followed by miconazole MBT and clotrimazole. However, the choice of antifungal agent should be individualized based on the patient's specific condition and medical history.",
        "eval": "1"
    },
    "170": {
        "summary": "Patients with Parkinson's disease who receive treadmill training are more likely to improve their impaired gait hypokinesia. However, the results must be interpreted with caution because there were variations between the trials in patient characteristics, the duration and amount of training, and types of treatment. Additionally, it is not known how long these improvements may last.",
        "model_output": "[/INST]  The findings from the seven studies provide valuable insights into the effects of treadmill training on gait parameters, balance, and falls in patients with Parkinson's disease. The key takeaways from the summary are:\n\n1. Immediate improvements in gait parameters, including speed, stride length, and cadence, were observed in patients with Parkinson's disease after treadmill training.\n2. Treadmill training improved dynamic balance and reduced the risk of falls in patients with Parkinson's disease.\n3. The effectiveness of treadmill training in improving gait parameters and reducing falls was observed in both incremental and structured interventions.\n4. The findings suggest that treadmill training may be a promising approach to reduce falls in patients with Parkinson's disease.\n5. The long-term effect of body weight-supported treadmill training on gait parameters in patients with Parkinson's disease was found to be lasting.\n6. Treadmill training with body weight support improved functional outcome in patients with Parkinson's disease.\n7. High-intensity exercise training can normalize corticomotor excitability in early Parkinson's disease.\n\nThese findings support the use of treadmill training as a promising intervention for improving gait parameters, balance, and reducing falls in patients with Parkinson's disease. Further research is needed to confirm the results and determine the optimal dosage and duration of treadmill training for maximum benefit.",
        "eval": "1"
    },
    "171": {
        "summary": "The results of this review show that airway clearance techniques have short-term effects in the terms of increasing mucus transport. No evidence was found on which to draw conclusions concerning the long-term effects.",
        "model_output": "[/INST]  The five studies reviewed here investigate the effectiveness of various chest physiotherapy (CPT) regimens in improving lung function and removing mucus in patients with cystic fibrosis. The studies compared different techniques, including postural drainage, positive expiratory pressure physiotherapy, high-frequency chest compression physiotherapy, and self-administered chest physiotherapy.\n\nKey findings from the studies include:\n\n1. Vigorous, regimented cough sessions may be as effective as more complex physiotherapy regimens in removing pulmonary secretions in patients with cystic fibrosis.\n2. Postural drainage alone or combined with mechanical percussion was not as effective as cough and postural drainage plus deep breathing with vibrations in removing mucus.\n3. Positive expiratory pressure physiotherapy improved whole lung and regional tracheobronchial clearance, but the improvement was not significant compared to postural drainage and forced expiration technique.\n4. Breathing with positive expiratory pressure increased lung volumes in patients with cystic fibrosis, but did not improve mucus transport.\n5. Self-administered high-pressure PEP-mask physiotherapy produced the highest amount of sputum, followed by autogenic drainage, and combined PEP-AD and AD-PEP techniques produced significantly more sputum than coughing.\n\nOverall, the studies suggest that different CPT regimens may be more effective for different patients with cystic fibrosis, and that further research is needed to determine the most effective and efficient CPT techniques for improving lung function and removing mucus in this patient population.",
        "eval": "1"
    },
    "172": {
        "summary": "This review shows a beneficial effect of EWS in time to recurrence, percentage of people hospitalised and functioning in people with bipolar disorder. However, the absence of data on the primary outcome measure in so many included studies is a source of concern and a potential source of bias. Mental health services should consider routinely providing EWS interventions to adults with bipolar disorder, as they appear to reduce hospitalisation and therefore may be cost-effective.",
        "model_output": "[/INST]  The findings from the provided abstracts suggest that psychotherapy and psychoeducation are effective in reducing relapse rates and improving outcomes for patients with bipolar disorder. Cognitive therapy and supportive therapy were found to be equally effective in preventing relapse and improving symptoms, while family-focused therapy was more effective in improving symptoms among patients whose families were high in expressed emotion. Psychoeducation was found to be an efficacious intervention in preventing recurrences in pharmacologically treated patients with bipolar I and II disorder. Additionally, teaching patients to recognize early symptoms of manic relapse and seek early treatment was associated with improved clinical outcomes. However, the study on group psychoeducation in bipolar patients whose disease is in remission found that group psychoeducation significantly reduced the number of relapsed patients and the number of recurrences per patient, and increased the time to depressive, manic, hypomanic, and mixed recurrences.\n\nThe studies highlight the importance of early intervention and the need for more research on the optimal duration and intensity of psychotherapy for bipolar disorder. The findings also suggest that a combination of psychotherapy and pharmacotherapy may be more effective than either treatment alone in managing bipolar disorder. Further research is needed to explore the long-term effects of psychotherapy and the optimal treatment approach for bipolar disorder.",
        "eval": "1"
    },
    "173": {
        "summary": "Children with ALL treated with CSF benefit from shorter hospitalisation and fewer infections. However, there was no evidence of shortened duration of neutropenia nor fewer treatment delays. There was also no useful information about survival.\nThe role of CSF in the context of febrile neutropenia episodes is still uncertain. Although current data show statistical benefit with CSF use, substantial heterogeneity between included trials does not allow this conclusion.",
        "model_output": "[/INST]  The studies summarized above investigate the use of granulocyte colony-stimulating factor (G-CSF) in the treatment of acute lymphoblastic leukemia (ALL) in children. The studies aim to determine whether G-CSF supportive therapy can offset the myelosuppressive effects of intensive chemotherapy, reduce the duration of neutropenia, and improve the overall outcome of treatment. The findings from the studies can be synthesized as follows:\n\n1. Study #1: The study found that G-CSF did not significantly reduce the duration of neutropenia or the number of days spent in hospital. However, the study did suggest that G-CSF may be useful in reducing the risk of infection in children with short durations of neutropenia.\n2. Study #2: The study found that G-CSF did not offset the myelosuppressive effects of intensive chemotherapy, and there was no significant difference in the number of days required to complete the second phase of therapy between the G-CSF and placebo groups.\n3. Study #3: The study found that G-CSF reduced the duration of neutropenia and the number of days spent in hospital in children receiving intensive chemotherapy. The study also suggested that G-CSF may allow improved compliance with treatment scheduling.\n4. Study #4: The study found that G-CSF significantly reduced the incidence of febrile neutropenia, the duration of neutropenia, and the total duration of intravenous antibiotic use in children with high-risk ALL. The study also found that G-CSF allowed for tighter adherence to the treatment schedule.\n5. Study #5: The study found that G-CSF did not increase the chemotherapy dose-intensity delivered during consolidation chemotherapy of childhood ALL.\n6. Study #6: The study found that G-CSF did not significantly lower the rate of hospitalization for febrile neutropenia, prolong survival, or reduce the cost of supportive care in children who received induction chemotherapy for acute lymphoblastic leukemia.\n\nIn conclusion, the findings from these studies suggest that G-CSF may be useful in reducing the risk of infection and improving the",
        "eval": "0"
    },
    "174": {
        "summary": "There is some evidence that 'adding on' services (or linkages) may improve the utilisation and outputs of healthcare delivery. However, there is no evidence to date that a fuller form of integration improves healthcare delivery or health status. Available evidence suggests that full integration probably decreases the knowledge and utilisation of specific services and may not result in any improvements in health status. More rigorous studies of\u00a0different strategies to promote integration over a wider range of services and settings are needed. These studies should include economic evaluation and the views of clients as clients' views will influence the uptake of integration strategies at the point of delivery and the effectiveness on community health of these strategies.",
        "model_output": "[/INST]  The seven studies synthesized in this summary investigate the impact of various interventions on HIV testing and counseling, family planning, and STI management in different settings in Africa. The key findings can be summarized as follows:\n\n1. Provider-initiated HIV counseling and testing significantly increased the proportion of adult TB patients who received HIV counseling and testing in South Africa, but the magnitude of the effect was small. (Study #1)\n2. The vertical program showed a greater impact on knowledge of family planning than the integrated program in rural Nepal. However, neither program showed an impact on current use or ever use of family planning. (Study #2)\n3. PITC (provider-initiated HIV testing and counseling) was successful in increasing the proportion of new STI patients tested for HIV in South Africa, despite a higher proportion of patients declining testing. (Study #3)\n4. Integrating STD services into the nearest Primary Health Clinic was the most effective approach in delivering STD services to women at high risk in Tanzania. (Study #4)\n5. An intervention that combined peer education, free condom distribution, income-generating projects, and clinic-based STI treatment and counseling did not reduce population-level HIV-1 incidence in a declining epidemic in eastern Zimbabwe. (Study #5)\n6. Dual-method contraceptive use was increased among HIV concordant and discordant couples in Zambia through an intervention that provided contraceptives at a research clinic. (Study #6)\n7. The integration of family planning and childhood immunization services in Togo was found to be effective in increasing awareness of available family planning services and the average monthly number of new family planning clients. (Study #7)\n\nOverall, the findings suggest that interventions that combine different approaches, such as provider-initiated HIV testing and counseling, integration of services, and dual-method contraceptive use, can be effective in improving HIV testing and counseling, family planning, and STI management in African settings.",
        "eval": "1"
    },
    "175": {
        "summary": "INO cannot be recommended for patients with AHRF. INO results in a transient improvement in oxygenation but does not reduce mortality and may be harmful.",
        "model_output": "[/INST]\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n,\n,\n,\n,\n,\n,\n,\n,\n\n\n,\n,\n,,,,,,,,\n,\n,,\n,\n,,\n,,,,,\n,,,,,,,,,,\n,\n,\n,\n\n\n\n\n\n\n\n\n\n\n\n,\n,,\n,\n\n,\n,,,,\n,\n,\n\n\n\n,\n\n\n,\n,,,,\n,\n,,,,,,, in, in, in, in,,,,,,, in, in, in,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\n,\n\n\n\n\n\n\n,\n,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, in, in in in in in in,,,,, in in in in in in in in in in in in in in in in in in in, in,,,,,,,,,,, in, in in in in in in,,,,, in in in in in in in in,,,, in, in, in,, in, in, in, in, in, in, in, in, in, in, in,  in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in, in,,,,,,,,,,,,,, , , ,     , , . ...... . .  in in in in, in        . .   .     . ......... . . . . .. in in in in in in in  in  in in in in  in",
        "eval": "0"
    },
    "176": {
        "summary": "If we assume that screening reduces breast cancer mortality by 15% and that overdiagnosis and overtreatment is at 30%, it means that for every 2000 women invited for screening throughout 10 years, one will avoid dying of breast cancer and 10 healthy women, who would not have been diagnosed if there had not been screening, will be treated unnecessarily. Furthermore, more than 200 women will experience important psychological distress including anxiety and uncertainty for years because of false positive findings. To help ensure that the women are fully informed before they decide whether or not to attend screening, we have written an evidence-based leaflet for lay people that is available in several languages on www.cochrane.dk. Because of substantial advances in treatment and greater breast cancer awareness since the trials were carried out, it is likely that the absolute effect of screening today is smaller than in the trials. Recent observational studies show more overdiagnosis than in the trials and very little or no reduction in the incidence of advanced cancers with screening.",
        "model_output": "[/INST]\n\n\n\n\n Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis to\n\n\n\n\n\n\n\n\n\n\n\n\n\n,\n,\n,\n, Hinweis Hinweis Hinweis Hinweis\n\n\n\n\n Hinweis Hinweis\n\n       to  to ,,, ,,,,,, and, and,,,,,......., , ,.,.,.,\n.\n.\n.\n\n\n\n\n\n\n\n,\n,\n,\n,\n,,,\n,,,,,\n,,,,,,,,,,,\n,\n\n,\n,\n,\n,,,,,,,,,,,,,,,,, , ,, ,,,,,,, to, to, . . . ..........,,,.,,,,\n,\n,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,.,.,.,,,,,,,,,,,, in, in, in, in,, , , , ,, in, in, in, in, in, in,,,,,,\n,\n,\n,\n,\n,\n, in, in,,,,,,,,,,,, , , ,,,,,,,,,,,,,,,,,,,, after,.\n,,,,,, \n,  ris, ris, \n, \n,  after,  after, after, after,  after,  after, \n, \n,  to, ,,,,, ,,  to,  to, \n\n\n, , , , , , , . ..,,,.,,,,,,.,.,,.,.,.... . . . . . \n. \n, \n, \n, ,  , ,  in  in, , in, in, , , , ,",
        "eval": "0"
    },
    "177": {
        "summary": "HS reduces the volume of intravenous fluid required to maintain patients undergoing surgery but transiently increases serum sodium. It is not known if HS effects patient survival and morbidity but it should be tested in randomized clinical trials that are designed and powered to test these outcomes.",
        "model_output": "[/INST]\n \u0409\n\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409...\u0409\u0409\u0409",
        "eval": "0"
    },
    "178": {
        "summary": "ICBI are effective tools for learning about sexual health, and they also show positive effects on self-efficacy, intention and sexual behaviour. More research is needed to establish whether ICBI can impact on biological outcomes, to understand how interventions might work, and whether they are cost-effective.",
        "model_output": "[/INST]  The studies reviewed here investigate the effectiveness of various interventions aimed at preventing HIV/AIDS, STDs, and unintended pregnancies among different populations, including adolescents, young adults, and rural communities. The interventions used include computer-assisted instruction, interactive video, and psychoeducational programs.\n\nThe findings suggest that these interventions can be effective in improving knowledge, attitudes, and behaviors related to HIV/AIDS prevention, STD prevention, and unintended pregnancy prevention. For example, computer-assisted instruction was found to be effective in improving autoimmune deficiency syndrome (AIDS) knowledge, self-evaluative outcome motivation, and intention to practice HIV preventive behaviors among college students. Similarly, interactive video was found to increase adherence with clinic recommendations to abstain from sex and increase readiness to change \"risky\" partner-selection behavior among men who have sex with men (MSM).\n\nPsychoeducational programs were also found to be effective in reducing emotional distress after HIV antibody testing and improving HIV/AIDS-related knowledge, protective attitudes, and self-efficacy for risk reduction among early adolescent females.\n\nThe studies also highlight the importance of tailoring interventions to the specific needs and preferences of the target population. For example, the computer-delivered, individually tailored HIV risk reduction intervention was found to be effective in increasing HIV/AIDS preventive behaviors among college students.\n\nOverall, the findings suggest that a combination of interventions, including computer-assisted instruction, interactive video, and psychoeducational programs, can be effective in preventing HIV/AIDS, STDs, and unintended pregnancies among different populations. However, more research is needed to determine the long-term effectiveness of these interventions and to identify the most effective approaches for different populations and contexts.",
        "eval": "1"
    },
    "179": {
        "summary": "We conclude that despite promising immunological responses no clinically effective antigen-specific active immunotherapy is yet available for ovarian cancer. Furthermore, the adoption of guidelines to ensure uniformity in trial conduct, response definitions and trial reporting is recommended to improve quality and comparability of immunotherapy trials.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "180": {
        "summary": "The results clearly demonstrate the superiority of antipsychotic drugs compared to placebo in preventing relapse. This effect must be weighed against the side effects of antipsychotic drugs. Future studies should focus on outcomes of social participation and clarify the long-term morbidity and mortality associated with these drugs.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "181": {
        "summary": "The evidence suggests that providing early orthodontic treatment for children with prominent upper front teeth is no more effective than providing one course of orthodontic treatment when the child is in early adolescence.",
        "model_output": "[/INST]  The findings from the eight studies synthesized suggest that the effectiveness of functional appliance treatment for Class II malocclusion varies depending on the type of appliance used and the age of treatment initiation.\n\n1. Functional appliance treatment using the PAR index may not be effective in assessing treatment outcomes, as lower incisor proclination can affect the assessment.\n2. Early treatment with functional appliances may not be as clinically effective as later treatment, as there was little difference in treatment outcomes between the two groups.\n3. Both bionator and headgear treatments corrected Class II molar relationships and reduced overjets and apical base discrepancies, but dental movements relapsed after treatment.\n4. Early treatment with the Twin-block appliance resulted in reduction of overjet and severity of malocclusion, with most of the correction due to dentoalveolar change.\n5. The Bass appliance showed significant improvements in skeletal Class II malocclusions, with favourable growth responses in both the maxilla and mandible.\n6. The bionator headgear combination appliance can restrain maxillary growth early and promote forward mandibular growth, contributing to functional jaws correction.\n7. Herbst appliance treatment resulted in a lower failure-to-complete rate for the functional appliance phase, but more appointments were needed for repair of the appliance.\n8. The Twin Block appliance and, to a lesser extent, the Bionator appeared the most effective in producing sagittal and vertical changes.\n\nIn conclusion, the findings suggest that the choice of functional appliance and the age of treatment initiation can impact treatment outcomes for Class II malocclusion. Further research is needed to determine the optimal treatment approach for this condition.",
        "eval": "1"
    },
    "182": {
        "summary": "There is insufficient evidence to determine possible advantages or disadvantages of immediate, immediate-delayed or delayed implants, therefore these preliminary conclusions are based on few underpowered trials often judged to be at high risk of bias. There is a suggestion that immediate and immediate-delayed implants may be at higher risks of implant failures and complications than delayed implants on the other hand the aesthetic outcome might be better when placing implants just after teeth extraction. There is not enough reliable evidence supporting or refuting the need for augmentation procedures at immediate implants placed in fresh extraction sockets or whether any of the augmentation techniques is superior to the others.",
        "model_output": "[/INST]  The studies summarized in this document investigate the clinical outcomes of immediate implant placement in extraction sockets, the effectiveness of different implant surfaces and types, and the impact of various factors on the success of implant placement. The key findings can be synthesized as follows:\n\n1. Immediate implant placement in extraction sockets is a viable option for single tooth replacement in the esthetic zone, with high survival rates and bone healing rates.\n2. The use of titanium implants with acid-etched surfaces (Osseotite) in extraction sockets leads to better bone healing and crestal bone changes compared to other implant types.\n3. The survival rate of immediately placed implants in chronic periapical infected sites is lower than that in healthy sites, but immediate implant placement may be indicated in some cases.\n4. The use of membranes and autogenous bone grafts can improve the efficacy of bone augmentation techniques at immediate implants, particularly in the presence of dehiscence defects of the labial plate.\n5. The decision to use either immediate or delayed implant placement must consider the movement of the facial gingival margin, which may require soft tissue support from a provisional restoration or similar type of anatomical healing abutment in critical esthetic patients.\n6. Non-submerged immediate implants grafted with anorganic bovine bone exhibit good healing of marginal defects and mucosal and radiographic outcomes 3-4 years following restoration.\n\nIn conclusion, the studies suggest that immediate implant placement is a viable option for single tooth replacement in the esthetic zone, and the use of titanium implants with acid-etched surfaces (Osseotite) can lead to better bone healing and crestal bone changes. The decision to use either immediate or delayed implant placement should consider the movement of the facial gingival margin, and the use of membranes and autogenous bone grafts can improve the efficacy of bone augmentation techniques at immediate implants.",
        "eval": "1"
    },
    "183": {
        "summary": "Dietitians were better than doctors at lowering blood cholesterol in the short to medium term, but there was no evidence that they were better than self-help resources. There was no evidence that dietitians provided better outcomes than nurses.The results should be interpreted with caution as the studies were not of good quality and the analysis was based on a limited number of trials.",
        "model_output": "[/INST]\n,\n,\n,\n,\n,\n,\n,\n,,,,,,,,, and, and, and, and, and,,,,,,,,,,,,,,,,,,,,,,,,\n,\n,\n\n\n\n\n,\n,\n,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, , , ,   , ,, , ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, , , \u00a0, , ,,,,,,,,,,, , ,          , , ,,, , , , , , ,   , , , , , ,,, , , ,    , , , , ,    \u00a0,    , , \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0          \u00a0 \u00a0 \u00a0 \u00a0, ,                  , , , , , , , , , , ,     ,   ,                                                                                 ,",
        "eval": "0"
    },
    "184": {
        "summary": "The review indicates low level evidence for the positive effects of neuropsychological rehabilitation in MS. Interventions included in the review were heterogeneous. Consequently, clinical inferences can basically be drawn from single studies. Therefore, new trials may change the strength and direction of the evidence. To further strengthen the evidence, well-designed high quality studies are needed. In this systematic review, recommendations are given for improving the quality of future studies on the effects of neuropsychological rehabilitation in MS.",
        "model_output": "[/INST]  The findings from the 11 studies provide valuable insights into the effectiveness of various cognitive interventions for improving cognitive function in individuals with multiple sclerosis (MS). The studies employed different methods and interventions, but they share common findings that can be synthesized as follows:\n\n1. Cognitive training programs: Several studies demonstrated the effectiveness of cognitive training programs in improving cognitive function in MS patients. For example, Study #2 found that a memory training program improved learning and memory abilities in MS patients, while Study #8 found that intensive cognitive rehabilitation improved attention, information processing, and executive functions in MS patients.\n2. Home-based training: Home-based training programs were found to be effective in improving cognitive function in MS patients. Study #1 found that a home-based cognitive training program improved verbal learning and memory performance in MS patients, while Study #9 found that home-based training improved verbal learning, long-delay verbal memory performance, and working memory performance in MS patients.\n3. Neuropsychological counseling: Study #5 found that neuropsychological counseling improved social behavior in cognitively-impaired MS patients.\n4. Brain stimulation: Study #4 found that brain stimulation-based intervention was effective in improving cognitive function in MS patients.\n5. Cognitive assessment and treatment: Study #6 found that providing a psychology service, including cognitive assessment and intervention, is appropriate for MS patients with mild to moderate cognitive impairment.\n6. Depression: Study #10 found that cognitive remediation strategies were effective in improving depression in MS patients.\n7. Working memory: Study #7 found that neuropsychological training in MS patients with working memory was improved cognitive function in MS patients with mild to moderately impaired cognitive training program improved cognitive function in MS patients with mild to trainings in MS patients with cognitive function in MS patients with cognitive function in MS patients with cognitive function in MS patients with cognitive function in MS patients with cognitive function in MS patients with cognitive function in MS patients with cognitive function in MS patients with cognitive function in MS patients with cognitive function in MS patients with cognitive function in MS patients with cognitive",
        "eval": "1"
    },
    "185": {
        "summary": "The results indicate that exercise has positive short-term effects on self-esteem in children and young people. Since there are no known negative effects of exercise and many positive effects on physical health, exercise may be an important measure in improving children's self-esteem. These conclusions are based on several small low-quality trials.",
        "model_output": "[/INST]  The studies reviewed here investigate the effects of aerobic exercise on various aspects of psychological well-being, including self-concept, mood, physical fitness, and creativity, among children and adolescents. The findings can be synthesized as follows:\n\n1. Aerobic exercise is associated with improved psychological status and physical fitness in adolescents, as shown in Study #1.\n2. Participation in an aerobic exercise program improved self-concept, mood, and physical fitness in boys with learning disabilities, as reported in Study #2.\n3. Running was found to enhance the cardiorespiratory health and creativity of schoolchildren, as shown in Study #3.\n4. A perceptual-motor training program improved self-concept and gross-motor skills in young children, as suggested in Study #5.\n5. Participation in selected physical activities improved health-related fitness and psychological well-being in women, as reported in Study #6.\n6. Improved performance in sports was associated with positive changes in self-concept, as shown in Study #7.\n7. Exposure to basketball movement skills improved self-concept and agility in preschoolers, as found in Study #8.\n8. Aerobic exercise enhanced cardiovascular fitness, agility, and self-esteem in preschoolers, as suggested in Study #9.\n9. Participation in an aerobic exercise program increased children's perceived athletic competence, physical appearance, social acceptance, behavioral conduct, and global self-worth, as well as their figural creativity, and improved aerobic power, as found in Study #10.\n10. A competitive endurance training program had positive effects on self-concept and peer approval, as reported in Study #11.\n\nIn conclusion, the findings from these studies suggest that aerobic exercise has a positive impact on various aspects of psychological well-being in children and adolescents, including self-concept, mood, physical fitness, creativity, and peer approval. These findings support the incorporation of aerobic exercise into school curricula and extracurricular programs to promote overall health and well",
        "eval": "1"
    },
    "186": {
        "summary": "The review identified no significant differences for the primary outcomes perinatal mortality, preterm birth less than 34 weeks' gestation, and childhood neurodevelopmental handicap, although the number of studies and participants was small. While treatment with heparin appears promising with a reduction in pre-eclampsia, eclampsia, and infant birthweight less than the 10th centile for gestational age, the number of studies and participants included was small, and to date important information about serious adverse infant and long-term childhood outcomes is unavailable. Further research is required.\n[Note: The 14 citations in the awaiting classification section of the review may alter the conclusions of the review once assessed.]",
        "model_output": "[/INST]  The findings from the four studies suggest that the use of heparin and low-molecular-weight heparin can effectively prevent the recurrence of preeclampsia and fetal growth restriction. The studies also indicate that heparin can improve placenta function and increase fetal growth and birth weight. Additionally, the studies found that dalteparin is effective in preventing the recurrence of placental-mediated complications in women without thrombophilia. The studies did not report any significant adverse effects of heparin or dalteparin use. Overall, the findings suggest that heparin and dalteparin may be effective in preventing preeclampsia and fetal growth restriction, and may be a useful addition to current treatment options for these conditions.",
        "eval": "1"
    },
    "187": {
        "summary": "Chemotherapy led to a small but significant benefit for overall survival and event-free survival. This benefit was essentially observed when chemotherapy was administered concomitantly with radiotherapy.",
        "model_output": "[/INST] and \u0409, and \u0409, and \u0409, and.\n.\n.\n.\n.\n.\n.\n.\n the the the  everybody.\n.\n.\n everybody.\n.\n.\n.\n.\n.\n\n\n\n\n\n\n\n\n\n\n\n hopefully hopefully hopefully Hinweis Hinweis hopefully hopefully Hinweis Hinweis Hinweis\n\n\n hopefully hopefully hopefully hopefully hopefully hopefully everybody Hinweis Hinweis hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully everybody hopefully everybody hopefully hopefully everybody hopefully everybody hopefully everybody hopefully hopefully hopefully hopefully and everybody and everybody everybody everybody everybody everybody and everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody hopefully everybody everybody everybody everybody everybody everybody everybody everybody everybody hopefully everybody hopefully everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody Hinweis Hinweis everybody everybody everybody everybody everybody everybody everybody hopefully everybody hopefully everybody everybody everybody hopefully everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis everybody everybody everybody everybody everybody everybody everybody Hinweis Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Hinweis Unterscheidung everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis hopefully obviously obviously hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully everybody everybody everybody everybody everybody obviously everybody everybody everybody everybody everybody everybody everybody everybody hopefully hopefully obviously obviously obviously obviously obviously obviously obviously obviously obviously everybody everybody everybody\n\n\n\n\n\n\n\n\n everybody everybody everybody everybody everybody everybody everybody everybody everybody obviously obviously obviously obviously obviously obviously\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n obviously obviously obviously obviously obviously\n\n\n\n\n\n\n\n\n everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody obviously\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n hopefully obviously\n\n\n\n\n\n\n\n\n hopefully hopefully hopefully obviously obviously obviously obviously obviously obviously obviously obviously everybody everybody everybody Hinweis hopefully everybody everybody everybody everybody hopefully everybody hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully\n\n Begriffe obviously everybody Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis\n\n\n\n\n\n\n\n\n \n\n\n\n\n\n Hinweis Hinweis",
        "eval": "0"
    },
    "188": {
        "summary": "The body of evidence summarised in this review is insufficient to allow any conclusion to be drawn about the use of pharmacological interventions in the treatment of antisocial personality disorder.",
        "model_output": "[/INST]  The findings from the provided abstracts suggest that there are various treatments available for impulsive aggression in individuals with alcohol use disorder and comorbid psychiatric disorders. The studies provide insights into the efficacy of different medications, including nortriptyline, bromocriptine, desipramine, phenytoin, valproate, and disulfiram, in reducing impulsive aggression in this population.\n\nKey findings include:\n\n1. Nortriptyline was found to reduce impulsive aggression in male alcoholics with comorbid psychiatric disorders, particularly those with antisocial personality disorder.\n2. Bromocriptine did not show significant effects on impulsive aggression in male alcoholics with comorbid psychiatric disorders.\n3. Desipramine was found to have a significant effect on impulsive aggression in cocaine-dependent individuals, particularly those without antisocial personality disorder.\n4. Phenytoin was found to reduce impulsive aggression in individuals with impulsive aggression, but not in those with antisocial personality disorder.\n5. Valproate was found to be effective in reducing impulsive aggression in impulsive aggressive men, with a slight delay in the treatment effect compared to phenytoin and bromocriptine.\n6. Disulfiram was found to have no advantage in treating impulsive aggression in dually diagnosed individuals with alcohol dependence and comorbid psychiatric disorders.\n\nOverall, the studies suggest that different medications may be more effective in reducing impulsive aggression in specific subgroups of individuals with alcohol use disorder and comorbid psychiatric disorders. Further research is needed to confirm these findings and to determine the optimal treatment approach for this population.",
        "eval": "1"
    },
    "189": {
        "summary": "Bupropion increases smoking abstinence rates in smokers with schizophrenia, without jeopardizing their mental state. Varenicline may also improve smoking cessation rates in schizophrenia, but its possible psychiatric adverse effects cannot be ruled out. CR may help this group of patients to quit and reduce smoking in the short term. We failed to find convincing evidence that other interventions have a beneficial effect on smoking in schizophrenia.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "190": {
        "summary": "Prior to the current update it appeared there was some evidence that cranberry juice may decrease the number of symptomatic UTIs over a 12 month period, particularly for women with recurrent UTIs. The addition of 14 further studies suggests that cranberry juice is less effective than previously indicated. Although some of small studies demonstrated a small benefit for women with recurrent UTIs, there were no statistically significant differences when the results of a much larger study were included. Cranberry products were not significantly different to antibiotics for preventing UTIs in three small studies. Given the large number of dropouts/withdrawals from studies (mainly attributed to the acceptability of consuming cranberry products particularly juice, over long periods), and the evidence that the benefit for preventing UTI is small, cranberry juice cannot currently be recommended for the prevention of UTIs. Other preparations (such as powders) need to be quantified using standardised methods to ensure the potency, and contain enough of the 'active' ingredient, before being evaluated in clinical studies or recommended for use.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "191": {
        "summary": "No significant differences were found between triflusal and aspirin for secondary prevention of serious vascular events in patients with stroke or TIA and AMI. However, our review cannot exclude moderate differences in efficacy. Triflusal was associated with a lower risk of hemorrhagic complications.",
        "model_output": "[/INST]  The studies summarized above investigate the effectiveness and safety of triflusal in the prevention of cardiovascular events, particularly in patients with a history of cerebral infarction or unstable angina. The findings can be consolidated as follows:\n\n1. Triflusal shows a significant reduction in the incidence of non-fatal cerebral infarctions in patients with carotid stenosis of more than 70% compared to aspirin.\n2. Triflusal reduces the risk of hemorrhagic complications by 76% compared to aspirin.\n3. Triflusal has a similar efficacy to aspirin in preventing further cardiovascular events after acute myocardial infarction, but triflusal has a more favorable safety profile.\n4. Triflusal significantly increased both the distance that could be walked and the clinical symptoms in patients with chronic peripheral arteriopathy, likely due to improved microperfusion.\n5. Triflusal can reduce the incidence of myocardial infarction in patients with unstable angina, but the low number of deaths hampered statistical analysis.\n6. Triflusal may be associated with a lower risk of hemorrhagic complications in the prevention of vascular events after stroke, although the results of this pilot trial cannot be ruled out due to the wide confidence interval.\n\nIn conclusion, the studies suggest that triflusal may be a promising antiplatelet agent for the prevention of cardiovascular events, particularly in patients with a history of cerebral infarction or unstable angina. However, further research is needed to confirm these findings and establish the long-term safety and efficacy of triflusal.",
        "eval": "1"
    },
    "192": {
        "summary": "Despite concerns surrounding the use of opioids for long-term management of chronic LBP, there remain few high-quality trials assessing their efficacy. The trials in this review, although achieving high internal validity scores, were characterized by a lack of generalizability, inadequate description of study populations, poor intention-to treat analyses, and limited interpretation of functional improvement. Based on our results, the benefits of opioids in clinical practice for the long-term management of chronic LBP remain questionable. Therefore, further high-quality studies that more closely simulate clinical practice are needed to assess the usefulness, and potential risks, of opioids for individuals with chronic LBP.",
        "model_output": "[/INST]  The four studies provide evidence for the efficacy and safety of tramadol in the treatment of chronic lower back pain. The studies suggest that tramadol, when used alone or in combination with other analgesics, can provide significant pain relief and improve quality of life measures. The studies also highlight the importance of titration and dose adjustment to achieve optimal pain management.\n\nKey findings:\n\n1. Tramadol 37.5 mg/APAP 325 mg combination tablets were effective and had a favorable safety profile in the treatment of chronic lower back pain (Study #1).\n2. Among patients who tolerated it well, tramadol was effective for the treatment of chronic low back pain (Study #2).\n3. Tramadol 37.5 mg/APAP 325 mg combination tablets show efficacy in pain reduction, in measures of physical functioning and quality of life, and in overall medication assessments, with a tolerability profile comparable with other opioids used for the treatment of chronic LBP (Study #3).\n4. Opioid therapy for chronic noncancer back pain has a positive effect on pain and mood but little effect on activity and sleep, and tapered-off opioid treatment is palliative and without long-term benefit (Study #4).\n\nOverall, the studies suggest that tramadol is a effective and safe treatment option for chronic lower back pain, and that titration and dose adjustment are important for achieving optimal pain management. However, the long-term benefits of opioid therapy for chronic noncancer back pain are limited.",
        "eval": "1"
    },
    "193": {
        "summary": "Olanzapine is an effective treatment for mania and may be more efficacious than divalproex, though leads to more weight gain. Clinicians should consider both the relative efficacy and the different incidence of specific adverse effects of available drugs.",
        "model_output": "[/INST]  The five studies reviewed here investigate the efficacy and safety of olanzapine in the treatment of acute mania and bipolar disorder. The studies compared olanzapine to placebo, lithium, divalproex, and valproate, respectively. The primary findings can be summarized as follows:\n\n1. Olanzapine is superior to placebo in reducing symptoms of acute mania, with a significantly greater mean improvement in Young Mania Rating Scale (YMRS) total scores.\n2. Olanzapine is at least as effective as lithium in treating mania, with no significant differences in outcome measures between the two groups.\n3. Olanzapine demonstrated greater efficacy than placebo in the treatment of acute bipolar mania, with a statistically significant greater mean improvement in YMRS total scores.\n4. The addition of olanzapine to valproate or lithium monotherapy improved patients' efficacy more than monotherapy, with significantly higher response and remission rates in the olanzapine cotherapy group.\n5. Olanzapine was generally well tolerated, with the most common treatment-emergent adverse events being dry mouth, increased appetite, somnolence, and weight gain.\n\nOverall, the studies suggest that olanzapine is a effective treatment option for acute mania and bipolar disorder, with a favorable safety profile. The addition of olanzapine to mood-stabilizer therapy may also improve efficacy in patients who are partially nonresponsive to valproate or lithium monotherapy.",
        "eval": "1"
    },
    "194": {
        "summary": "There is limited evidence that contracts can potentially contribute to improving adherence, but there is insufficient evidence from large, good quality studies to routinely recommend contracts for improving adherence to treatment or preventive health regimens.",
        "model_output": "[/INST] ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( (   ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( (  (  ( ( ( ( ( ( ( ( ( (    ( ( ( ( ( ( ( ( (     (  ( ( ( ( ( ( ( ( ( (\n ( ( ( ( (  ( ( ( ( ( ( ( ( (\n ( \n  (  ( . (\n (. \n \n  \n, (\u0409 (\u0409 (\u0409 (\u0409 (\u0409 (\u0409 (\n (\n ( ( ( ( ( ( (. (. (. (. ( ( ( ( (  (  ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( (  ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( (\n    ( (. (\u0409 (. (\u0409.\u0409 (\u0409 (\u0409.\u0409\n\u0409 (\u0409 (\u0409 (\u0409 ( (. . ( ( (\n ( ( ( ( ( ( ( (  ( ( ( ( ( ( ( ( ( ( ( ( (\n (\u0409 (\u0409 (\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "195": {
        "summary": "There is insufficient evidence from randomised trials to establish the best strategies for enhancing mobility after hip fracture surgery.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "196": {
        "summary": "In asthmatic subjects with gastro-oesophageal reflux, (but who were not recruited specifically on the basis of reflux-associated respiratory symptoms), there was no overall improvement in asthma following treatment for gastro-oesophageal reflux. Subgroups of patients may gain benefit, but it appears difficult to predict responders.",
        "model_output": "[/INST]  The findings from the 10 studies provide valuable insights into the relationship between gastro-oesophageal reflux (GER) and asthma. The studies suggest that:\n\n1. GER is common among patients with asthma, with a prevalence ranging from 30% to 60%.\n2. GER can exacerbate asthma symptoms, particularly at night, and can lead to reduced lung function.\n3. Treatment of GER with antireflux medication can improve asthma symptoms, peak expiratory flow rate, and quality of life in patients with both asthma and GER.\n4. The effect of antireflux medication on asthma symptoms, peak expiratory flow rate, and quality of life varies across studies, but there is a trend towards improved outcomes with antireflux treatment.\n5. The relationship between GER and asthma is complex and may involve multiple pathways, including vagal stimulation, inflammation, and immune system dysfunction.\n6. The findings suggest that antireflux medication should be considered as an important part of asthma management, particularly in patients with severe GER and those with nocturnal asthma symptoms.\n7. The studies highlight the need for further confirmation of the importance of GER in patients with asthma and GER and quality of life in patients with both clinical trials, and GER and quality of life in patients with asthma and GER and quality of life in patients with asthma and quality of life in patients with asthma and quality of life in patients with quality of life in patients with quality of life in patients with quality of life in patients with quality of life in patients with quality of life in patients with quality of life in patients with life in patients with quality of life in patients with life in patients with quality of life in patients with life in patients with life in patients with life in patients with life in patients with life in patients with life in patients with life in patients with life in patients with life in patients with life in patients with life in patients with life in patients with life in patients with life in patients with life in patients with life in patients with life in patients with life in patients with life in patients with life in patients with life in patients with life in",
        "eval": "1"
    },
    "197": {
        "summary": "This review indicates that swimming training is well-tolerated in children and adolescents with stable asthma, and increases lung function (moderate strength evidence) and cardio-pulmonary fitness (high strength evidence). There was no evidence that swimming training caused adverse effects on asthma control in young people 18 years and under with stable asthma of any severity. However whether swimming is better than other forms of physical activity cannot be determined from this review. Further adequately powered trials with longer follow-up periods are needed to better assess the long-term benefits of swimming.",
        "model_output": "[/INST]  The findings from the seven studies synthesized suggest that swimming interventions can have beneficial effects on asthma symptoms and pulmonary function tests in children. The studies provide evidence that swimming can improve cardiorespiratory fitness, reduce bronchial hyperresponsiveness, and decrease exercise-induced bronchospasm. The studies also suggest that individualized training intensity may be important for maximizing the benefits of swimming for asthmatic children. However, the studies have limitations in terms of sample size and study duration, and further research is needed to confirm the findings and establish the long-term effects of swimming on asthma in children.\n\nKey findings:\n\n1. Swimming interventions can improve pulmonary function tests (PFTs) and reduce bronchial hyperresponsiveness in children with asthma.\n2. Individualized training intensity may be important for maximizing the benefits of swimming for asthmatic children.\n3. Swimming can improve cardiorespiratory fitness and reduce exercise-induced bronchospasm in children with asthma.\n4. The studies suggest that swimming interventions are generally safe and well-tolerated in children with asthma.\n5. Further research is needed to confirm the findings and establish the long-term effects of swimming on asthma in children.",
        "eval": "1"
    },
    "198": {
        "summary": "This review found a beneficial effect of banding ligation on primary prevention of upper gastrointestinal bleeding in patient with oesophageal varices. The effect on bleeding did not reduce mortality. Additional evidence is needed to determine whether our results reflect that non-selective beta-blockers have other beneficial effects than on bleeding.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409.\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409.\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "199": {
        "summary": "Providing additional placental blood to the preterm baby by either delaying cord clamping for 30 to 120 seconds, rather than early clamping, seems to be associated with less need for transfusion, better circulatory stability, less intraventricular haemorrhage (all grades) and lower risk for necrotising enterocolitis. However, there were insufficient data for reliable conclusions about the comparative effects on any of the primary outcomes for this review.",
        "model_output": "[/INST]  The findings from the ten studies are synthesized into a cohesive summary. The studies investigated the effects of delayed cord clamping on various outcomes, including hematocrit, blood pressure, and the need for red blood transfus, and neonatal adaptation. The studies found that delayed cord clamping significantly increased RBC volume/mass and Hct, and the need for red blood pressure, and the need for circulatory and respiratory support. The studies found that delayed cord clamping significantly increased RBC volume/hematocrit, and Hct, and the need for circulatory and respiratory support. The studies found that delayed cord clamping significantly increased RBC, and Hct, and the need for red blood pressure, and the need for red blood pressure, and the need for red blood pressure, and the need for red blood pressure, and the need for red blood pressure, and the need for red blood, and the need for red blood, and the need for red blood, and the need for red blood, and the need for the red blood, and the need for the red blood, and the need for the need for red blood, and the need for red blood, and the need for red blood, and the need for red, and red, and the need for red, and the need for red, and red, and the need for red, and red, and need for red, and red, and the need for red, and red, and the need for red, and red, and the need for red, and red, and the need for red, and red, and the need for red, and red, and need for red, and red, and need and red, and red, and red, and need and red, and red, and need and red, and red, and need and red, and red, and red, and red, red, red, red, red, red, red, red, red, red, red, red, red, red, red, red, red, red, red, red, red, red, red, red, red, red, red, red, red, red, red, red, red, red, red, red, red, red, red, red, red, red, red, red, red, red, red, red, red, red, red, red, red, red, red, red, red, red,",
        "eval": "0"
    },
    "200": {
        "summary": "Based on the limited evidence found we cannot conclude whether thrombolytic therapy is better than heparin for pulmonary embolism. More double-blind RCTs, with subgroup analysis of patients presenting with haemodynamically stable acute pulmonary embolism compared to those patients with a haemodynamic unstable condition, are required.",
        "model_output": "[/INST]  The seven studies reviewed here investigate the use of thrombolytic agents, specifically heparin, streptokinase, and recombinant tissue plasminogen activator (rt-PA), in the treatment of acute pulmonary embolism. The studies have some similarities in their design and methods, but they also have some differences. Here is a summary of the key findings from each study:\n\nStudy #1: Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism.\n\n* The use of thrombolytic agents in the treatment of hemodynamically stable patients with acute submassive pulmonary embolism remains controversial.\n* In this study, heparin plus alteplase was associated with a lower incidence of treatment escalation (24.6% vs. 10.2%, P=0.004) and a lower probability of 30-day event-free survival (3.4% vs. 2.2%, P=0.71) compared to heparin alone.\n* No fatal bleeding or cerebral bleeding occurred in patients receiving heparin plus alteplase.\n\nStudy #2: A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism.\n\n* Recombinant tissue plasminogen activator (rt-PA) produces continuing thrombolysis after it is cleared from the circulation and both thrombolysis and bleeding are reduced when rt-PA is administered over a short period.\n* In this study, a bolus regimen of rt-PA produced accelerated thrombolysis and provided an alternative and convenient approach to thrombolytic therapy in patients with pulmonary embolism.\n* There were no major bleeds in either group, but minor bleeding occurred in 15 of the rt-PA patients mainly at angiogram-catheter insertion and venipuncture sites.\n\nStudy #3: A controlled clinical trial of streptokinase and heparin in the treatment of major pulmonary embolism.",
        "eval": "1"
    },
    "201": {
        "summary": "The findings of this review indicate that the number of systemic and topical drugs used for the different subforms of pruritus is increasing. Different interventions have been shown to be effective in the treatment of pruritus of different origins. Nevertheless, an optimal therapy for pruritus is constrained due to the limited understanding of crucial itch mediators and receptors in the various subforms of itch. Ideal antipruritic therapies are still lacking, especially for palliative care patients.\nThis systematic review also indicates that there is insufficient evidence to give any concrete recommendations regarding treatment of pruritus in palliative care patients. Due to the very small sample sizes and poor methodological quality of the majority of studies that were included, the results of this review need to be interpreted with caution. Furthermore, the generalizability is questionable. Additional studies, and particularly carefully designed treatment trials, are needed to provide valid evidence for adequate treatment of pruritus in palliative care patients.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "202": {
        "summary": "Chemotherapy significantly improves survival in comparison to best supportive care. In addition, combination chemotherapy improves survival compared to single-agent 5-FU. All patients should be tested for their HER-2 status and trastuzumab should be added to a standard fluoropyrimidine/cisplatin regimen in patients with HER-2 positive tumours. Two and three-drug regimens including 5-FU, cisplatin, with or without an anthracycline, as well as irinotecan or docetaxel-containing regimens are reasonable treatment options for HER-2 negative patients.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409 (91\u0409 (91\u0409 (G\u0409 (O\u0409G\u0409 (O\u0409GOOOOGOOGOGOGOGOGOG999999999999999990\u04091 (1\u04091 (11 (999999999999OG999999999999999999999999999999999999999 Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung\\\\ Unterscheidung Unterscheidung\\\\ Unterscheidung Unterscheidung Unterscheidung\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\9\\\\GGGGGGGGGOG\\\\ Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung",
        "eval": "0"
    },
    "203": {
        "summary": "Laparoscopic resection of carcinoma of the colon is associated with a long term outcome no different from that of open colectomy. Further studies are required to determine whether the incidence of incisional hernias and adhesions is affected by method of approach. Laparoscopic surgery for cancer of the upper rectum is feasible, but more randomised trials need to be conducted to assess long term outcome.",
        "model_output": "[/INST] #,\n,\n,\n,\n\n\n,\n,\n,\n,-\n-\n-\n,\n,\n, , ,\n, \n, \n \n, ,\n,\n,\n,\n,\n,\n,\n,\n\n\n\n\n,\n,\n,\n,\n,,,,,,,,,,,, \n, \n, , , ,.\n,,,.,..,.,...,\n,\n,\n,\n,,,,,,,,,,,,,,,, , ,,, .,.,., less,,,, less,,,,,,\n,\n,,,\n,,,, in,,,,,,,,,, in,,,,,,,,,,,,,\n, less less, less,\n-\n-\n,\n\n less less after, after, \n. \n\n. \n,\n,\n to to to to\n to\n\n\n, less, \n less less less  less  less  less less less less less less less less less  less \n  \u00a0 \u00a0  to  to \n\n\n\n\n\n, \n,\n,\n,\n,\n-\n, \n, . -\n-\n--\n-\n-\n- , , , , , . ..\u00a0.\u00a0.......\n.\n.\n.\u00a0\u00a0. \n \n   \n in  in in in  in \n     . . . . . . ............. . . . \n.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n.\n\u0409,\n\u0409\n\u0409\n. .\n.\n.\n.\n.\n.\n.\n-.\n-\n-\n-\n-\n-.-.-\n-. to to to to to,\n. . \n. from.\n\u0409.\n\u0409...\n\u0409..\n\u0409-\u0409-\u0409-\u0409\n\u0409\n\u0409,\n\u0409,.\u0409,",
        "eval": "0"
    },
    "204": {
        "summary": "Calcium antagonists reduce the risk of poor outcome and secondary ischaemia after aneurysmal SAH. The results for 'poor outcome' depend largely on a single large trial of oral nimodipine; the evidence for other calcium antagonists is inconclusive. The evidence for nimodipine is not beyond all doubt, but given the potential benefits and modest risks of this treatment, oral nimodipine is currently indicated in patients with aneurysmal SAH. Intravenous administration of calcium antagonists cannot be recommended for routine practice on the basis of the present evidence. Magnesium sulphate is a promising agent but more evidence is needed before definite conclusions can be drawn.",
        "model_output": "[/INST]\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n's'\n\n\n \u0409.\n \u0409 \u0409 \u0409 \u0409 \u0409 and \u0409.\n \u0409.\n.\n \u0409.\n.\n \u0409, \n \u0409, \n \u0409, \n \u0409,\n,\n,\n,\n \n \n \n \n \n \n \n \n \n.\n \n \n \n \n \n, clin, kwiet, kwiet, \n \n .\n,\n\n\n\n\n,\n, kwiet, kwiet, kwiet, kwiet, hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully.  kwiet everybody, hopefully, hopefully, hopefully, hopefully, \n \u0409,  kwiet, and  kwiet,             pass,  kwiet,  kwiet.\n.\n.\n.",
        "eval": "0"
    },
    "205": {
        "summary": "Current evidence suggests that antihistamine-analgesic-decongestant combinations have some general benefit in adults and older children. These benefits must be weighed against the risk of adverse effects. There is no evidence of effectiveness in young children.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "206": {
        "summary": "There was insufficient robust evidence from randomised trials to establish the relative effectiveness of different methods of anaesthesia, different associated physical techniques or the use of drug adjuncts in the treatment of distal radial fractures. There is, however, some indication that haematoma block provides poorer analgesia than IVRA, and can compromise reduction.\nGiven the many unresolved questions over the management of these fractures, we suggest an integrated programme of research, which includes consideration of anaesthesia options, is the way forward.",
        "model_output": "[/INST]  The studies summarized in this response provide valuable insights into the various techniques and approaches used in the management of Colles' fractures. The findings suggest that:\n\n1. Bier's block is a more effective technique than haematoma block for reducing Colles' fractures, with less pain during manipulation and better radiological outcomes.\n2. The addition of clonidine to local anesthetics can prolong the onset time of sensory blockade but shorten the duration of motor blockade.\n3. Muscle relaxants can improve the quality of analgesia and reduce the pain of fracture manipulation when used in combination with Bier's block.\n4. Hyaluronidase is not a useful addition to haematoma block for pain relief.\n5. Brachial plexus block using the proximal cranial needle approach is a safe and effective technique with low complication rates.\n6. Intravenous diazepam may be useful in reducing the pain of fractures of the lower end of the radius.\n\nThese findings highlight the importance of careful technique selection and individualized patient management in the management of Colles' fractures.",
        "eval": "1"
    },
    "207": {
        "summary": "In patients with moderate to severe ulcerative colitis whose disease is refractory to conventional treatment using corticosteroids and/or immunosuppressive agents, infliximab is effective in inducing clinical remission, inducing clinical response, promoting mucosal healing, and reducing the need for colectomy at least in the short term. Serious adverse events attributable to infliximab were not common in the included studies but physicians should be aware of and be prepared to deal with potential adverse events such as anaphylactic reactions and infections.",
        "model_output": "[/INST]  The six studies reviewed provide evidence for the efficacy and safety of infliximab in the treatment of ulcerative colitis. The key findings can be synthesized as follows:\n\n1. Infliximab is effective in inducing and maintaining remission in patients with moderate-to-severe active ulcerative colitis, despite being treated with concurrent medications (Study #1).\n2. Infliximab is as effective as methylprednisolone in maintaining remission in patients with steroid-dependent ulcerative colitis (Study #2).\n3. Infliximab does not support the use as a rescue therapy in severe to moderately severe ulcerative colitis not responding to conventional treatment (Study #4).\n4. Infliximab is well tolerated and may provide clinical benefit for some patients with acute ulcerative colitis who are not steroid-refractory (Study #6).\n5. The benefits of infliximab in Crohn's disease are established, and these findings suggest the potential efficacy of repeated treatment with infliximab for short-term maintenance of remission and steroid withdrawal in glucocorticoid-dependent ulcerative colitis (Study #3).\n6. Infliximab is effective in inducing and maintaining remission in patients with moderately active glucocorticoid resistant ulcerative colitis (Study #2).\n\nOverall, the studies suggest that infliximab is a promising treatment option for ulcerative colitis, with evidence of efficacy and safety in inducing and maintaining remission, as well as in rescue therapy for severe cases. However, further large-scale controlled trials are needed to confirm these findings and establish the long-term safety and efficacy of infliximab for ulcerative colitis treatment.",
        "eval": "1"
    },
    "208": {
        "summary": "There is good evidence that cementing the prostheses in place will reduce post-operative pain and lead to better mobility. From the trials to date there is no evidence of any difference in outcome between bipolar and unipolar prosthesis. There is some evidence that a total hip replacement leads to better functional outcome than a hemiarthroplasty. Further well-conducted randomised trials are required.",
        "model_output": "[/INST]\n,\n,\n,\n,\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n,\n,\n,\n,\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n,\n,\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n,\n,\n,\n,\n,\n,\n\n\n\n\n\n,\n,\n,\n,\n,\n,\n,\n,\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n.\n.\n.\n.\n.\n\n\n\n\n\n\n\n\n\n\n\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n\n\n\n\n\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n,\n,\n,\n.\n.\n.\n\n\n\n\n\n\n\n,\n,,,,,,,\n,,,\n,\n,\n,\n,,\n,\n,\n,\n,,,,,,,,,,,,\n,\n,\n.\n.\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n\n\n\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,,,,,,,,,,,,,,\n,\n,\n,,,,,,,,,,,,,,.,.,....,.,....,.,,,,,,,,,,,,,,,,\u00a0,\u00a0,.....",
        "eval": "0"
    },
    "209": {
        "summary": "The overall quality of evidence was moderate. Half of these postpartum interventions led to fewer repeat pregnancies or births or more contraceptive use. However, the evidence of intervention effectiveness was of low to moderate quality. Trials with evidence of effectiveness included two that provided one or two sessions and three that had multiple contacts. The former had limitations, such as self-reported outcomes and showing no effect for many comparisons. The interventions with multiple sessions were promising but would have to be adapted for other locations and then retested. Researchers and health care providers will have to determine which intervention might be appropriate for their setting and level of resources.",
        "model_output": "[/INST] pass,  Hinweis, stand.  Hinweis.\nstand.\n\n.\n.\n.\n.\n.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n,\n,\n,\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n,\n,\n,\n\n,\n\n\n\n\n everybody, kwiet, kwiet, kwiet, kwiet, Hinweis Hinweis, Hinweis,\n\n Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis\n,\n.\n.\n Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis, Hinweis, Hinweis Hinweis Hinweis, Hinweis, Hinweis Hinweis Hinweis Hinweis, Hinweis, Hinweis, Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis,\n,\n,\n,\n,\n,\n, \n,\n, pass, pass, pass, pass,\n,\n, \n  \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n, , ,  , ,  \n\n,\n\n\n\n\n   \n  \n\n\n\n\n\n\n\n,\n\n\n   ,    \n          \n, \n   \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n\n\n\n\n\n\n,\n,\n,, , ,,,,,,,,,,,\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n,\n,\n,\n,\n\n\n,\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n,",
        "eval": "0"
    },
    "210": {
        "summary": "Three updates of this review have resulted in more included studies and more people randomised but still relatively little useful additional data. The results remain inconclusive. The new trials all compare the omega-3 polyunsaturated fatty acids, in particular eicosapentaenoic acid and its ester, ethyl-eicosapentaenoic acid. The use of omega-3 polyunsaturated fatty acids for schizophrenia still remains experimental and this review highlights the need for large, well designed, conducted and reported studies.",
        "model_output": "[/INST]  The findings from the six studies suggest that EPA/E-EPA may have a potential therapeutic effect in reducing symptoms of TD, improving tolerability of antipsychotic medications, and accelerating treatment response in FEP. However, the studies failed to demonstrate a sustained symptomatic benefit of EPA/E-EPA in early psychosis, possibly due to a ceiling effect. The studies also found that EPA/E-EPA may be an effective and well-tolerated add-on treatment in schizophrenia, with significant reductions in Positive and Negative Syndrome Scale (PANSS) total scores and dyskinesia scores in the EPA group compared to the placebo group. Additionally, the studies found that EPA/E-EPA may have a positive effect on cognition in schizophrenia patients, with improvement in residual symptoms and cognitive impairment.\n\nThe studies also highlighted some limitations and potential sources of bias. For example, the sample sizes were relatively small, and the studies were generally underpowered. Additionally, the studies were largely conducted in patients with chronic, severe schizophrenia, which may limit the generalizability of the findings to other populations. Furthermore, the studies used different doses and duration of EPA/E-EPA treatment, which may have affected the results.\n\nOverall, the findings suggest that EPA/E-EPA may have a potential therapeutic effect in reducing symptoms of TD and improving tolerability of antipsychotic medications, but further research is needed to confirm these findings and establish the optimal dosage and duration of treatment.",
        "eval": "0"
    },
    "211": {
        "summary": "Caution is required in interpreting the results given the methodological limitations of the included trials in terms of internal and external validity. Further, the size and clinical meaningfulness of statistically significant results are uncertain. However, given the risks of untreated depression in terms of completed suicide and impacts on functioning, if a decision to use medication is agreed, then fluoxetine might be the medication of first choice given guideline recommendations. Clinicians need to keep in mind that there is evidence of an increased risk of suicide-related outcomes in those treated with antidepressant medications.",
        "model_output": "[/INST]\n, \n, , ,\n,\n,\n\n\n\n\n\n,\n,\n,\n,\n,\n,\n,\n,\n\n\n\n\n\n\n\n\n\n\n\n, \n, \n, \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n,\n,\n,\n,\n\n\n\n\n\n\n\n\n\n\n\n\n,\n,,,,,,,,,,,,,,,\n,\n,\n\n\n\n\n\n\n\n,\n, \n\n\n\n\n\n\n\n\n   \n\n\n\n\n\n\n\n\n,\n,\n,\n, , ,\n,\n,\n,\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n,\n,\n,\n,\n,\n,\n\n\n\n,\n,\n,\n,,,,,,,,\n,,\n, \n, \n, , , , , ,, ,,,,,,,,,\n,\n\n\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,,,,,\n,,,,,,,,,,,\n, #, #, #,\n,\n,\n,\n,\n,\n,,,,,,,,,,,,,,, , ,,,,,,,,,,,,,,,,,,,,,,,,,,,\n,\n,\n,\n,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\u00a0, \u00a0, ,    , ,,,,,,,,,,,,, ,  \u00a0\u00a0,\u00a0\u00a0\u00a0\u00a0,\u00a0,,,,,,,, in, in,,,,,,,,,, , ,, , , - - -",
        "eval": "0"
    },
    "212": {
        "summary": "There is insufficient evidence to support the routine use of any particular intervention either for pituitary down regulation, ovarian stimulation or adjuvant therapy in the management of poor responders to controlled ovarian stimulation in IVF. More robust data from good quality RCTs with relevant outcomes are needed.",
        "model_output": "[/INST]  The studies summarized in this document investigate the effectiveness of various protocols for improving ovarian response and pregnancy outcomes in women undergoing in vitro fertilization (IVF). The studies compare different approaches to ovarian stimulation, including the use of gonadotropin-releasing hormone (GnRH) agonists and antagonists, as well as different dosing regimens of gonadotropins.\n\nThe key findings from the studies can be summarized as follows:\n\n1. Commencement of recombinant follicle-stimulating hormone (FSH) during the luteal phase simultaneously with the long-protocol gonadotropin-releasing hormone (GnRH) agonist regiment in poor responder women produces better results compared with the conventional long-protocol GnRH agonist plus high-dose FSH regimen.\n2. GnRH antagonist in IVF poor-responder patients results in a significantly reduced duration of ovarian stimulation, fewer cancellations, and a higher number of follicles with a diameter >15 mm at human chorionic gonadotrophin administration.\n3. The use of GNRHa prior to and during ovarian stimulation with human menopausal gonadotropins (hMG) offers a very good alternative for patients with repetitive unsuccessful IVF cycles due to inadequate response.\n4. In poor responders, natural-cycle IVF is at least as effective as controlled ovarian hyperstimulation, especially in younger patients, with a better implantation rate.\n5. The early cessation of GnRHa combined with high doses of gonadotrophins permitted the retrieval of a significantly higher number of oocytes.\n6. GnRH antagonists have a suppressive effect on the production of estradiol.\n7. The flare-up protocol appears to be more effective than the GnRH-antagonist protocol in terms of mature oocytes retrieved, fertilization rate, and top-quality embryos transferred in poor-responder patients.\n8. The use of GnRH antagonist in IVF poor-responder patients results in",
        "eval": "1"
    },
    "213": {
        "summary": "No major advantages from any of the catheter-related interventions which have been purported to reduce the risk of PD peritonitis could be demonstrated in this review. The frequency and quality of available trials are suboptimal.",
        "model_output": "[/INST]\n,\n,\n,\n,\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\npass\npass\npass\npass, and pass, and pass, and the pass, pass, pass,  kwiet,\n kwiet\npass,\npass.\npass.\npass.\npass.\n\n\npass.\n.\n\n\n\n few,\n\n few.\n few.\n\n\n\n\n\n,\n,\n,\n,\n\n \n \n \n pass,\n\n\n pass, \n,\n.\n.\n.\n kwiet. kwiet.\n,\n.\n, kwiet.\n,\n, \n,\n, sierp, sierp, sierp, kwiet,\n,\n,\n\n\n\n\n.\n\n.\n.\n. Hinweis Hinweis Hinweis everybody everybody everybody Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis.\n. Hinweis Hinweis Hinweis obviously everybody obviously everybody hopefully obviously everybody everybody hopefully everybody Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis, kwiet, kwiet Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis obviously obviously obviously obviously obviously obviously obviously obviously obviously obviously obviously obviously obviously obviously obviously obviously obviously\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n,\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n,\n,\n,\n,\n,\n,\n\n\n\n\n\n,\n,\n\n\n\n\n\n,\n,\n,\n,\n,\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n,\n,\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n and",
        "eval": "0"
    },
    "214": {
        "summary": "Steam inhalation has not shown any consistent benefits in the treatment of the common cold, hence is not recommended in the routine treatment of common cold symptoms until more double-blind, randomised trials with a standardised treatment modality are conducted.",
        "model_output": "[/INST]  The five studies reviewed here investigate the effectiveness of steam inhalation in treating common cold symptoms. The studies employed different methods, including randomized controlled trials, double-blind studies, and in vitro experiments. The key findings can be synthesized as follows:\n\n1. Steam inhalation significantly alleviated cold symptoms, such as nasal congestion, nasal drainage, and sneezing, in a higher percentage of patients in the actively treated group than in the placebo-treated group (Study #1, #2, and #5).\n2. Inhaling heated vapor did not have any beneficial effect on common cold symptoms in a randomized, double-blind study (Study #3).\n3. Local hyperthermia (inhaling fully humidified air at 43\u00b0C) improved the course of a common cold and provided immediate relief of symptoms (Study #3).\n4. Steam inhalation did not affect viral shedding in volunteers with experimental RV colds (Study #4).\n5. The proportion of volunteers who shed virus on each day was similar in the two groups receiving steam inhalation treatments (Study #4).\n\nIn conclusion, while some studies suggest that steam inhalation may alleviate common cold symptoms, the evidence is not consistent across all studies. Further research is needed to determine the optimal conditions and duration of steam inhalation treatment for common cold symptoms.",
        "eval": "0"
    },
    "215": {
        "summary": "The use of antiglucocorticoids in the treatment of mood disorders is at the proof-of-concept stage. Considerable methodological differences exist between studies with respect to the compounds used and the patient cohorts studied. Results in some diagnostic subtypes are promising and warrant further investigation to establish the clinical utility of these drugs in the treatment of mood disorders.",
        "model_output": "[/INST]  The studies reviewed suggest that mifepristone may be effective in treating psychotic depression, with rapid improvements in symptoms observed in some studies. Ketoconazole was found to have limited efficacy in treating treatment-refractory major depression. Antiglucocorticoid treatment, including mifepristone and ketoconazole, may have antidepressant effects in hypercortisolemic depressed patients. Metyrapone was found to be an effective adjunct in the treatment of major depression, accelerating the onset of antidepressant action. Mifepristone was more effective than placebo in treating psychotic symptoms in patients with psychotic major depression. The combination of metyrapone and hydrocortisone may also have antidepressant effects. Further research is needed to confirm these findings and to determine the optimal dosage and duration of treatment for each of these interventions.",
        "eval": "1"
    },
    "216": {
        "summary": "There was no evidence to suggest a shortened fluid fast results in an increased risk of aspiration, regurgitation or related morbidity compared with the standard 'nil by mouth from midnight' fasting policy. Permitting patients to drink water preoperatively resulted in significantly lower gastric volumes. Clinicians should be encouraged to appraise this evidence for themselves and when necessary adjust any remaining standard fasting policies (nil-by-mouth from midnight) for patients that are not considered 'at-risk' during anaesthesia.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409 (\u0409\u0409\u0409.\n\u0409\n\u0409.\u0409.\n\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409. (\u0409. (\u0409.\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409. . \n\n\n\n.\n\u0409\n\u0409\n\u0409.\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "217": {
        "summary": "Further studies are needed to compare chemoradiation versus thermoradiation versus chemoradiation plus hyperthermia in well selected/conducted and quality controlled randomised trials.",
        "model_output": "[/INST]  The five studies reviewed here investigate the use of hyperthermia in combination with radiation therapy for the treatment of locally advanced pelvic tumors, including bladder, cervical, and rectal cancers. The studies suggest that adding hyperthermia to standard radiation therapy may improve local control and survival rates in these patients.\n\nKey findings from the studies include:\n\n1. Adding hyperthermia to standard radiation therapy may improve complete response rates in locally advanced pelvic tumors. For example, Study #1 found that the complete response rate was 55% in the group receiving radiation therapy plus hyperthermia, compared to 39% in the group receiving radiation therapy alone.\n2. Hyperthermia may be especially useful in locally advanced cervical tumors. Study #2 found that the 5-year survival rate of patients with locally advanced cervical cancer who received combined heat and radiation therapy was 35.6%, compared to 6.6% in the control group.\n3. The addition of hyperthermia to radiation therapy may improve local control and survival rates in locally advanced rectal cancer. Study #4 found that the combination of VHF microwave therapy and external beam radiotherapy did not produce any significant therapeutic advantage over standard external beam radiotherapy alone in the treatment of locally recurrent rectal carcinoma.\n4. The use of endocavitary hyperthermia in combination with preoperative radiation therapy may improve survival rates in patients with advanced rectal cancer. Study #5 found that the 5-year survival rate was 66.7% in the group receiving preoperative radiation therapy combined with endocavitary hyperthermia, compared to 40.5% in the control group.\n\nOverall, the studies suggest that the addition of hyperthermia to radiation therapy may improve outcomes in patients with locally advanced pelvic tumors, particularly in those with cervical and rectal cancers. However, further research is needed to confirm these findings and to determine the optimal dosage and duration of hyperthermia for maximum effectiveness.",
        "eval": "1"
    },
    "218": {
        "summary": "Squeezable bottles appear easier to use than rigid feeding bottles for babies born with clefts of the lip and/or palate, however, there is no evidence of a difference in growth outcomes between the bottle types. There is weak evidence that breastfeeding is better than spoon-feeding following surgery for cleft. There was no evidence to suggest that maxillary plates assist growth in babies with clefts of the palate. No evidence was found to assess the use of any types of maternal advice and/or support for these babies.",
        "model_output": "[/INST]  The five studies reviewed here investigate the feeding patterns and nutritional outcomes of infants with cleft lip and/or palate. The studies compared different feeding methods, including breast feeding versus spoon feeding, and the use of squeezable bottles versus rigid bottles. The findings can be synthesized as follows:\n\n1. Feeding difficulties are common in infants with cleft lip and/or palate, and squeezable bottles may be more reliable than rigid bottles for these infants (Study #2).\n2. Both squeezable and rigid bottles were found to be effective in achieving similar anthropometric outcomes, including weight and head circumference, in infants with cleft palate (Study #3).\n3. Infant orthopedics, which involves the use of passive maxillary plates, did not improve feeding, weight, or length in infants with cleft lip and palate (Study #4).\n4. Early postoperative breast feeding after cleft lip repair is safe and results in more weight gain at 6 weeks compared to spoon feeding (Study #5).\n\nOverall, the studies suggest that feeding difficulties are a common challenge for infants with cleft lip and/or palate, and that both squeezable and rigid bottles can be effective in supporting their nutritional needs. Additionally, early breast feeding after cleft lip repair appears to be safe and more economical than spoon feeding. These findings highlight the importance of proper feeding techniques and nutritional support for infants with cleft lip and/or palate.",
        "eval": "1"
    },
    "219": {
        "summary": "The results of this review suggest that phakic IOLs are safer than excimer laser surgical correction for moderate to high myopia in the range of -6.0 to -20.0 D and phakic IOLs are preferred by patients. While phakic IOLs might be accepted clinical practice for higher levels of myopia (greater than or equal to 7.0 D of myopic spherical equivalent with or without astigmatism), it may be worth considering phakic IOL treatment over excimer laser correction for more moderate levels of myopia (less than or equal to 7.0 D of myopic spherical equivalent with or without astigmatism). Further RCTs adequately powered for subgroup analysis are necessary to further elucidate the ideal range of myopia for phakic IOLs.",
        "model_output": "[/INST]  The three studies compared the effectiveness and safety of Artisan lens implantation, LASIK, and PRK in correcting myopia between -9.00 and -19.50 diopters. The key findings are:\n\n1. Artisan lens implantation and LASIK were found to be similarly effective, stable, and reasonably safe for the correction of myopia between -9.00 and -19.50 diopters. Better uncorrected and spectacle-corrected visual acuity, a lower enhancement rate, and exchangeability are the main advantages of Artisan lens implantation.\n2. The Visian Toric Implantable Collamer Lens (TICL) was found to be better than PRK in terms of mean best spectacle-corrected visual acuity, proportion of cases with improvement of 1 or more lines of BSCVA, and predictability.\n3. In cases of moderately high myopia, LASIK and Artisan phakic intraocular lenses seemed to produce a similar predictability, with better-corrected visual acuity and subjective evaluation of quality of vision for Artisan.\n\nOverall, the studies suggest that Artisan lens implantation and TICL are effective and safe options for correcting myopia, while LASIK may have a slightly better predictability and quality of vision. However, the differences between the three procedures are relatively small, and the choice of treatment should be individualized based on patient factors and preferences.",
        "eval": "1"
    },
    "220": {
        "summary": "Infliximab 5 mg/kg or 10 mg/kg, given every 8 weeks, is effective for the maintenance of remission and maintenance of fistula healing in patients who have responded to infliximab induction therapy. Adalimumab 40 mg weekly or every other week is effective for the maintenance of remission in patients who have responded to adalimumab induction therapy. Certolizumab pegol 400 mg every 4 weeks is effective for the maintenance of remission in patients who have responded to certolizumab induction therapy. No comparative trials have evaluated the relative efficacy of these agents. Adverse events are similar in the infliximab, adalimumab, and certolizumab groups compared with placebo, but study size and duration generally are insufficient to allow an adequate assessment of serious adverse events associated with long-term use.",
        "model_output": "[/INST] everybody Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis\n Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis, \n, \n, \n,\n,\n, Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis\n Hinweis\n\n Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis\n\n Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis,\n, \n, \n, , ,,,,\n,,,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n,\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n,\n,\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n,\n,\n,\n, ,\n,\n,,,,,, , , , , ,,, , , ,                       \n,\n,\n, \n, \n\n\n\n\n, \n,\n,",
        "eval": "0"
    },
    "221": {
        "summary": "Although there are shortcomings and gaps in the data, there appears to be enough overall consistency for different outcomes. The efficacy and adverse effects profile of penfluridol are similar to other typical antipsychotics; both oral and depot. Furthermore, penfluridol is shown to be an adequate treatment option for people with schizophrenia, especially those who do not respond to oral medication on a daily basis and do not adapt well to depot drugs. One of the results favouring penfluridol was a lower drop out rate in medium term when compared to depot medications. It is also an option for chronic sufferers of schizophrenia with residual psychotic symptoms who nevertheless need continuous use of antipsychotic medication. An additional benefit of penfluridol is that it is a low-cost intervention.\nNote: the eight citations in the awaiting classification section of the review may alter the conclusions of the review once assessed.",
        "model_output": "[/INST]  The studies reviewed suggest that penfluridol is a effective and well-tolerated long-acting oral neuroleptic for the treatment of chronic schizophrenia. The studies compare penfluridol to other long-acting neuroleptics, such as flupenthixol decanoate and chlorpromazine, and find it to be similarly effective in maintaining control of symptoms. The studies also suggest that penfluridol has a lower incidence of side effects compared to other long-acting neuroleptics. Additionally, the studies find that penfluridol can be used as a maintenance therapy for chronic schizophrenic patients, with some studies showing improvement in social functioning and quality of life. The studies also compare penfluridol to other oral antipsychotics, such as thiothixene, and find it to be more effective and better tolerated.\n\nThe studies also investigate the practical advantages of penfluridol, such as its oral administration and once-a-week dosing, which make it more manageable for patients and clinicians. The studies also explore the efficacy of penfluridol in acute psychosis and its comparison to other antipsychotics in this context.\n\nOverall, the studies suggest that penfluridol is a useful and well-tolerated long-acting oral neuroleptic for the treatment of chronic schizophrenia, with potential advantages over other available treatments.",
        "eval": "1"
    },
    "222": {
        "summary": "Regimens for the acute phase of illness should contain ceftazidime or imipenem. It is not yet clear if combinations of treatments in the early phase reduce relapse. For oral therapy after the acute phase of treatment, trials suggest that conventional four drug regimens can be used for treatment.",
        "model_output": "[/INST]\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n everybody hopefully everybody hopefully hopefully hopefully Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung\n \u0409\n \u0409\n everybody \u0409 Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Einzeln Unterscheidung Einzeln Unterscheidung Einzeln Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung nobody nobody nobody nobody nobody nobody nobody nobody Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Unterscheidung Hinweis Hinweis Hinweis Hinweis Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Hinweis Hinweis Unterscheidung Unterscheidung Unterscheidung Hinweis Unterscheidung Unterscheidung Hinweis Unterscheidung Hinweis Hinweis everybody Hinweis everybody Hinweis Hinweis Hinweis Hinweis Unterscheidung Unterscheidung Unterscheidung Unterscheidung Hinweis Unterscheidung Hinweis Unterscheidung Hinweis Unterscheidung Hinweis Unterscheidung Hinweis Unterscheidung Unterscheidung Hinweis Hinweis Hinweis Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Unterscheidung Hinweis Hinweis Hinweis Unterscheidung Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Unterscheidung Einzeln Hinweis Unterscheidung Unterscheidung Unterscheidung Unterscheidung everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody Hinweis Unterscheidung Unterscheidung Unterscheidung Unterscheidung Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis everybody Begriffe Begriffe everybody Hinweis Hinweis Hinweis Hinweis Begriffe obviously Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis\n\n Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Einzeln due Hinweis Einzeln Einzeln Einzeln Einzeln due Einzeln Einzeln,\n\n\n\n\n\n\n\n,\n,\n,\n,\n,\n\n\n\n\n trim Hinweis\n\n\n\n\n\n\n\n\n\n Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Einzeln Einzeln Einzeln Einzeln Einzeln Hinweis Einzeln Hinweis Einzeln Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis, \n\n\n\n\n, \n, \n,\n,\n,\n,\n, Hinweis Hinweis Hinweis Hinweis Einzeln Hinweis Einzeln Einzeln Einzeln Einzeln Einzeln Einzeln Einzeln Einzeln Einzeln Einzeln Einzeln Einzeln Einzeln Einzeln Einzeln Einzeln Einzeln Einzeln\n\n\n\n\n\n\n\n\n\n\n\n\n everybody nobody everybody nobody everybody everybody everybody everybody",
        "eval": "0"
    },
    "223": {
        "summary": "The potential benefit of antibiotics in the treatment of clinically diagnosed acute rhinosinusitis needs to be seen in the context of a high prevalence of adverse events. Taking into account antibiotic resistance and the very low incidence of serious complications, we conclude that there is no place for antibiotics for the patient with clinically diagnosed, uncomplicated acute rhinosinusitis. This review cannot make recommendations for children, patients with a suppressed immune system and patients with severe disease, as these populations were not included in the available trials.",
        "model_output": "[/INST]\n\n\n\n\n\n\n\n\n\n\n,\n, , , ,\n,\n,\n,\n,\n,\n,\n,\n,\n,,,,,\n,\n,\n,\n,\n, \n, \n, \n,\n,\n,\n, \n, \n\n\n\n\n\n\n\n\n\n\n\n,\n,\n,\n, and,\n,\n,\n, \n, \n, \n,\n,\n,\n,,,,,,,,,,,,,,,,,,, \n,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, to to to\n,\n to\n to\n,\n,\n,\n,\n,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\n,\n,\n,\n,\n,\n,,,\n,\n,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,#,#,#,,,,,,,,,,,,,, ,,,,, , ,     , ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, ...,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, \u00a0,\u00a0,, ,,,,,,,,,,,,,,,,,,,,,,\u00a0,\u00a0,\u00a0,\u00a0, in,,,,,,,, in,,,,,,,,,,,,,,,,,,,",
        "eval": "0"
    },
    "224": {
        "summary": "The findings of our work indicate that Polyethylene glycol is better than lactulose in outcomes of stool frequency per week, form of stool, relief of abdominal pain and the need for additional products. On subgroup analysis, this is seen in both adults and children, except for relief of abdominal pain. Polyethylene Glycol should be used in preference to Lactulose in the treatment of Chronic Constipation.",
        "model_output": "[/INST]  The six studies provide valuable insights into the comparative efficacy and safety of lactulose and polyethylene glycol (PEG) in the treatment of chronic idiopathic constipation. The key findings can be synthesized as follows:\n\n1. Lactulose and PEG both improve bowel movements and stool consistency, but PEG is more effective in increasing the number of bowel movements and improving stool consistency.\n2. PEG is more effective than lactulose in relieving opioid-induced constipation, with a higher success rate and fewer side effects.\n3. PEG is more effective than lactulose in reducing hard stool formation and improving bowel habits in children with constipation.\n4. PEG is better tolerated than lactulose, with fewer adverse events reported.\n5. PEG is more effective than lactulose in treating faecal impaction, with a higher success rate and shorter time to disimpaction.\n6. PEG is a safe and effective laxative for the treatment of chronic constipation in children, with similar stool frequency and form but easier passage compared to lactulose.\n\nOverall, the studies suggest that PEG may be a more effective and better-tolerated option than lactulose for the treatment of chronic idiopathic constipation, particularly in opioid-induced constipation and faecal impaction. However, further research is needed to confirm these findings and to determine the long-term safety and efficacy of PEG in the treatment of chronic constipation.",
        "eval": "1"
    },
    "225": {
        "summary": "There was not enough evidence to judge whether or not the included drugs cured bedwetting when used alone. There was limited evidence to suggest that desmopressin, imipramine and enuresis alarms therapy were better than the included drugs to which they were compared. In other reviews, desmopressin, tricyclics and alarm interventions have been shown to be effective during treatment. There was also evidence to suggest that combination therapy with anticholinergic therapy increased the efficacy of other established therapies such as imipramine, desmopressin and enuresis alarms by reducing the relapse rates, by about 20%, although it was not possible to identify the characteristics of children who would benefit from combination therapy. Future studies should evaluate the role of combination therapy against established treatments in rigorous and adequately powered trials.",
        "model_output": "[/INST]\u0409\u0409\u0409\n\u0409\n\u0409.\u0409\u0409\u0409.\n\u0409 \n. \u0409\n\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409.\u0409\n\u0409....\u0409\u0409.\u0409\u0409\u0409\u0409\u0409\u0409.....\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "226": {
        "summary": "Massage might be beneficial for patients with subacute and chronic non-specific low-back pain, especially when combined with exercises and education. The evidence suggests that acupuncture massage is more effective than classic massage, but this need confirmation. More studies are needed to confirm these conclusions, to assess the impact of massage on return-to-work, and to determine cost-effectiveness of massage as an intervention for low-back pain.",
        "model_output": "[/INST]  The summary of the provided abstracts highlights the findings from studies related to the effectiveness of massage therapy, acupuncture, and relaxation techniques in managing chronic low back pain. The key takeaways are:\n\n1. Massage therapy is effective in reducing pain and improving function in patients with chronic low back pain, according to Study #3.\n2. Acupuncture is superior to relaxation therapy in reducing pain and improving function in patients with chronic low back pain, according to Study #1.\n3. Relaxation acupoint stimulation and acupressure with aromatic lavender essential oil are effective in reducing pain and improving functional activities in patients with sub-acute or chronic non-specific low back pain, according to Study #4.\n4. Manual therapy with specific adjuvant exercise is beneficial in treating chronic low back pain, according to Study #6.\n5. Acupressure and physical therapy are effective in reducing low back pain, according to Study #7.\n6. Massage therapy is another effective alternative medicine in reducing low back pain, according to Study #8.\n\nThese findings suggest that a combination of massage, acupuncture, relaxation, and physical therapy may be effective in managing chronic low back pain. Further research is needed to confirm these findings and explore the long-term effects of these interventions on low back pain.",
        "eval": "1"
    },
    "227": {
        "summary": "Choice of therapy for second stage Gambiense HAT will continue to be determined by what is locally available, but eflornithine and NECT are likely to replace melarsoprol, with careful parasite resistance monitoring. We need research on reducing adverse effects of currently used drugs, testing different regimens, and experimental and clinical studies of new compounds, effective for both stages of the disease.",
        "model_output": "[/INST]\n \u0409\n \u0409 \u0409 \u0409 \u0409 . \u0409\n \u0409 \n \n \n   everybody  everybody  everybody  everybody everybody everybody everybody  kwiet  kwiet Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis everybody.\n  everybody.  everybody\n  everybody  kwiet  kwiet Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis everybody everybody  everybody  everybody  everybody, everybody, everybody Hinweis\n  Hinweis Hinweis  Hinweis  Hinweis, \n\n, Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis everybody Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis, kwiet, Hinweis, Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis obviously obviously Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody Hinweis Hinweis everybody Hinweis everybody Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis, \n,\n,\n\n\n \n \n    \n \n \n \n    \n \n\n\n\n\n\n\n\n\n\n \n \n \n \n \n \n \n \n   \n \n\n\n\n\n\n\n\n\n\n\n \n \n \n \n \n \n \n \n\n\n\n to \n\n\n\n\n, \n\n\n,\n,\n, Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis\n \n\n\n\n\n\n Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis",
        "eval": "0"
    },
    "228": {
        "summary": "Based on this analysis, the most prudent prescription for water intake to premature infants would seem to be careful restriction of water intake so that physiological needs are met without allowing significant dehydration. This practice could be expected to decrease the risks of patent ductus arteriosus and necrotizing enterocolitis without significantly increasing the risk of adverse consequences.",
        "model_output": "[/INST]  The five studies reviewed here investigate the effects of fluid administration on various outcomes in premature and newborn infants. The studies have some similarities in their methodology and findings, which are summarized below:\n\n1. High fluid intake (>20 ml/kg/day) in premature infants is associated with an increased risk of patent ductus arteriosus (PDA) and congestive heart failure (CHF). This finding is consistent across all five studies.\n2. The risk of PDA and CHF is significantly higher in infants who receive excess fluid intake, especially in the high-volume group.\n3. The studies suggest that limiting fluid intake to meet estimated requirements can reduce the risks of PDA and CHF in premature infants.\n4. The optimal fluid intake for premature infants is still unclear, and the studies suggest that a moderate approach may be more effective than either a high or low fluid intake.\n5. The studies did not find any significant differences in the occurrence of other adverse effects, such as jaundice, hypoglycaemia, and hypotension, between the fluid groups.\n6. The studies highlight the importance of careful fluid management in premature and newborn infants, particularly during the first days of life.\n\nIn conclusion, the findings of these studies suggest that fluid restriction may be a useful strategy for reducing the risk of PDA and CHF in premature infants. However, further research is needed to determine the optimal fluid intake for these infants and to avoid any potential adverse effects.",
        "eval": "1"
    },
    "229": {
        "summary": "Although statistically significant, the differences between disc replacement and conventional fusion surgery for degenerative disc disease were not beyond the generally accepted clinical important differences with respect to short-term pain relief, disability and Quality of Life. Moreover, these analyses only represent a highly selected population. The primary goal of prevention of adjacent level disease and facet joint degeneration by using total disc replacement, as noted by the manufacturers and distributors, was not properly assessed and not a research question at all. Unfortunately, evidence from observational studies could not be used because of the high risk of bias, while these could have improved external validity assessment of complications in less selected patient groups. Non-randomised studies should however be very clear about patient selection and should incorporate independent, blinded outcome assessment, which was not the case in the excluded studies. Therefore, because we believe that harm and complications may occur after years, we believe that the spine surgery community should be prudent about adopting this technology on a large scale, despite the fact that total disc replacement seems to be effective in treating low-back pain in selected patients, and in the short term is at least equivalent to fusion surgery.",
        "model_output": "[/INST] and \u0409.\n\n\n\n\n\n\n\n\n\n\n, \u0409, \u0409, \u0409,\n,\n, .\n \u0409, \n\n,  sierp, \n, pass, pass, pass, pass, pass,\n,\n, pass, pass, pass,  kwiet,  kwiet\n,  kwiet\n  kwiet\n.\n.\n.\n\n\n\n everybody.\n\n\n\n\n\n\n\n\n everybody, kwiet everybody\n sierp\n\n\n\n\n\n,\n,\n,\n,\n\n\n\n\n kwiet everybody\n kwiet Hinweis\n kwiet\n\n\n\n\n\n\n\n\n sierp\n\n everybody\n everybody\n Hinweis\n hopefully\n Hinweis\n Hinweis\n hopefully\n\n\n\n\n\n\n\n\n\n sierp\n sierp\n sierp everybody everybody, kwiet everybody everybody everybody everybody everybody everybody everybody everybody.\n Hinweis Einzeln everybody everybody everybody everybody everybody everybody\npass\npass\npass\n\n\n\n\n nobody\n everybody everybody everybody nobody nobody everybody everybody everybody\n\n\n\n\n\n\n\n\n\n\n\n\n\n Hinweis Hinweis\n Hinweis Hinweis Hinweis\n Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis everybody Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis everybody everybody everybody Hinweis Hinweis everybody everybody Hinweis everybody Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis.\n\n.\n.\n Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis hopefully hopefully Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully everybody hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully hopefully Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis\n\n\n\n\n\n Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis hopefully hopefully Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis\n\n\n\n\n\n\n\n Hinweis hopefully everybody hopefully everybody\n\n\n,\n,\n\n\n\n\n\n\n\n\n Hinweis Hinweis Hinweis",
        "eval": "0"
    },
    "230": {
        "summary": "This update of the review published in 2004 incorporates additional trials and more mature data. It demonstrates the benefit of concurrent chemoradiation over radiotherapy alone or sequential chemoradiotherapy. Patient selection is an important consideration in view of the added toxicity of concurrent treatment. Uncertainty remains as to how far this is purely due to a radiosensitising effect and whether similar benefits could be achieved by using modern radiotherapy techniques and more dose intensive accelerated and/ or hyperfractionated radiotherapy regimens.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "231": {
        "summary": "Complex approaches show promise, with some persistence of abstinence (30 days point prevalence abstinence or continuous abstinence at six months), especially those incorporating elements sensitive to stage of change and using motivational enhancement and CBT.\u00a0 We await results of recent trials of Not on Tobacco trials and more data is needed on sustained quitting that allows for the episodic nature of much adolescent smoking. There were few trials with evidence about pharmacological interventions (nicotine replacement and bupropion), and none demonstrated effectiveness for adolescent smokers.\u00a0There is not yet sufficient evidence to recommend widespread implementation of any one model.\nThere continues to be a need for well-designed adequately powered randomized controlled trials of interventions for this population of smokers.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "232": {
        "summary": "There is significant evidence to suggest that topical application of chlorhexidine to umbilical cord reduces neonatal mortality and omphalitis in community and primary care settings in developing countries. It may increase cord separation time however, there is no evidence that it increases risk of subsequent morbidity or infection.\nThere is insufficient evidence to support the application of an antiseptic to umbilical cord in hospital settings compared with dry cord care in developed countries.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "233": {
        "summary": "We found insufficient evidence to determine if overground physical therapy gait training benefits gait function in patients with chronic stroke, though limited evidence suggests small benefits for uni-dimensional variables such as gait speed or 6MWT. These findings must be replicated by large, high quality studies using varied outcome measures.",
        "model_output": "[/INST]  The studies summarized in this document investigate the effectiveness of various interventions, including community-based exercise programs, physiotherapy, home-based physical therapy, task-oriented interventions, and dual-task exercise programs, on improving mobility and functional abilities in individuals with chronic stroke. The findings suggest that these interventions can lead to significant improvements in mobility, gait speed, and functional performance, with some interventions showing maintenance of these improvements over time. The studies highlight the importance of tailoring interventions to the individual needs and abilities of stroke survivors and the potential benefits of task-oriented and dual-task exercise programs in improving walking ability and functional performance.\n\nKey Findings:\n\n1. Community-based exercise programs can improve mobility and functional abilities in individuals with chronic stroke.\n2. Physiotherapy interventions can improve mobility and gait speed in patients with mobility problems more than 1 year after stroke.\n3. Home-based physical therapy can improve lower limb motor function in chronic stroke survivors.\n4. A task-oriented intervention enhances walking distance and speed in the first year post-stroke, particularly in people with moderate walking deficits.\n5. Dual-task exercise programs can improve walking ability in subjects with chronic stroke.\n6. Task-oriented progressive resistance strength training can improve lower extremity muscle strength and functional performance in individuals with chronic stroke.\n\nOverall, these studies suggest that tailored interventions that focus on improving mobility and functional abilities can lead to significant improvements in outcomes for individuals with chronic stroke.",
        "eval": "1"
    },
    "234": {
        "summary": "CABG is associated with reduced rates of major adverse cardiac events, mostly driven by reduced repeat revascularisation. However, the RCT data are limited by follow-up, unrepresentative samples and rapid development of both surgical techniques and stenting. Research on real-world patient population or patient level data meta-analyses may identify risk factors and groupings who may benefit most from one strategy over the other.",
        "model_output": "[/INST] \n\nThe task is to compare coronary artery bypass grafting versus percutaneous coronary interventions in single left anterior descending versus CABG versus PCI versus CABG versus PCI versus CABG versus PCI versus PCI versus CABG versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI versus PCI and PCI and PCI and PCI and PCI and PCI and PCI and PCI and PCI and PCI and PCI and PCI and PCI and PCI and PCI and PCI and PCI and PCI and PCI.\nCI.\nCI and CI and CI and CI and CI and CI.",
        "eval": "0"
    },
    "235": {
        "summary": "Carbamazepine is effective in chronic neuropathic pain, with caveats. No trial was longer than four weeks, of good reporting quality, using outcomes equivalent to at least moderate clinical benefit. In these circumstances, caution is needed in interpretation, and meaningful comparison with other interventions is not possible.",
        "model_output": "[/INST]  The studies reviewed suggest that corticosteroids, such as prednisolone, may be effective in reducing the incidence and duration of post-herpetic neuralgia (PHN) compared to carbamazepine. Tegretol, a carbamazepine-based drug, has been shown to be effective in managing facial pain, diabetic neuropathy, and trigeminal neuralgia. However, the studies also indicate that nortriptyline-fluphenazine may be as effective as carbamazepine in treating diabetic neuropathy, and that pimozide may be more effective than carbamazepine in treating trigeminal neuralgia. Additionally, clomipramine has been shown to be effective in reducing the symptoms of post-herpetic neuralgia.\n\nIt is important to note that the studies have some limitations, such as small sample sizes and open-label designs, which may affect the accuracy of the results. Furthermore, the studies were conducted over a period of four years, and some of the drugs may have been less effective or more toxic over time.\n\nIn conclusion, the studies suggest that corticosteroids may be effective in reducing the incidence and duration of PHN, and that carbamazepine-based drugs, such as Tegretol, may be effective in managing various types of neuropathic pain. However, further research is needed to confirm these findings and to determine the long-term efficacy and safety of these drugs.",
        "eval": "0"
    },
    "236": {
        "summary": "Magnesium sulphate more than halves the risk of eclampsia, and probably reduces maternal death. There is no clear effect on outcome after discharge from hospital. A quarter of women report side effects with magnesium sulphate.",
        "model_output": "[/INST]\n\n\n\n\n\n\n\n\n\n\n\n \n\n\n\n\n\n\n\n\n\n\n, \n\n\n\n\n\n\n,\n\n\n,\n,\n,\n,\n,\n,\n,\n,\n,\n\n\n\n\n\n, \n,\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n,\n, \n, \n\n    \n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n, \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n,\n,\n,\n,\n,\n,\n,\n,\n,\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n, ..., , ,,,,,,,,,,,,,,,, , , ..., ..., ,,,,,,,,...,...,...,...,...,...,,,,...,,,,,,,,,, ,,,..., ......,\n.\n...\n.......................................,...,...,...,...,...,...,...,...,...,...,.........,...,............................................................... ... ... ... , , , ..., ...     , , , ,,,...,...,...,..., ,...,...,...,...,..., , ,,,,,,,,, ...,...,...,...,,,,,,,,,...,...,,,,,,,,,...,...,...,...,...,...,...,..., ,,,, , .........,...,......, ,...,..., ..., ,        , , ...,...,..., ..., ,           ,   ...",
        "eval": "0"
    },
    "237": {
        "summary": "Early intervention programmes for preterm infants have a positive influence on cognitive and motor outcomes during infancy, with the cognitive benefits persisting into pre-school age. There is a great deal of heterogeneity between studies due to the variety of early developmental intervention programmes trialled and gestational ages of the preterm infants included, which limits the comparisons of intervention programmes. Further research is needed to determine which early developmental interventions are the most effective at improving cognitive and motor outcomes, and on the longer-term effects of these programmes.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "238": {
        "summary": "A single dose of paracetamol provides effective analgesia for about half of patients with acute postoperative pain, for a period of about four hours, and is associated with few, mainly mild, adverse events.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "239": {
        "summary": "The results of this review give some support to ciclesonide as an equivalent therapy to other ICS at similar nominal doses. The studies assessed low doses of steroids, in patients whose asthma required treatment with low doses of steroids. At half the dose of FP and BDP/BUD, the effects of ciclesonide were more inconsistent The effect on candidiasis may be of importance to people who find this to be problematic. The role of ciclesonide in the management of asthma requires further study, especially in paediatric patients. Further assessment against FP at a dose ratio of 1:2 is a priority.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "240": {
        "summary": "Both TCAs and SSRIs are effective for depression treated in primary care.",
        "model_output": "[/INST] \n\n\nThe findings of the studies are summarized as follows:\n\n\nStudy #1:\n\n\nStudy #1:\n\n\nStudy #2:\n\n\nStudy #3:\n\nStudy #4:\n\nStudy #5:\n\nStudy #6:\nStudy #7:\nStudy #8:\n\nStudy #8:\n\nStudy #10:\n\nStudy #10:\nStudy #10:\nStudy #10:\nStudy #10:\nStudy #10:\nStudy #1:\nStudy #10:\nStudy #10:\nStudy #1:\nStudy #10:\nStudy #10:\nStudy #10:\nStudy #10:\nStudy #10:\nStudy #10:\nStudy #10:\nStudy #10:\nStudy #10:\nStudy #10:\nStudy #10:\nStudy #10:\nStudy #10:\nStudy #10:\nStudy #10:\nStudy #10:\nStudy #10:\nStudy #10:\nStudy #10:\nStudy #10:\nStudy #10:\nStudy #10:\nStudy #10:\nStudy #Study #Study #Study #10Study #10Study #10Study #Study #Study #Study #Study #Study #Study #Study #Study #Study #Study #Study #StudyStudyStudyStudyStudyStudy, Study, and Study, and StudyStudyStud andStud andStud andStud.\nStud.\nStud.\nStud.\nStud. St, St, St, St,",
        "eval": "0"
    },
    "241": {
        "summary": "No effect was shown for specific outcomes: laboratory-proven influenza, pneumonia and death from pneumonia. An effect was shown for the non-specific outcomes of ILI, GP consultations for ILI and all-cause mortality in individuals \u2265 60. These non-specific outcomes are difficult to interpret because ILI includes many pathogens, and winter influenza contributes < 10% to all-cause mortality in individuals \u2265 60. The key interest is preventing laboratory-proven influenza in individuals \u2265 60, pneumonia and deaths from pneumonia, and we cannot draw such conclusions.\nThe identified studies are at high risk of bias.\nSome HCWs remain unvaccinated because they do not perceive risk, doubt vaccine efficacy and are concerned about side effects. This review did not find information on co-interventions with HCW vaccination: hand washing, face masks, early detection of laboratory-proven influenza, quarantine, avoiding admissions, anti-virals, and asking HCWs with ILI not to work. We conclude there is no evidence that vaccinating HCWs prevents influenza in elderly residents in LTCFs. High quality RCTs are required to avoid risks of bias in methodology and conduct, and to test these interventions in combination.",
        "model_output": "[/INST]  The five studies reviewed here investigate the effectiveness of influenza vaccination of various groups, including healthcare workers, nursing home staff, and residents, in preventing deaths, morbidity, and health service use among the elderly. The studies were conducted in different settings, including the UK, Japan, and the US, during various influenza seasons.\n\nThe key findings from the studies can be summarized as follows:\n\n1. Vaccinating care home staff against influenza can prevent deaths, health service use, and influenza-like illness in residents during periods of moderate influenza activity (Study #1).\n2. Staff influenza vaccination rates were significantly higher in vaccination arms compared to control arms in three of the studies (Studies #2, #3, and #5), indicating that vaccinating healthcare workers and other staff caring for institutionalized elderly people can increase vaccination coverage and reduce the risk of influenza transmission.\n3. Vaccinating healthcare workers in long-term geriatric care was associated with reductions in total patient mortality and influenza-like illness (Study #3).\n4. Vaccination of healthcare workers was associated with a substantial decrease in mortality among patients in one study (Study #4), but virological surveillance showed no associated decrease in non-fatal influenza infection in patients.\n5. Outbreaks and number of cases were significantly reduced by vaccination in one study (Study #5), highlighting the importance of vaccination in preventing influenza outbreaks in long-term-care facilities.\n\nOverall, the studies suggest that vaccinating healthcare workers and other staff caring for institutionalized elderly people can help prevent influenza transmission and reduce the risk of morbidity and mortality among the elderly. However, the studies also highlight the need for further research to determine the optimal vaccination strategies and to evaluate the effectiveness of vaccination in different populations and settings.",
        "eval": "1"
    },
    "242": {
        "summary": "The value of the various approaches to conservative management of postprostatectomy incontinence after radical prostatectomy remains uncertain. It seems unlikely that men benefit from one-to-one pelvic floor muscle training therapy after transurethral resection of the prostate (TURP). \u00a0Long-term incontinence may be managed by external penile clamp, but there are safety problems.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "243": {
        "summary": "There were insufficient data to establish whether oral EPA was better than placebo. Comparisons of EPA combined with a protein energy supplementation versus a protein energy supplementation (without EPA) in the presence of an appetite stimulant (Megestrol Acetate) provided no evidence that EPA improves symptoms associated with the cachexia syndrome often seen in patients with advanced cancer.",
        "model_output": "[/INST]  The findings from the five studies suggest that fish oil supplements may not have a significant impact on appetite, weight loss, or nutritional status in patients with advanced cancer and anorexia/cachexia. The studies found that:\n\n1. Fish oil supplements did not improve symptoms such as appetite, tiredness, nausea, well-being, caloric intake, nutritional status, or function in patients with advanced cancer and loss of both weight and appetite. (Study #1)\n2. A protein and energy dense N-3 fatty acid enriched oral supplement did not arrest weight loss or improve lean tissue in cachectic patients with advanced pancreatic cancer, despite evidence of dose-response relationships. (Study #2)\n3. An eicosapentaenoic acid (EPA) supplement did not improve weight gain or appetite in patients with cancer-associated wasting, and combination therapy with megestrol acetate (MA) was not more effective than MA alone. (Study #3)\n4. EPA supplementation did not inhibit lipolysis or lipid oxidation in weight-losing cancer patients or healthy subjects. (Study #4)\n5. Dietary omega-3 polyunsaturated fatty acids plus vitamin E restored immunodeficiency and prolonged survival for severely ill patients with generalized malignancy, with a significant immunomodulating effect in malnourished patients. (Study #5)\n\nOverall, the findings suggest that while fish oil supplements may have potential as a treatment for cancer-related anorexia/cachexia, further research is needed to determine their effectiveness and optimal dosage. Additionally, other interventions such as protein and energy dense supplements, EPA supplementation, and dietary omega-3 polyunsaturated fatty acids may also be effective in improving symptoms and survival in patients with advanced cancer.",
        "eval": "0"
    },
    "244": {
        "summary": "Based on two small trials, there was no significant difference in pain relief in women receiving oral analgesics compared with placebo or no treatment (129 women; MD -3.51; 95% CI -10.03 to 3.01). We consider this evidence to be of a low to moderate quality. In routine clinical practice, intracervical injection of local anaesthetic with a vasoconstrictor (lignocaine plus adrenaline or prilocaine plus felypressin) appears to be the optimum analgesia for treatment. However, further high-quality, adequately powered trials should be undertaken in order to provide the data necessary to estimate the efficacy of oral analgesics, the optimal route of administration and dose of local anaesthetics.",
        "model_output": "[/INST]  The summary of the provided abstracts is as follows:\n\n1. Study #1: Citanest with Octapressin provides effective pain relief during laser vaporization of the cervix.\n2. Study #2: Local anesthetic spray does not reduce pain during cervical injection.\n3. Study #3: Lidocaine infiltration is effective in reducing pain during cervical cryosurgery.\n4. Study #5: Superficial injection of lignocaine reduces pain during LLETZ.\n5. Study #6: Benzocaine gel reduces pain during loop electrosurgical excision of the cervix.\n6. Study #7: Self-administered isoflurane and desflurane reduce pain during outpatient colposcopy.\n7. Study #8: Prilocaine and felypressin (Citanest and Octapressin) reduce pain during cervical biopsy and treatment with the Semm coagulator.\n8. Study #9: Intracervical injection of prilocaine and felypressin reduces pain experienced during cervical biopsy and treatment.\n9. Study #10: Lignocaine with adrenaline causes more side effects than prilocaine with felypressin during large loop excision of the transformation zone.\n10. Study #11: Cocaine spray provides effective pain relief during laser vaporization of the cervix.\n11. Study #12: No statistically significant difference in pain levels between groups receiving different types of analgesia before laser surgery for CIN.\n\nOverall, the studies suggest that various local anesthetics, including lidocaine, benzocaine, prilocaine, and cocaine, can effectively reduce pain during cervical procedures. However, the optimal choice of local anesthetic and the most effective method of administration may vary depending on the specific procedure and individual patient factors.",
        "eval": "1"
    },
    "245": {
        "summary": "Studies evaluated in this review report significant improvements in knowledge measures and protective behaviours. Results might have differed had the true ICCs from studies been available or cluster-adjusted results been available. Several studies reported harms, suggesting a need to monitor the impact of similar interventions. Retention of knowledge should be measured beyond 3-12 months. Further investigation of the best forms of presentation and optimal age of programme delivery is required.",
        "model_output": "[/INST]  The provided abstracts present various studies related to the prevention of child abuse and sexual assault. The studies evaluate different interventions and programs aimed at improving children's knowledge and skills in preventing and dealing with abusive situations. The key findings from the studies can be synthesized as follows:\n\n1. Knowledge and efficacy expectations: Studies #1 and #2 demonstrate that child abuse prevention programs can increase children's knowledge of abuse prevention concepts and improve their efficacy expectations regarding abusive situations. However, Study #2 suggests that the gains may be small and may not be maintained over time.\n2. Personal safety skills: Studies #3 and #4 highlight the importance of teaching children personal safety skills to prevent sexual abuse. These studies show that children who receive training in personal safety skills demonstrate greater preventive knowledge and skills than those who do not receive such training.\n3. Proximate effects: Study #4 shows that a sexual abuse prevention program in elementary school children resulted in significant knowledge gains and improved preventive skills, but the gains may attenuate over time. Study #5 suggests that a coeducational program for teenagers on preventing sexual coercion can be effective in reducing coercive attitudes and behaviors.\n4. Differential effectiveness: Study #6 highlights the importance of tailoring interventions to the individual needs of children. The study found that children with initial coercive attitude scores at or above the mean benefited significantly more than children with the same range of scores in the control group.\n5. Television techniques: Study #7 compares the effectiveness of a videotape training program with other methods of teaching children self-protection. The study finds that the videotape program with behavior rehearsal is highly effective in teaching children safe responses to potential abductors.\n6. Cultural considerations: Study #8 evaluates the effectiveness of a sexual abuse prevention program for female Chinese adolescents with mild mental retardation. The study finds that the program can be effective in improving knowledge and skills, but modifications may be necessary to accommodate cultural differences.\n7. Victimization prevention: Study #9 employs a posttest-only control group design to assess the effectiveness of a victimization prevention program, Project TRUST. The study finds",
        "eval": "1"
    },
    "246": {
        "summary": "We do not know whether PQ added to treatment regimens for patients with P. falciparum infection reduces transmission of malaria. In individual patients, it reduces gametocyte prevalence and density. In practical terms, even if PQ results in large reductions in gametocytes in people being treated for malaria, there is no reliable evidence that this will reduce transmission in a malaria-endemic community, where many people are infected but have no symptoms and are unlikely to be treated.\u00a0Since PQ is acting as a monotherapy against gametocytes, there is a risk of the parasite developing resistance to the drug. In terms of harms, there is insufficient evidence from trials to know whether the drug can be used safely in this way in populations where G6PD deficiency occurs.\nIn light of these doubts about safety, and lack of evidence of any benefit in reducing transmission, countries should question whether to continue to use PQ routinely in primary treatment of malaria. Further synthesis of observational data on safety and new trials may help elucidate a role for PQ in malaria elimination, or in situations where most infected individuals are symptomatic and receive treatment.",
        "model_output": "[/INST] \n\n\n\n\n.\n\n\n\n\n\n\n\n,\n,\n, , , ,         \n\n\n\n\n\n...\n\n\n............\n\n\n\n\u0409\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n\n\n. . \n\n, , . ,      , , , , ,                    . .   . . . . . , , \u00a0, \u00a0,    \u00a0 \u00a0                                , ,                      ,                .           ,                                    \n  \n,                                           , ,                                                                , ,                   \u00a0           \u0409, .  \u00a0, \u00a0.   . .        , , , ,, , , ,              \n\n\n   \n\n\n\u0409                , ,",
        "eval": "0"
    },
    "247": {
        "summary": "Despite collating more event data than previous systematic reviews of randomised controlled trials (665 deaths in some 6,250 participants), there is still insufficient power to exclude clinically important effects of reduced dietary salt\u00a0on mortality or cardiovascular morbidity in normotensive or hypertensive populations. Our estimates of benefits from dietary salt restriction are consistent with the predicted small effects on clinical events attributable to the small blood pressure reduction achieved.",
        "model_output": "[/INST]  The five studies reviewed here investigate the effects of weight loss, sodium reduction, and their combination on blood pressure and hypertension incidence in various populations. The findings can be synthesized as follows:\n\n1. Weight loss and sodium reduction interventions were effective in lowering diastolic and systolic blood pressure in overweight adults with high-normal blood pressure in the short-term (6 months) (Study #1).\n2. Potassium-enriched salt was associated with a significant reduction in CVD mortality and medical expenditures in elderly veterans (Study #2).\n3. Reduced sodium intake and weight loss were found to be effective and safe nonpharmacologic therapies for the treatment of hypertension in older persons (Study #3).\n4. The Hypertension Prevention Trial showed that dietary changes, including reduced calories, sodium, and increased potassium, resulted in lower mean blood pressures in healthy men and women (Study #4).\n5. Nonpharmacologic interventions, such as weight reduction and sodium reduction, were found to be effective in reducing blood pressure in persons with high normal diastolic blood pressure (Study #5).\n\nIn conclusion, these studies suggest that weight loss, sodium reduction, and their combination are effective strategies for lowering blood pressure and reducing the incidence of hypertension in various populations. These findings have implications for the prevention of cardiovascular disease through dietary and lifestyle modifications.",
        "eval": "1"
    },
    "248": {
        "summary": "Cytisine increases the chances of quitting, although absolute quit rates were modest in two recent trials. Varenicline at standard dose increased the chances of successful long-term smoking cessation between two- and threefold compared with pharmacologically unassisted quit attempts. Lower dose regimens also conferred benefits for cessation, while reducing the incidence of adverse events. More participants quit successfully with varenicline than with bupropion. Two open-label trials of varenicline versus NRT suggested a modest benefit of varenicline but confidence intervals did not rule out equivalence. Limited evidence suggests that varenicline may have a role to play in relapse prevention. The main adverse effect of varenicline is nausea, but mostly at mild to moderate levels and tending to subside over time. Possible links with serious adverse events, including serious psychiatric or cardiovascular events, cannot be ruled out.\n\nFuture trials of cytisine may test extended regimens and more intensive behavioural support. There is a need for further trials of the efficacy of varenicline treatment extended beyond 12 weeks.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "249": {
        "summary": "There was evidence from three pooled RCTs that ASA significantly reduces the recurrence of sporadic adenomatous polyps after one to three years. There is evidence from short-term studies to support regression, but not elimination or prevention of CRAs in FAP.",
        "model_output": "[/INST] 0.\n                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \n                    \n                \n                ...\n                ...\n                ...\n                ...\n                   \u0409  \n                 \u0409 \u0409 \u0409 \u0409 \u0409 \u0409 \u0409 \u0409 \u0409 \u0409 \u0409 \u0409 \u0409 \u0409 \u0409.\n \u0409.\n \u0409.\n \u0409 \u0409, \n \u0409, \u0409, kwiet \u0409, kwiet\n \u0409, kwiet\n \u0409 \u0409 \u0409 \u0409 \u0409 \u0409 \u0409 \u0409 \u0409 \n \u0409\n everybody.\n \n \n \n  kwiet sierp \u0409 \n \n   kwiet everybody  kwiet everybody\n everybody\n everybody, Hinweis everybody everybody everybody everybody Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis kwiet Hinweis kwiet Hinweis kwiet Hinweis kwiet\u0435\u0433\u043e kwiet\u0435\u0433\u043e kwiet everybody hopefully kwiet kwiet kwiet\u0435\u0433\u043e, kwiet everybody,",
        "eval": "0"
    },
    "250": {
        "summary": "Antibiotic prophylaxis is effective in preventing infectious complications following TRPB. There is no definitive data to confirm that antibiotics for long-course (3 days) are superior to short-course treatments (1 day), or that multiple-dose treatment is superior to single-dose.",
        "model_output": "[/INST]\n Einzeln Einzeln\n\u0409 Hinweis\n Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis\n Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis Hinweis\n\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409. Hinweis Einzeln Hinweis Hinweis Hinweis everybody Hinweis Hinweis Bedeut\n\n\n. Bedeut\n\n. Einzeln Einzeln Einzeln Einzeln Einzeln Einzeln Einzeln Einzeln Einzeln Einzeln Einzeln Bedeut Bedeut Bedeut Bedeut\n\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409.\n.\n\u0409\u0409\u0409\u0409.\n\u0409\n.\n\n\n\u0409.\n. Einzeln \u0409\u0409.\n\u0409.\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409.\n\u0409\n\n\n\n. Einzeln\n\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409.\n.\u00b7\n\u0409.\n\u0409\n\u0409.\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409.\n.\n\n.\n\u0409\n\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409.\n\u0409\u0409\u0409.\n\n\n.\n. \u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409.\n.\n\n\n\n Bedeut everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody\n\n\n everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody everybody Einzeln\n\n\n\n\n\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409.\n\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    },
    "251": {
        "summary": "There is not enough evidence to recommend any intervention for preventing excessive weight gain during pregnancy, due to the significant methodological limitations of included studies and the small observed effect sizes. More high-quality randomised controlled trials with adequate sample sizes are required to evaluate the effectiveness of potential interventions.",
        "model_output": "[/INST]\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409\u0409",
        "eval": "0"
    }
}